<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">


<meta name="wpd_version" content="0.2">
<meta name="wpd_baseurl" content="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199709113371102">
<meta name="wpd_url" content="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199709113371102">
<meta name="wpd_date" content="2013-04-29T17:11Z">
<script src="auth013.js" type="text/javascript"></script>

<script src="g" async="" type="text/javascript"></script><script type="text/javascript" src="monetate.js"></script>






<title>Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy — NEJM</title>
<meta name="description" content="Original Article from The New England Journal of Medicine — Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy">

<meta name="pageType" content="Article">
<meta name="evt-pageType" content="Article">








   <meta property="og:title" content="Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy — NEJM">
   <meta property="og:description" content="Original Article from The New England Journal of Medicine — Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy">
   <meta property="og:type" content="article">
   <meta property="og:image" content="http://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1997/nejm_1997.337.issue-11/nejm199709113371102/production/images/small/nejm199709113371102_f3.gif">
   <meta name="twitter:card" content="summary">
   <meta name="twitter:site" content="@NEJM">



















	
	    <meta name="evt-doiPage" content="10.1056/NEJM199709113371102">
	
	
	
	    <meta name="evt-dt" content="1997-09-11">
	
	
	
	    <meta name="evt-ageContent" content="6Months-1990">
	
	
	
	    <meta name="evt-free" content="yes">
	

	
		
				<meta name="evt-artView" content="full">
				
			
	
			
	
		<link rel="canonical" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199709113371102">
		
	
















<meta name="sessionEvt-individual" content="">
<meta name="sessionEvt-idGUID" content="">
<meta name="sessionEvt-freeCntry" content="">
<meta name="sessionEvt-instId" content="1452137">
<meta name="sessionEvt-audSegment" content="">
<meta name="sessionEvt-prodCode" content="">
<meta name="sessionEvt-nejmSource" content="">
<meta name="sessionEvt-offers" content="N-institution-currentArticles">






	








<!-- Load CSS via Ad Placeholders -->
<!-- placeholder id=null, description=N-config-css-global -->
<!-- placeholder id=null, description=N-config-css-ads -->

<script type="text/javascript" src="jquery.js"></script>
<script type="text/javascript" src="siteEditor.js"></script>
<script type="text/javascript" src="jquery.cookie.js"></script>
<script type="text/javascript" src="jquery.bbq.js"></script>
<script type="text/javascript" src="mmsEventMappings.js"></script>
<script type="text/javascript" src="mmsEvents.js"></script>
<script type="text/javascript" src="script.js"></script>
<script type="text/javascript" src="mmsFilterBanks.js"></script>
<script type="text/javascript" src="mmsMenus.js"></script>
<script type="text/javascript" src="mmsClassData.js"></script>
<script type="text/javascript" src="mmsAds.js"></script>
<script type="text/javascript" src="mmsCarousels.js"></script>
<script type="text/javascript" src="mmsUtilities.js"></script>
<script type="text/javascript" src="mmsTabPanel.js"></script>
<script type="text/javascript" src="mmsViews.js"></script>
<script type="text/javascript" src="mmsBoxy.js"></script>
<script type="text/javascript" src="jquery.form.js"></script>
<script type="text/javascript" src="swfobject.js"></script>
<script type="text/javascript" src="jquery.dimensions.js"></script>
<script type="text/javascript" src="jquery.cluetip.js"></script>
<script type="text/javascript" src="jquery.highlight.js"></script>
<script type="text/javascript" src="jquery.jcarousel.js"></script>
<script type="text/javascript" src="jquery-ui-1.7.2.custom.min.js"></script>
<script type="text/javascript" src="mmsLayers.js"></script>
<script type="text/javascript" src="mmsAddThis.js"></script>

<!--[if IE]><script language="javascript" type="text/javascript" src="http://cdn.nejm.org.libgate.library.nuigalway.ie/5.2/js/lib/excanvas.min.js"></script><![endif]-->






<!--[if lte IE 6]><script type="text/javascript" src="http://cdn.nejm.org.libgate.library.nuigalway.ie/5.2/js/DD_belatedPNG.js"></script><![endif]-->
<script type="text/javascript" src="ntpagetag.js"></script><script src="unica_eluminate.js" type="text/javascript"></script>

<script type="text/javascript">var _sf_startpt=(new Date()).getTime()</script>

<!-- Load JS via Ad Placeholders -->
<!-- placeholder id=null, description=N-config-js-global-top -->

<script async="" src="270661079" type="text/javascript"></script><meta http-equiv="P3P" content="CP=&quot;NOI DSP ADM OUR IND OTC&quot;"><div id="_atssh" style="visibility: hidden; height: 1px; width: 1px; position: absolute; z-index: 100000;"><iframe src="NEJM199709113371102_1.html" style="height: 1px; width: 1px; position: absolute; z-index: 100000; border: 0px none; left: 0px; top: 0px;" title="AddThis utility frame" id="_atssh69"></iframe></div><script src="core079.js" type="text/javascript"></script>
<link rel="stylesheet" type="text/css" href="NEJM199709113371102.css" media="all">
</head>
<body class="article">

<div id="dic_bubble" class="selection_bubble fontSize13 noSelect" style="z-index: 9999; border: 1px solid rgb(74, 174, 222);"></div><noscript>

<img src="http://pt000185.unica.com/ntpagetag.gif?site=nejm&js=0" height="1" width="1" border="0" hspace="0" vspace="0" alt=" ">
</noscript>





<script type="text/javascript">

   
    var servicesURL="http://imc.nejm.org/ExamService/ExamService.asmx";
</script>


















<script type="text/javascript">

    var CM8Server = "web.checkm8.com";
    var CM8Cat = "mms.nej.articles";
    var CM8Profile = "pharma=no&articlecat=research";
</script>
<script type="text/javascript" language="JavaScript" src="cm8adam_1_ajax.js"></script>



<!--[if lte IE 6]><div class="ie6and7" id="ie6"><![endif]-->
<!--[if IE 7]><div class="ie6and7" id="ie7"><![endif]-->
<!--[if IE 8]><div id="ie8"><![endif]-->















<div id="topAdBar">
<div class="bannerAd">
<div class="inner">














<div id="CM8ShowAd1369847410833" title="Topbanner" class="Topbanner CM8">
<noscript><a href="http://web.checkm8.com/adam/ep/click/mms.nej.articles/Topbanner"><img src="http://web.checkm8.com/adam/noscript?cat=mms.nej.articles&amp;page=1369847410833&amp;format=Topbanner" border="0" alt="Advertisement" /></a></noscript>

</div></div>
</div>
</div>






<div style="margin-top: 30px;" align="center">
    <!-- placeholder id=null, description=N-ad-global-top --><div style="background: none repeat ; 0% rgb(255, 255, 255); padding: 0px; width: 970px; height: 20px; margin: 0px auto 10px;" align="left"><p style="font: 11px/15px arial,sans-serif; color: rgb(51, 51, 51);">Learn how NEJM.org uses cookies at the <a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3528&amp;url=%2Fpage%2Fabout-nejm%2Fcookie-information&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Cookie Information</a> page.</p></div>
</div>











<script type="text/javascript">

    $(document).ready(function() {
        $("#lnkSignOut").click(function(){
            $.cookie("redirectUri",null, {path: '/', domain: '.nejm.org'});
        });
    })
</script>

<div id="authInfo">

    <!-- placeholder id=null, description=N-ad-global-top-left -->
        <!-- topLeftAniv -->
            <div class="topLeftAniv">
             
            </div>
        <!-- /topLeftAniv -->
    

    <ul>
        
        
                
                        <li class="status firstChild">Welcome</li>
                    
            

        
        <!-- placeholder id=null, description=N-ad-authstring -->
            <li class="authOptions">
            <span class="renewSubscribe"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=4972&amp;url=%2Faction%2FcdfProxy%3Faction%3Drenew%26promo%3DONFLRNA2&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" class="renew">Renew</a>, <a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=4972&amp;url=%2Faction%2FcdfProxy%3Faction%3Dsubscribe%26promo%3DONFQN1A2&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" class="subscribe">Subscribe</a> or <a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=4972&amp;url=%2Faction%2FcdfProxy%3Faction%3Dregister%26promo%3DONFLNAR3&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" class="createAccount">Create Account</a></span>
            </li>
        

        
        
                <li class="signin lastChild">
                    
                            <a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showLogin?uri=http%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102" class="viewType-Layer viewClass-WideLayer signin-header">

                                
                                        
                                    
                                Sign In
                            </a>
                        
                </li>
            

    </ul>
</div>






<div id="header" class="withAd">
	<h1><a href="http://www.nejm.org.libgate.library.nuigalway.ie/">The New England Journal of Medicine</a></h1>
    
        <!-- placeholder id=null, description=N-ad-header-1 -->
            <div class="ad"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3944&amp;url=%2Faction%2FcdfProxy%3Faction%3Dsubscribe%26url%3Dhttp%253A%252F%252Fwww.nejm.org%252Fdoi%252Ffull%252F10.1056%252FNEJM199709113371102%26promo%3DONFQRN03&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252"><img src="DefaultSubscribe_SubscribeOrRenew_Cover_280x83.jpg">
</a></div>
        
    
</div>






	

<div style="position: relative;" id="topNav">
<ul>
<li class="firstChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/">Home</a></li>
<li class="menu dropDownTrigger-articles"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-article-index">Articles &amp; Multimedia</a></li>
<li class="menu dropDownTrigger-issueArchive"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-index">Issues</a></li>
<li class="menu dropDownTrigger-topics"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-specialties">Specialties &amp; Topics</a></li>
<li class="menu authors dropDownTrigger-authors"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/cdfProxy?action=authorCenter">For Authors</a></li>
<li class="menu cmeButton lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/continuing-medical-education">CME</a></li>
</ul>
    <form action="http://www.nejm.org.libgate.library.nuigalway.ie/search?pageType=search" class="search" method="get"><fieldset>
    <div style="position: absolute; left: 654px; top: 23px; width: 225px; visibility: hidden; z-index: 99999999;" class="autocomplete"></div><input id="sli_search_1" class="text" name="q" value="Keyword, Title, Author, or Citation" size="15" maxlength="450" autocomplete="off" type="text">	
	<input class="searchSubmit" value="Search" src="search_icon.gif" type="image">
    <input disabled="" name="asug" value="" type="hidden">
    <a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-search" class="more advSearch">Advanced<br>Search</a>
    </fieldset></form>
</div>

<div id="main">

    <div id="content">

    
    




    <a name="articleTop" rel="10.1056/NEJM199709113371102"></a><p class="articleType">Original Article</p><h1>Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy</h1><p class="authors">Roy M. Gulick, M.D., M.P.H., John W. Mellors, M.D., Diane Havlir, M.D., Joseph J. Eron, M.D., Charles Gonzalez, M.D., Deborah McMahon, M.D., Douglas D. Richman, M.D., Fred T. Valentine, M.D., Leslie Jonas, B.S., Anne Meibohm, Ph.D., Emilio A. Emini, Ph.D., Jeffrey A. Chodakewitz, M.D., Paul Deutsch, M.D., Ph.D., Daniel Holder, Ph.D., William A. Schleif, M.S., and Jon H. Condra, Ph.D.</p><p class="citationLine"><span class="citation">N Engl J Med 1997;  337:734-739</span><a href="http://www.nejm.org.libgate.library.nuigalway.ie/toc/nejm/337/11/">September 11, 1997</a><span class="doi">DOI:  10.1056/NEJM199709113371102</span></p><!--DiscussionPollOpenDateReplacer--><!-- share -->
<div class="share addthis_toolbox no-pad-bot" addthis:url="http://www.nejm.org/doi/full/10.1056/NEJM199709113371102">
    <div class="cols">
        <div class="col"><span class="label">Share:</span></div>
        <div class="col">
            <a href="#" title="Facebook" class="addthis_button_facebook at300b"><span class="icon add facebook"></span></a>
        </div>
        <div class="col">
            <a href="#" title="Tweet" class="addthis_button_twitter at300b"><span class="icon add twitter"></span></a>
        </div>
        <div class="col">
            <a title="Google+" target="_top" href="http://www.addthis.com/bookmark.php?v=300&amp;winname=addthis&amp;pub=ra-4ddfaaf00b1e6fbf&amp;source=tbx-300&amp;lng=en-US&amp;s=google_plusone_share&amp;url=http%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;title=Treatment%20with%20Indinavir%2C%20Zidovudine%2C%20and%20Lamivudine%20in%20Adults%20with%20Human%20Immunodeficiency%20Virus%20Infection%20and%20Prior%20Antiretroviral%20Therapy%20%E2%80%94%20NEJM&amp;ate=AT-ra-4ddfaaf00b1e6fbf/-/-/51a636972d3c34e5/2&amp;frommenu=1&amp;uid=51a63697b39c9c00&amp;ct=1&amp;ui_cobrand=NEJM.org&amp;pre=http%3A%2F%2Fvmserver39.nuigalway.ie%2Fpds%3Ffunc%3Dload-login%26calling_system%3Dezp_pds%26institute%3DGAL%26url%3Dhttp%253A%252F%252Fek%252Elibrary%252Enuigalway%252Eie%252Fcgi-bin%252Fezp%255Fpds%252Ecgi%253Finstitute%253DGAL%2526url%253Dhttp%25253A%25252F%25252Fwww%25252Enejm%25252Eorg%25252Fdoi%25252Ffull%25252F10%25252E1056%25252FNEJM199709113371102&amp;tt=0&amp;captcha_provider=nucaptcha" class="addthis_button_google_plusone_share at300b"><span class="icon add google"></span></a>
        </div>
        <div class="col">
            <a title="Linkedin" target="_top" href="http://www.addthis.com/bookmark.php?v=300&amp;winname=addthis&amp;pub=ra-4ddfaaf00b1e6fbf&amp;source=tbx-300&amp;lng=en-US&amp;s=linkedin&amp;url=http%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;title=Treatment%20with%20Indinavir%2C%20Zidovudine%2C%20and%20Lamivudine%20in%20Adults%20with%20Human%20Immunodeficiency%20Virus%20Infection%20and%20Prior%20Antiretroviral%20Therapy%20%E2%80%94%20NEJM&amp;ate=AT-ra-4ddfaaf00b1e6fbf/-/-/51a636972d3c34e5/3&amp;frommenu=1&amp;uid=51a636972f76f1e2&amp;shortener=bitly&amp;bitly.login=nejm&amp;bitly.apiKey=R_644f2c9aae1c9bcb164b6f24392c94f4&amp;ct=1&amp;ui_cobrand=NEJM.org&amp;pre=http%3A%2F%2Fvmserver39.nuigalway.ie%2Fpds%3Ffunc%3Dload-login%26calling_system%3Dezp_pds%26institute%3DGAL%26url%3Dhttp%253A%252F%252Fek%252Elibrary%252Enuigalway%252Eie%252Fcgi-bin%252Fezp%255Fpds%252Ecgi%253Finstitute%253DGAL%2526url%253Dhttp%25253A%25252F%25252Fwww%25252Enejm%25252Eorg%25252Fdoi%25252Ffull%25252F10%25252E1056%25252FNEJM199709113371102&amp;tt=0&amp;captcha_provider=nucaptcha" class="addthis_button_linkedin at300b"><span class="icon add linkedin"></span></a>
        </div>
        <div class="col">
            <a class="addthis_button"><span class="icon add addmore"></span></a>
        </div>
    </div>
<div class="atclear"></div></div>
<!-- /share --><dl class="articleTabs tabPanel lastChild"><dt class="active abstract firstChild sideBySide" id="abstractTab">Abstract</dt><dt class="article sideBySide inactive" id="articleTab">Article</dt><dt class="references sideBySide inactive" id="referencesTab">References</dt><dt class="citedby sideBySide inactive" id="citedbyTab">Citing Articles <span>(808) </span></dt><!--DiscussionReplacer_Tab_--><dd style="display: block;" id="abstract"><div class="left section"><div class="section"> </div><div class="section"> <h3 id="abstractBackground">Background</h3> <p>The new protease inhibitors are potent inhibitors of the human immunodeficiency virus (HIV), and in combination with other antiretroviral drugs they may be able to cause profound and sustained suppression of HIV replication.</p> <p class="fullTextLink"><a rel="gotofulltext" href="#Background" id="Background">Full Text of Background...</a></p></div><div class="section"> </div><div class="section"> <h3 id="abstractMethods">Methods</h3> <p>In this double-blind study, 97 HIV-infected patients who had received zidovudine treatment for at least 6 months and had 50 to 400 CD4 cells per cubic millimeter and at least 20,000 copies of HIV RNA per milliliter were randomly assigned to one of three treatments for up to 52 weeks: 800 mg of indinavir every eight hours; 200 mg of zidovudine every eight hours combined with 150 mg of lamivudine twice daily; or all three drugs. The patients were followed to monitor the occurrence of adverse events and changes in viral load and CD4 cell counts.</p> <p class="fullTextLink"><a rel="gotofulltext" href="#Methods" id="Methods">Full Text of Methods...</a></p></div><div class="section"> </div><div class="section"> <h3 id="abstractResults">Results</h3> <p>The decrease in HIV RNA over the first 24 weeks was greater in the three-drug group than in the other groups (P&lt;0.001 for each comparison). RNA levels decreased to less than 500 copies per milliliter at week 24 in 28 of 31 patients in the three-drug group (90 percent), 12 of 28 patients in the indinavir group (43 percent), and none of 30 patients in the zidovudine–lamivudine group. The increase in CD4 cell counts over the first 24 weeks was greater in the two groups receiving indinavir than in the zidovudine–lamivudine group (P&lt;0.01 for each comparison). The changes in the viral load and the CD4 cell count persisted for up to 52 weeks. All the regimens were generally well tolerated.</p> <p class="fullTextLink"><a rel="gotofulltext" href="#Results" id="Results">Full Text of Results...</a></p></div><div class="section"> </div><div class="section"> <h3 id="abstractConclusions">Conclusions</h3> <p>In most HIV-infected patients with prior antiretroviral therapy, the combination of indinavir, zidovudine, and lamivudine reduces levels of HIV RNA to less than 500 copies per milliliter for as long as one year. </p> <p class="fullTextLink"><a rel="gotofulltext" href="#Discussion" id="Conclusions">Full Text of Discussion...</a></p></div><div class="section"> </div><p class="fullTextLink"><a rel="gotofulltext" href="#Top">Read the Full Article...</a></p></div><div class="right section"><div class="articleMedia"><h3 class="title">Media in This Article</h3><div class="mediaRefs"><div class="mediaRef"><span class="fig"><span class="figureTitle">Figure 3</span><a class="figureLink viewType-Layer viewClass-ImageViewerLayer event-articleThumb" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371102&amp;iid=f03"><img src="nejm199709113371102_f3.gif" alt=""></a><span class="figureCaption">Changes from Base Line in the CD4 Cell Count during the 52 Weeks of the Study.</span></span></div><div class="mediaRef"><span class="fig"><span class="figureTitle">Figure 2</span><a class="figureLink viewType-Layer viewClass-ImageViewerLayer event-articleThumb" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371102&amp;iid=f02"><img src="nejm199709113371102_f2.gif" alt=""></a><span class="figureCaption">Proportion of Patients with Serum HIV RNA Levels of Less Than 500 Copies per Milliliter (Upper Panel) and Less Than 50 Copies per Milliliter (Lower Panel).</span></span></div></div></div><div class="articleActivity"><h3 class="title">Article Activity</h3><p><a href="#citedby" class="articleActivity-citedby more">808 articles have cited this article</a></p></div></div></dd><dd style="display: none;" id="article"><div class="section"> <p>Combination therapy with two nucleoside analogues is better than monotherapy in reducing levels of human immunodeficiency virus (HIV) RNA, increasing CD4 cell counts, and preventing the acquired immunodeficiency syndrome (AIDS) and death.<span class="ref"><a href="#ref1" class="showRefLayer" rel="#refLayer">1-5</a></span> The HIV-protease inhibitors are a newer class of agents with potent antiretroviral activity.<span class="ref"><a href="#ref6" class="showRefLayer" rel="#refLayer">6-9</a></span> Early dose-escalation studies showed that monotherapy with indinavir or ritonavir affected HIV RNA levels and CD4 cell counts markedly.<span class="ref"><a href="#ref10" class="showRefLayer" rel="#refLayer">10-12</a></span> These antiretroviral effects were transient in some patients at lower drug doses and were associated with the emergence of drug-resistant virus.<span class="ref"><a href="#ref13" class="showRefLayer" rel="#refLayer">13-15</a></span> A recent study showed that a combination of zidovudine, zalcitabine, and saquinavir had more antiretroviral activity than zidovudine combined with either zalcitabine or saquinavir, although the treatment effects were relatively small and transient.<span class="ref"><a href="#ref16" class="showRefLayer" rel="#refLayer">16</a></span> </p> <p>Because of the potent antiretroviral activity of indinavir<span class="ref"><a href="#ref8" class="showRefLayer" rel="#refLayer">8,12</a></span> and the sustained antiretroviral effects of the combination of zidovudine and lamivudine,<span class="ref"><a href="#ref1" class="showRefLayer" rel="#refLayer">1,2</a></span> we decided to study regimens designed for maximal suppression of HIV replication. We compared the safety and antiretroviral activity of three treatments — indinavir alone, zidovudine and lamivudine in combination, and all three drugs together — in a group of HIV-infected patients with substantial prior antiretroviral therapy.</p> </div><div class="section"> <h3 id="articleMethods">Methods</h3> <div class="subSection"> <h3 id="articleStudy Patients">Study Patients</h3> <p>Adults who were seropositive for HIV type 1 and who had at least six months of prior zidovudine therapy were screened for enrollment at four sites. They were eligible for the study if they had a serum HIV RNA level of at least 20,000 copies per milliliter (Amplicor HIV Monitor test, Roche Diagnostics Systems, Branchburg, N.J.) at the time of screening and 50 to 400 CD4 cells per cubic millimeter when the values obtained in two determinations at least one week apart were averaged. Additional criteria for enrollment included a hemoglobin level exceeding 9.0 g per deciliter (in men) or 8.5 g per deciliter (in women), a neutrophil count greater than 1000 per cubic millimeter, a platelet count of at least 100,000 per cubic millimeter, a serum creatinine level less than 1.5 times the upper limit of normal, a total bilirubin level in the normal range, and levels of hepatic aminotransferases and alkaline phosphatase less than 2 times the upper limit of normal.</p> <p>Patients were excluded if they had received lamivudine or any HIV-protease inhibitor, if they required maintenance therapy for an opportunistic infection, or if they had received investigational or immunomodulatory drugs within 30 days before entry into the study. Also excluded were pregnant or breast-feeding women, as were patients with active substance abuse, hepatitis B surface antigenemia, substantial elevations of hepatic aminotransferases in the prior year, or intolerance to zidovudine. Patients were permitted to take prophylaxis for <em>Pneumocystis carinii</em> pneumonia.</p> </div> <div class="subSection"> <h3 id="articleStudy Design">Study Design</h3> <p>This was a randomized, double-blind, controlled study of the safety and activity of three antiretroviral regimens. Randomization followed a permuted-block design stratified according to site and CD4 cell count (either 50 to 250 or 251 to 400 cells per cubic millimeter). The planned duration of the double-blind study was 52 weeks, but because there were preliminary findings of antiretroviral activity, the study design was amended to provide open-label therapy with all three drugs after a minimum of 24 weeks of blinded, randomized therapy. This change resulted in periods of blinded, randomized treatment of varying lengths, from 24 weeks to 52 weeks. Only data corresponding to the blinded portion of the study are presented here. All the patients continued to be monitored while they were receiving open-label therapy. The study was approved by the internal review boards at each site, and all the patients gave written informed consent.</p> </div> <div class="subSection"> <h3 id="articleTreatment Regimens">Treatment Regimens</h3> <p>Eligible patients discontinued their antiretroviral therapy two weeks before entry and were then randomly assigned one of three regimens given orally: 800 mg of indinavir (Crixivan, Merck, West Point, Pa.) every 8 hours; 200 mg of zidovudine (Retrovir, Glaxo–Wellcome, Research Triangle Park, N.C.) every 8 hours combined with 150 mg of lamivudine (Epivir, Glaxo–Wellcome) every 12 hours; or all three drugs at the same doses. The regimens included appropriate matching placebos.</p> </div> <div class="subSection"> <h3 id="articleAssessments">Assessments</h3> <p>The patients were assessed weekly for four weeks, every two weeks through week 16, and every four weeks through week 52. At base line and each study visit, the medical history was reviewed, a physical examination was performed, and standardized laboratory tests were conducted. A pregnancy test of serum was performed in eligible women before the study and every four weeks thereafter. Blood samples were collected from a subgroup of patients on day 8 to determine plasma drug concentrations. Patients who discontinued the study were reevaluated two weeks after their last dose of the study drugs. Adverse events were managed by investigators unaware of the treatment assignments, using predetermined guidelines.</p> </div> <div class="subSection"> <h3 id="articleVirologic and Immunologic Studies">Virologic and Immunologic Studies</h3> <p>Samples were obtained at screening, at base line, and at each study visit. Serum was processed, stored at -70°C, and assayed later for HIV RNA by a quantitative reverse-transcriptase–polymerase-chain-reaction (PCR) assay (Amplicor test). The lower limit of quantification was 500 RNA copies per milliliter. The assay results were reported as values when there were 500 or more copies per milliliter or as “less than 500 copies per milliliter,” or as “negative” if no amplification signal was detected. An investigational version of an ultrasensitive PCR assay was performed on samples in which the standard assay detected a level of less than 500 copies per milliliter. This assay had a consistent cutoff of detection of approximately 50 RNA copies per milliliter. In the analyses of resistance, viral RNA was extracted from serum, amplified by PCR, and cloned and sequenced by a previously described method.<span class="ref"><a href="#ref13" class="showRefLayer" rel="#refLayer">13,14</a></span> T-lymphocyte subgroups were quantified by flow cytometry.</p> </div> <div class="subSection"> <h3 id="articleStatistical Analysis">Statistical Analysis</h3> <p>The primary measures of antiretroviral-drug activity were the magnitude and duration of changes in serum HIV RNA and CD4 cell counts over a period of 24 weeks, as summarized by an area-under-the-curve measurement that incorporated the base-line value.<span class="ref"><a href="#ref17" class="showRefLayer" rel="#refLayer">17,18</a></span> All the patients with determinations made at base line and at least once subsequently were included in the analyses. For the purpose of analysis, RNA values reported as “less than 500 copies per milliliter” were considered equivalent to 500 copies per milliliter, and values reported as “negative” were considered equivalent to 250 copies per milliliter. The HIV RNA values underwent a log<sub>10</sub> transformation before analysis. The area under the curve was compared among the treatment groups with an analysis-of-variance model that included the study treatment and a variable defined according to site and CD4 stratum. In calculating the proportion of patients who had HIV RNA levels of less than 50 copies per milliliter by the ultrasensitive investigational assay, we assumed that patients who had at least 500 RNA copies per milliliter by the standard assay had at least 50 copies per milliliter. For each pair of treatments, Fisher's exact test was used to compare the groups with respect to the proportion of patients with clinical nephrolithiasis, severe drug-related adverse events, and clinically significant laboratory abnormalities. A clinically significant laboratory abnormality was considered to be present if a value exceeded the predefined criteria or an abnormality present at base line became worse. The analyses were performed on an intention-to-treat basis. Nominal unadjusted two-sided P values were reported.</p> </div> </div><div class="section"> </div><div class="section"> <h3 id="articleResults">Results</h3> <div class="subSection"> <h3 id="articleStudy Patients">Study Patients</h3> <p>Ninety-seven patients were enrolled in the study from April to December 1995. Initially, 27 patients were enrolled for a four-week analysis of safety; when no serious adverse events occurred, the remaining 70 patients were enrolled. The base-line characteristics of the patients were similar in the three treatment groups (<a class="viewType-Layer viewClass-ImageViewerLayer" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371102&amp;iid=t01">Table 1</a><span class="table"><span class="figureTitle">Table 1</span><a class="figureLink viewType-Layer viewClass-ImageViewerLayer event-articleThumb" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371102&amp;iid=t01"><img src="nejm199709113371102_t1.gif" alt=""></a><span class="figureCaption">Base-Line Characteristics of the Study Patients.</span></span>).</p> <p>Of the 97 patients, 92 were studied on a randomized, blinded basis for 24 weeks, 79 for 36 weeks, and 16 for 52 weeks. The patients switched to open-label three-drug therapy after a median of 41 weeks (range, 24 to 52). Seven patients discontinued the study after 4 to 44 weeks, for various reasons: an adverse event (one patient), loss to follow-up (one), the use of medications prohibited by the protocol (two), and the patient's request (three). There were no significant differences among the treatment groups in the rates of discontinuation (P&gt;0.35 for each pairwise comparison).</p> </div> <div class="subSection"> <h3 id="articlePharmacokinetic Analysis">Pharmacokinetic Analysis</h3> <p>Plasma concentrations of the study drug were measured in the first 27 patients enrolled in the study. There were no clinically significant pharmacokinetic interactions among the study medications.</p> </div> <div class="subSection"> <h3 id="articleHIV RNA">HIV RNA</h3> <p>Over a 24-week period, serum HIV RNA levels declined in all three groups, with adjusted mean (±SE) decreases (in the area-under-the-curve analysis) of 1.77±0.11 log<sub>10</sub> in the three-drug group, 1.24±0.11 log<sub>10</sub> in the indinavir group, and 0.83±0.11 log<sub>10</sub> in the zidovudine–lamivudine group (<a class="viewType-Layer viewClass-ImageViewerLayer" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371102&amp;iid=f01">Figure 1</a><span class="fig"><span class="figureTitle">Figure 1</span><a class="figureLink viewType-Layer viewClass-ImageViewerLayer event-articleThumb" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371102&amp;iid=f01"><img src="nejm199709113371102_f1.gif" alt=""></a><span class="figureCaption">Changes from Base Line in Serum HIV RNA Levels during the 52 Weeks of the Study.</span></span>). The decrease was significantly greater in the three-drug group than in the other two groups (P&lt;0.001 for each pairwise comparison). In addition, the decrease in the indinavir group was significantly greater (P = 0.005) than that in the zidovudine–lamivudine group. In the three-drug group there was a median reduction of more than 2 log<sub>10</sub> in the HIV RNA level that lasted from week 8 to week 52. In contrast, after initial decreases, the RNA levels increased in both the indinavir and zidovudine–lamivudine groups.</p> <p> <a class="viewType-Layer viewClass-ImageViewerLayer" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371102&amp;iid=f02">Figure 2A</a><span class="fig"><span class="figureTitle">Figure 2</span><a class="figureLink viewType-Layer viewClass-ImageViewerLayer event-articleThumb" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371102&amp;iid=f02"><img src="nejm199709113371102_f2.gif" alt=""></a><span class="figureCaption">Proportion of Patients with Serum HIV RNA Levels of Less Than 500 Copies per Milliliter (Upper Panel) and Less Than 50 Copies per Milliliter (Lower Panel).</span></span> shows the proportion of patients in each group who had decreases in HIV RNA levels to less than 500 copies per milliliter. At week 24, 90 percent of the patients in the three-drug group (28 of 31) had levels of less than 500 RNA copies per milliliter, as compared with 43 percent of the indinavir group (12 of 28 patients) and none of 30 patients in the zidovudine–lamivudine group. These proportions were sustained for up to 52 weeks. <a class="viewType-Layer viewClass-ImageViewerLayer" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371102&amp;iid=f02">Figure 2B</a> shows the proportion of patients in each group whose levels decreased to less than 50 copies per milliliter.</p> </div> <div class="subSection"> <h3 id="articleGenotypic Analysis">Genotypic Analysis</h3> <p>There was no evidence of resistance to lamivudine<span class="ref"><a href="#ref19" class="showRefLayer" rel="#refLayer">19-21</a></span> at base line. After 24 weeks of therapy, 84 percent of the zidovudine–lamivudine group (26 of 31) had such resistance, and 53 percent (10 of 19) of patients with amplifiable RNA in the indinavir group had mutations conferring resistance to indinavir.<span class="ref"><a href="#ref14" class="showRefLayer" rel="#refLayer">14</a></span> At the same time, 26 of 31 serum samples from patients in the three-drug group could not be amplified because of low HIV RNA levels. Of the five patients in that group who had more than 500 RNA copies per milliliter by week 32, all had virus with resistance to lamivudine, and three acquired indinavir-resistance mutations.</p> </div> <div class="subSection"> <h3 id="articleCD4 Cell Counts">CD4 Cell Counts</h3> <p>CD4 cell counts increased during the first 24 weeks of treatment in all the groups, with adjusted mean (±SE) increases (in the area-under-the-curve analysis) of 86.0±11.9 cells per cubic millimeter in the three-drug group, 100.6±12.5 in the indinavir group, and 46.3±12.1 in the zidovudine–lamivudine group (<a class="viewType-Layer viewClass-ImageViewerLayer" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371102&amp;iid=f03">Figure 3</a><span class="fig"><span class="figureTitle">Figure 3</span><a class="figureLink viewType-Layer viewClass-ImageViewerLayer event-articleThumb" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371102&amp;iid=f03"><img src="nejm199709113371102_f3.gif" alt=""></a><span class="figureCaption">Changes from Base Line in the CD4 Cell Count during the 52 Weeks of the Study.</span></span>). The increase was significantly greater in the groups assigned to the two regimens containing indinavir than in the zidovudine–lamivudine group (P&lt;0.01 for each comparison). There was no significant difference between the three-drug group and the indinavir group over the first 24 weeks (P = 0.36). The CD4 cell count in each group remained at approximately the same level from week 24 to week 52.</p> </div> <div class="subSection"> <h3 id="articleAdverse Events">Adverse Events</h3> <p>The study treatments were generally well tolerated for up to 52 weeks (<a class="viewType-Layer viewClass-ImageViewerLayer" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371102&amp;iid=t02">Table 2</a><span class="table"><span class="figureTitle">Table 2</span><a class="figureLink viewType-Layer viewClass-ImageViewerLayer event-articleThumb" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371102&amp;iid=t02"><img src="nejm199709113371102_t2.gif" alt=""></a><span class="figureCaption">Adverse Events According to Treatment Group.</span></span>). One patient withdrew from the study because of an adverse event (nausea). Elevated bilirubin levels and clinical nephrolithiasis, defined as pain in the flank with or without hematuria or the passage of a stone or gravel in the urine, occurred more often in the patients receiving indinavir. There were no other significant differences among the groups in the occurrence of severe, drug-related clinical events or clinically important laboratory abnormalities. One new AIDS-defining illness (presumptive candida esophagitis) occurred in a patient randomly assigned to zidovudine and lamivudine. There were no deaths among the study patients.</p> </div> </div><div class="section"> </div><div class="section"> <h3 id="articleDiscussion">Discussion</h3> <p>The three-drug combination of indinavir, zidovudine, and lamivudine reduced the viral load in serum to less than 500 copies per milliliter for up to one year in more than 80 percent of the HIV-infected patients we studied, all of whom had prior antiretroviral therapy. Most patients in the three-drug group whose HIV RNA levels were reduced to less than 500 copies per milliliter also had less than 50 RNA copies per milliliter when the ultrasensitive investigational assay was used. The sustained response in HIV RNA levels with the three-drug therapy was superior to that with either indinavir monotherapy or the combination of zidovudine and lamivudine. No prior antiretroviral regimen has produced the marked, sustained decreases in viral load achieved with this three-drug combination.</p> <p>The continued suppression of HIV RNA levels for one year without evidence of the emergence of resistant virus suggests that there was little, if any, continuing HIV replication in the patients receiving three-drug therapy. At 24 weeks, high levels of resistance to lamivudine had developed in most of the patients receiving zidovudine and lamivudine,<span class="ref"><a href="#ref19" class="showRefLayer" rel="#refLayer">19-21</a></span> and over half the patients with amplifiable HIV RNA who were receiving indinavir alone had resistance to indinavir.<span class="ref"><a href="#ref14" class="showRefLayer" rel="#refLayer">14</a></span> In contrast, most patients treated with the three-drug combination provided serum samples from which HIV RNA could not be amplified, implying that the virus continued to be susceptible. The durable antiretroviral activity of the three-drug regimen appears to result directly from the inability of resistant virus to emerge.</p> <p>If there is to be long-term control of HIV infection, the goal of antiretroviral therapy should be the sustained, complete suppression of HIV replication and the prevention of resistance to the antiretroviral drugs. Without complete viral suppression, antiretroviral regimens will probably select for drug-resistant mutants, leading to the failure of therapy. The patients we studied had taken neither lamivudine nor any protease inhibitor before entering the study. When lamivudine and indinavir were introduced concurrently as part of the three-drug regimen, they had potent antiretroviral activity, thus preventing the development of resistance to lamivudine, which is typically seen within weeks after the start of lamivudine treatment, either alone or with zidovudine.<span class="ref"><a href="#ref22" class="showRefLayer" rel="#refLayer">22,23</a></span> Patients previously treated with lamivudine or a protease inhibitor may not have similar sustained benefits with this three-drug regimen.</p> <p>The reasons for the rebound of serum HIV RNA levels in a few patients taking the three drugs are not clear. Among the five patients in the three-drug group who had more than 500 HIV RNA copies per milliliter by week 32, all had resistance to lamivudine and three had resistance to indinavir. One of these five patients discontinued therapy prematurely, and three others reported intermittent adherence to the study regimen. In the fifth patient, the HIV RNA level declined markedly but then increased, with the concomitant development of resistance to both lamivudine and indinavir. The rebound in HIV RNA levels did not appear to be associated with base-line resistance to zidovudine, base-line polymorphisms of viral-protease residues, or the level of HIV RNA at entry.</p> <p>This study was designed to compare the treatment groups with respect to viral load and CD4 cell responses, not clinical end points. Recent evidence from natural-history studies and clinical trials links viral load and clinical outcome.<span class="ref"><a href="#ref1" class="showRefLayer" rel="#refLayer">1,2,4,5,24-29</a></span> These studies suggest that the sustained reductions of HIV RNA we observed will probably translate into delayed progression to AIDS and prolonged survival.</p> <p>The dissociation between the marked decreases in viral load and the incomplete restoration of CD4 cell counts in the three-drug group remains unexplained. Some patients may have ongoing, slower increases in CD4 cell counts after six months of therapy. In patients with autoimmune disease or cancer who receive intensive radiation therapy or chemotherapy, CD4 cell counts recover slowly and may take three years or more to reach normal levels.<span class="ref"><a href="#ref30" class="showRefLayer" rel="#refLayer">30,31</a></span> Further study is needed to determine what level of restoration of CD4 cell number and function can ultimately be attained with the three-drug regimen. It remains to be seen whether the immune system can be fully reconstituted even when regimens that achieve maximal HIV suppression are used.</p> <p>All the study treatments were generally well tolerated, with only a single patient discontinuing the blinded portion of the study because of an adverse event. As expected, the use of indinavir was associated with episodes of clinical nephrolithiasis and asymptomatic increases in indirect bilirubin. The proportion of patients who met our definition of nephrolithiasis was higher in this study than has previously been observed.<span class="ref"><a href="#ref32" class="showRefLayer" rel="#refLayer">32</a></span> To facilitate long-term compliance with drug regimens, it is essential that the antiretroviral drugs be well tolerated.</p> <p>In summary, the antiretroviral-drug combination of indinavir, zidovudine, and lamivudine reduced HIV RNA levels to less than 500 copies per milliliter in most HIV-infected patients previously treated with zidovudine for as long as one year. This suggests that profound suppression of HIV replication inhibits the emergence of drug-resistant virus and that such inhibition should be an important goal in the long-term treatment of HIV infection. A regimen that falls short of maximal viral suppression will probably be accompanied by the emergence of drug resistance and by ultimate clinical failure. The results of this study support a new standard for the evaluation of antiretroviral therapies and suggest a new paradigm for the treatment of HIV disease.</p> </div><div class="section"> </div><div class="section section-hr"></div><div class="section section-back"> <p>Presented in part at the Third Conference on Retroviruses and Opportunistic Infections, Washington, D.C., January 28–February 1, 1996; and the 11th International Conference on AIDS, Vancouver, Canada, July 7–12, 1996.</p>  <p>Supported by contracts (P30-AI-27742, U01-AI-27665, N01-AI-27670, N01-AI-38858, N01-AI-36214, N01-AI-29164, M01-RR00056, M01-RR00096, M01-RR00046) with the National Institutes of Health and by grants from Merck Research Laboratories.</p> <p>We are indebted to the patients who volunteered for the study; to our study coordinators, Candida Talabucon, R.N., Richard Hutt, R.N., Nancy Mantz, B.S.N., Carl Garrubba, P.A., Kathy Nuffer, R.N., and Janet Kozel, P.A.; to Charles Lin for performing pharmacokinetic assays; to Andrew Sterrett for statistical support; to Malathi Shivaprakash, M.S., Donald Graham, M.S., Robert Danovich, Ph.D., Tao Yang, M.S., and Donna Laird, B.S., for technical virologic support; to Olivia Ortiz, M.D.; and to James Rooney, M.D., Glaxo–Wellcome, for providing zidovudine and lamivudine.</p></div><div class="section section-back"><div class="sourceInfo"><h3>Source Information</h3><p>From the New York University School of Medicine, New York (R.M.G., C.G., F.T.V.); the University of Pittsburgh and Veterans Affairs Medical Center, Pittsburgh (J.W.M., D.M.); the University of California, San Diego (D.H., D.D.R.); the University of North Carolina, Chapel Hill (J.J.E.); and Merck Research Laboratories, West Point, Pa. (L.J., A.M., E.A.E., J.A.C.).</p><p>Address reprint requests to Dr. Gulick at NYU Medical Center, Department of Medicine, 550 First Ave., New York, NY 10016.</p> <p>Other authors were Paul Deutsch, M.D., Ph.D., Daniel Holder, Ph.D., William A. Schleif, M.S., and Jon H. Condra, Ph.D. (all from Merck Research Laboratories, West Point, Pa.).</p> </div></div><div class="section section-back lastChild"></div></dd><dd style="display: none;" id="references"><div class="section"><h3>References</h3><ol class="striped"><a name="ref1"></a><li class="odd" id="refItem1"><p class="number">1</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Eron JJ</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Benoit SL</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Jemsek J</contrib>, et al. Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. <span class="NLM_source">N Engl J Med</span> 1995;333:1662-1669<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r001&amp;dbid=20&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1056%2FNEJM199512213332502" onclick="newWindow(this.href);return false">Free Full Text</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r001&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1995TL40100002" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r001&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=7477218" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref2"></a><li class="even" id="refItem2"><p class="number">2</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Bartlett JA</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Benoit SL</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Johnson VA</contrib>, et al. Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection: a randomized, double-blind, placebo-controlled trial. <span class="NLM_source">Ann Intern Med</span> 1996;125:161-172<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r002&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1996UZ28700001" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r002&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=8686973" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref3"></a><li class="odd" id="refItem3"><p class="number">3</p><p class="content"><contrib-group xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><contrib contrib-type="author">The Delta Coordinating Committee</contrib></contrib-group>. Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. <span class="NLM_source">Lancet</span> 1996;348:283-291<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r003&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1016%2FS0140-6736%2896%2905387-1" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r003&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1996VA25000007" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r003&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=8709686" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref4"></a><li class="even" id="refItem4"><p class="number">4</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Hammer SM</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Katzenstein DA</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Hughes MD</contrib>, et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. <span class="NLM_source">N Engl J Med</span> 1996;335:1081-1090<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r004&amp;dbid=20&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1056%2FNEJM199610103351501" onclick="newWindow(this.href);return false">Free Full Text</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r004&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1996VN39900001" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r004&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=8813038" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref5"></a><li class="odd" id="refItem5"><p class="number">5</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Katzenstein DA</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Hammer SM</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Hughes MD</contrib>, et al. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. <span class="NLM_source">N Engl J Med</span> 1996;335:1091-1098<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r005&amp;dbid=20&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1056%2FNEJM199610103351502" onclick="newWindow(this.href);return false">Free Full Text</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r005&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1996VN39900002" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r005&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=8813039" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref6"></a><li class="even" id="refItem6"><p class="number">6</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Roberts NA</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Martin JA</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Kinchington D</contrib>, et al. Rational design of peptide-based HIV proteinase inhibitors. <span class="NLM_source">Science</span> 1990;248:358-361<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r006&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1126%2Fscience.2183354" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r006&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1990CZ83700036" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r006&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=2183354" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref7"></a><li class="odd" id="refItem7"><p class="number">7</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Kempf DJ</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Marsh KC</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Denissen JF</contrib>, et al. ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans. <span class="NLM_source">Proc Natl Acad Sci U S A</span> 1995;92:2484-2488<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r007&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1073%2Fpnas.92.7.2484" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r007&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1995QP88900016" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r007&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=7708670" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref8"></a><li class="even" id="refItem8"><p class="number">8</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Vacca JP</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Dorsey BD</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Schleif WA</contrib>, et al. L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor. <span class="NLM_source">Proc Natl Acad Sci U S A</span> 1994;91:4096-4100<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r008&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1073%2Fpnas.91.9.4096" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r008&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1994NJ03400129" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r008&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=8171040" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref9"></a><li class="odd" id="refItem9"><p class="number">9</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Kim EE</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Baker CT</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Dwyer MD</contrib>, et al. Crystal structure of HIV-1 protease in complex with VX-478, a potent and orally bioavailable inhibitor of the enzyme. <span class="NLM_source">J Am Chem Soc</span> 1995;117:1181-1182<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r009&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1021%2Fja00108a056" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r009&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1995QD40600056" onclick="newWindow(this.href);return false">Web of Science</a></p></li><a name="ref10"></a><li class="even" id="refItem10"><p class="number">10</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Danner SA</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Carr A</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Leonard JM</contrib>, et al. A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. <span class="NLM_source">N Engl J Med</span> 1995;333:1528-1533<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r010&amp;dbid=20&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1056%2FNEJM199512073332303" onclick="newWindow(this.href);return false">Free Full Text</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r010&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1995TH15700003" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r010&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=7477167" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref11"></a><li class="odd" id="refItem11"><p class="number">11</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Markowitz M</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Saag M</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Powderly WG</contrib>, et al. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. <span class="NLM_source">N Engl J Med</span> 1995;333:1534-1539<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r011&amp;dbid=20&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1056%2FNEJM199512073332204" onclick="newWindow(this.href);return false">Free Full Text</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r011&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1995TH15700004" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r011&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=7477168" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref12"></a><li class="even" id="refItem12"><p class="number">12</p><p class="content">Mellors J, Steigbigel R, Gulick R, et al. Antiretroviral activity of the oral protease inhibitor, MK-639, in p24 antigenemic, HIV-1 infected patients with &lt;500 CD4/mm<sup>3</sup>. In: Abstracts of the 35th International Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September 17–20, 1995. Washington, D.C.: American Society of Microbiology, 1995:235. abstract.<br></p></li><a name="ref13"></a><li class="odd" id="refItem13"><p class="number">13</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Condra JH</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Schleif WA</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Blahy OM</contrib>, et al. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. <span class="NLM_source">Nature</span> 1995;374:569-571<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r013&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1038%2F374569a0" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r013&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1995QR06900060" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r013&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=7700387" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref14"></a><li class="even" id="refItem14"><p class="number">14</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Condra JH</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Holder DJ</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Schleif WA</contrib>, et al. Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor. <span class="NLM_source">J Virol</span> 1996;70:8270-8276<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r014&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1996VT70400003" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r014&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=8970946" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref15"></a><li class="odd" id="refItem15"><p class="number">15</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Molla A</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Korneyeva M</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Gao Q</contrib>, et al. Ordered accumulation of mutations in HIV protease confers resistance to ritonavir. <span class="NLM_source">Nat Med</span> 1996;2:760-766<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r015&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1038%2Fnm0796-760" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r015&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1996UU68000031" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r015&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=8673921" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref16"></a><li class="even" id="refItem16"><p class="number">16</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Collier AC</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Coombs RW</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Schoenfeld DA</contrib>, et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. <span class="NLM_source">N Engl J Med</span> 1996;334:1011-1017<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r016&amp;dbid=20&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1056%2FNEJM199604183341602" onclick="newWindow(this.href);return false">Free Full Text</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r016&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1996UE73300002" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r016&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=8598838" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref17"></a><li class="odd" id="refItem17"><p class="number">17</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Dawson JD</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Lagakos SW</contrib>. Analyzing laboratory marker changes in AIDS clinical trials. <span class="NLM_source">J Acquir Immune Defic Syndr</span> 1991;4:667-676<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r017&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1991FR76000004" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r017&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=2051307" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref18"></a><li class="even" id="refItem18"><p class="number">18</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Dawson JD</contrib>. Comparing treatment groups on the basis of slopes, areas-under-the-curve, and other summary measures. <span class="NLM_source">Drug Inf J</span> 1994;28:723-732<br></p></li><a name="ref19"></a><li class="odd" id="refItem19"><p class="number">19</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Tisdale M</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Kemp SD</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Parry NR</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Larder BA</contrib>. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. <span class="NLM_source">Proc Natl Acad Sci U S A</span> 1993;90:5653-5656<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r019&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1073%2Fpnas.90.12.5653" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r019&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1993LH12900058" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r019&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=7685907" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref20"></a><li class="even" id="refItem20"><p class="number">20</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Schinazi RF</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Lloyd RM Jr</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Nguyen MH</contrib>, et al. Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides. <span class="NLM_source">Antimicrob Agents Chemother</span> 1993;37:875-881<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r020&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1993KV99100044" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r020&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=7684216" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref21"></a><li class="odd" id="refItem21"><p class="number">21</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Gao Q</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Gu Z</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Parniak MA</contrib>, et al. The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine. <span class="NLM_source">Antimicrob Agents Chemother</span> 1993;37:1390-1392<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r021&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1993LF13500036" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r021&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=8392313" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref22"></a><li class="even" id="refItem22"><p class="number">22</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Schuurman R</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Nijhuis M</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">van Leeuwen R</contrib>, et al. Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC). <span class="NLM_source">J Infect Dis</span> 1995;171:1411-1419<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r022&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1093%2Finfdis%2F171.6.1411" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r022&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1995RB29800004" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r022&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=7539472" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref23"></a><li class="odd" id="refItem23"><p class="number">23</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Kuritzkes DR</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Quinn JB</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Benoit SL</contrib>, et al. Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients. <span class="NLM_source">AIDS</span> 1996;10:975-981<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r023&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1097%2F00002030-199610090-00007" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r023&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1996VA50200007" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r023&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=8853730" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref24"></a><li class="even" id="refItem24"><p class="number">24</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Mellors JW</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Rinaldo CR Jr</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Gupta P</contrib>, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. <span class="NLM_source">Science</span> 1996;272:1167-1170<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r024&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1126%2Fscience.272.5265.1167" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r024&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1996UM88900049" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r024&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=8638160" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref25"></a><li class="odd" id="refItem25"><p class="number">25</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">O'Brien TR</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Blattner WA</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Waters D</contrib>, et al. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. <span class="NLM_source">JAMA</span> 1996;276:105-110<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r025&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1001%2Fjama.276.2.105" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r025&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1996UV48500024" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r025&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=8656501" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref26"></a><li class="even" id="refItem26"><p class="number">26</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">O'Brien WA</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Hartigan PM</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Martin D</contrib>, et al. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. <span class="NLM_source">N Engl J Med</span> 1996;334:426-431<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r026&amp;dbid=20&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1056%2FNEJM199602153340703" onclick="newWindow(this.href);return false">Free Full Text</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r026&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1996TU69600003" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r026&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=8552144" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref27"></a><li class="odd" id="refItem27"><p class="number">27</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Welles SL</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Jackson JB</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Yen-Lieberman B</contrib>, et al. Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. <span class="NLM_source">J Infect Dis</span> 1996;174:696-703<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r027&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1093%2Finfdis%2F174.4.696" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r027&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1996VK04500003" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r027&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=8843205" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref28"></a><li class="even" id="refItem28"><p class="number">28</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Coombs RW</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Welles SL</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Hooper C</contrib>, et al. Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. <span class="NLM_source">J Infect Dis</span> 1996;174:704-712<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r028&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1093%2Finfdis%2F174.4.704" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r028&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1996VK04500004" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r028&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=8843206" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref29"></a><li class="odd" id="refItem29"><p class="number">29</p><p class="content">Staszewski S, Bartlett J, Eron J, et al. Reductions in HIV-1 disease progression for AZT/3TC relative to control treatments: a meta analysis. In: Supplement to abstracts of the 11th International Conference on AIDS, Vancouver, B.C., July 7–12, 1996:21. abstract.<br></p></li><a name="ref30"></a><li class="even" id="refItem30"><p class="number">30</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Buckton KE</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Brown WM</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Smith PG</contrib>. Lymphocyte survival in men treated with x-rays for ankylosing spondylitis. <span class="NLM_source">Nature</span> 1967;214:470-473<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r030&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1038%2F214470a0" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r030&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A19679255200014" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r030&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=6032868" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref31"></a><li class="odd" id="refItem31"><p class="number">31</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Michie CA</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">McLean A</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Alcock C</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Beverley PC</contrib>. Lifespan of human lymphocyte subsets defined by CD45 isoforms. <span class="NLM_source">Nature</span> 1992;360:264-265<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r031&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371102&amp;key=10.1038%2F360264a0" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r031&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371102&amp;key=A1992JY96000053" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r031&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371102&amp;key=1436108" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref32"></a><li class="lastChild even" id="refItem32"><p class="number">32</p><p class="content">Crixivan. In: Physicians' desk reference. 51st ed. Montvale, N.J.: Medical Economics, 1997:1670-3.<br></p></li></ol></div></dd><dd style="display: none;" class="lastChild" id="citedby"><div class="section"><h3>Citing Articles</h3><ol class="striped"><li class="firstChild odd"><p class="number">1</p><p class="content">Donglin Ding, Xiying Qu, Lin Li, Xin Zhou, Sijie Liu, Shiguan Lin, Pengfei Wang, Shaohui Liu, Chuijin Kong, Xiaohui Wang, Lin Liu, Huanzhang Zhu.  (2013) Involvement of histone methyltransferase GLP in HIV-1 latency through catalysis of H3K9 dimethylation. <i><span class="NLM_source">Virology</span></i> <b>440</b>:2, 182-189<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.virol.2013.02.022" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">2</p><p class="content">Zachary Y. Kerr, Katye R. Miller, Dylan Galos, Randi Love, Charles Poole.  (2013) Challenges, Coping Strategies, and Recommendations Related to the HIV Services Field in the HAART Era: A Systematic Literature Review of Qualitative Studies from the United States and Canada. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>27</b>:2, 85-95<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/apc.2012.0356" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">3</p><p class="content">Kristine B. Patterson, Heather A. Prince, Trenton Stevens, Nicholas J. Shaheen, Evan S. Dellon, Ryan D. Madanick, Steven Jennings, Myron S. Cohen, Angela D.M. Kashuba.  (2013) Differential Penetration of Raltegravir throughout Gastrointestinal Tissue. <i><span class="NLM_source">AIDS</span></i>1<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e32835f2b49" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">4</p><p class="content">Shannon Byrne, Nancy M. Petry.  (2013) Reliability and validity of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) in patients with drug and alcohol use disorders. <i><span class="NLM_source">AIDS Care</span></i> <b>25</b>:1, 118-125<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1080/09540121.2012.687811" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">5</p><p class="content">Igor Kozak, J. Allen McCutchan, William R. Freeman. HIV-Associated Infections. In: Retina. Elsevier, 2013:1441-1472.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/B978-1-4557-0737-9.00081-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">6</p><p class="content">Ramakrishna Nirogi, Vishwottam Kandikere, Prashanth Komarneni, Raghupathi Aleti, NagaSuryaPrakash Padala, Ilayaraja Kalaikadhiban, Gopinadh Bhyrapuneni, Nageswararao Muddana.  (2012) Exploring dried blood spot sampling technique for simultaneous quantification of antiretrovirals: lamivudine, stavudine and nevirapine in a rodent pharmacokinetic study. <i><span class="NLM_source">Biomedical Chromatography</span></i> <b>26</b>:12, 1472-1481<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/bmc.2718" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">7</p><p class="content">Daniel Kulke, Jürgen Krücken, Janina Demeler, Achim Harder, Heinz Mehlhorn, Georg Samson-Himmelstjerna.  (2012) In vitro efficacy of cyclooctadepsipepdtides and aminophenylamidines alone and in combination against third-stage larvae and adult worms of Nippostrongylus brasiliensis and first-stage larvae of Trichinella spiralis. <i><span class="NLM_source">Parasitology Research</span></i><br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s00436-012-3141-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">8</p><p class="content">Murali Krishna Matta, Nageswara Rao Pilli, Jaswanth Kumar Inamadugu, Laxminarayana Burugula, Seshagiri Rao JVLN.  (2012) Simultaneous quantitation of lamivudine, zidovudine and nevirapine in human plasma by liquid chromatography–tandem mass spectrometry and application to a pharmacokinetic study. <i><span class="NLM_source">Acta Pharmaceutica Sinica B</span></i> <b>2</b>:5, 472-480<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.apsb.2012.07.003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">9</p><p class="content">Michael P. Carey, Lori A. J. Scott-Sheldon, Peter A. Vanable. HIV/AIDS. In: Handbook of Psychology, Second Edition. John Wiley &amp; Sons, Inc., 2012.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/9781118133880.hop209010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">10</p><p class="content">Julio S.G. Montaner.  (2012) Consecuencias nefastas para la epidemia de virus de la inmunodeficiencia humana en España a raíz del nuevo marco legal sanitario sobre los inmigrantes en situación irregular: ahorra hoy y pagarás mañana. <i><span class="NLM_source">Enfermedades Infecciosas y Microbiología Clínica</span></i><br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.eimc.2012.08.002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">11</p><p class="content">S.I. Bello.  (2012) Management Outcomes of HIV/aids Patients on Haart in a Secondary Health Institution in North Central, Nigeria. <i><span class="NLM_source">Pharmacologia</span></i> <b>3</b>:8, 336-343<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.5567/pharmacologia.2012.336.343" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">12</p><p class="content">Vanessa A. Evans, Gabriela Khoury, Suha Saleh, Paul U. Cameron, Sharon R. Lewin.  (2012) HIV persistence: Chemokines and their signalling pathways. <i><span class="NLM_source">Cytokine &amp; Growth Factor Reviews</span></i> <b>23</b>:4-5, 151-157<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.cytogfr.2012.05.002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">13</p><p class="content">Michael-John Milloy, Julio Montaner, Evan Wood.  (2012) Barriers to HIV treatment among people who use injection drugs. <i><span class="NLM_source">Current Opinion in HIV and AIDS</span></i> <b>7</b>:4, 332-338<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/COH.0b013e328354bcc8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">14</p><p class="content">Guillaume Mousseau, Mark&nbsp;A. Clementz, Wendy&nbsp;N. Bakeman, Nisha Nagarsheth, Michael Cameron, Jun Shi, Phil Baran, Rémi Fromentin, Nicolas Chomont, Susana&nbsp;T. Valente.  (2012) An Analog of the Natural Steroidal Alkaloid Cortistatin A Potently Suppresses Tat-Dependent HIV Transcription. <i><span class="NLM_source">Cell Host &amp; Microbe</span></i> <b>12</b>:1, 97-108<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.chom.2012.05.016" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">15</p><p class="content">Douglas D Richman.  (2012) Contending with the challenges of HIV: a first-hand account. <i><span class="NLM_source">Future Virology</span></i> <b>7</b>:7, 645-648<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2217/fvl.12.50" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">16</p><p class="content">, David A. Martinez, Kathy Goggin, Delwyn Catley, Mary M. Gerkovich, Karen Williams, Julie Wright, Jannette Berkley-Patton.  (2012) Do Coping Styles Mediate the Relationship Between Substance Use and Educational Attainment and Antiretroviral Adherence?. <i><span class="NLM_source">AIDS and Behavior</span></i><br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10461-012-0222-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">17</p><p class="content">Tae-Wook Chun, Anthony S. Fauci.  (2012) HIV reservoirs. <i><span class="NLM_source">AIDS</span></i> <b>26</b>:10, 1261-1268<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e328353f3f1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">18</p><p class="content">V. Le Douce, A. Janossy, H. Hallay, S. Ali, R. Riclet, O. Rohr, C. Schwartz.  (2012) Achieving a cure for HIV infection: do we have reasons to be optimistic?. <i><span class="NLM_source">Journal of Antimicrobial Chemotherapy</span></i> <b>67</b>:5, 1063-1074<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/jac/dkr599" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">19</p><p class="content">Daniel&nbsp;E. Goldberg, Robert&nbsp;F. Siliciano, William&nbsp;R. Jacobs.  (2012) Outwitting Evolution: Fighting Drug-Resistant TB, Malaria, and HIV. <i><span class="NLM_source">Cell</span></i> <b>148</b>:6, 1271-1283<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.cell.2012.02.021" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">20</p><p class="content">Michael&nbsp;S. Glickman, Charles&nbsp;L. Sawyers.  (2012) Converting Cancer Therapies into Cures: Lessons from Infectious Diseases. <i><span class="NLM_source">Cell</span></i> <b>148</b>:6, 1089-1098<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.cell.2012.02.015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">21</p><p class="content">Benjamin L Jilek, Melissa Zarr, Maame E Sampah, S Alireza Rabi, Cynthia K Bullen, Jun Lai, Lin Shen, Robert F Siliciano.  (2012) A quantitative basis for antiretroviral therapy for HIV-1 infection. <i><span class="NLM_source">Nature Medicine</span></i><br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1038/nm.2649" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">22</p><p class="content">Ingrid A. Beck, Minyoung Jang, Jennifer McKernan-Mullin, Marta Bull, Thor Wagner, Sharon Huang, Lin-Ye Song, Sharon Nachman, Paul Krogstad, Susan H. Eshleman, Andrew Wiznia, Lisa M. Frenkel.  (2012) Monitoring of HIV Type 1 DNA Load and Drug Resistance in Peripheral Blood Mononuclear Cells During Suppressive Antiretroviral Therapy Does Not Predict Virologic Failure. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i>120127074704008<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2011.0039" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">23</p><p class="content">Catherine S. Adamson.  (2012) Protease-Mediated Maturation of HIV: Inhibitors of Protease and the Maturation Process. <i><span class="NLM_source">Molecular Biology International</span></i> <b>2012</b>, 1-13<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1155/2012/604261" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">24</p><p class="content">Murali Krishna Matta, Laxminarayana Burugula, Nageswara Rao Pilli, Jaswanth Kumar Inamadugu, Seshagiri Rao JVLN.  (2012) A novel LC-MS/MS method for simultaneous quantification of tenofovir and lamivudine in human plasma and its application to a pharmacokinetic study. <i><span class="NLM_source">Biomedical Chromatography</span></i>n/a-n/a<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/bmc.2679" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">25</p><p class="content">Marianne Harris, Bohdan Nosyk, Richard Harrigan, Viviane Dias Lima, Calvin Cohen, Julio Montaner.  (2012) Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future. <i><span class="NLM_source">AIDS Research and Treatment</span></i> <b>2012</b>, 1-8<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1155/2012/595762" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">26</p><p class="content">Marilia Rita Pinzone, Michelino Di Rosa, Bruno Cacopardo, Giuseppe Nunnari.  (2012) HIV RNA Suppression and Immune Restoration: Can We Do Better?. <i><span class="NLM_source">Clinical and Developmental Immunology</span></i> <b>2012</b>, 1-12<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1155/2012/515962" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">27</p><p class="content">Ingrid A Beck, Minyoung Jang, Jennifer McKernan, Marta Bull, Thor A Wagner, Sharon Huang, Lin-Ye Song, Sharon Nachman, Paul Krogstad, Susan Eshleman, Andrew Wiznia, Lisa Marie Frenkel.  (2011) Monitoring of HIV-1 DNA Load and Drug Resistance in Peripheral Blood Mononuclear Cells during Suppressive Antiretroviral Therapy does not Predict Virologic Failure. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i>111115031133002<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/AID.2011.0039" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">28</p><p class="content">Donald M Coen, Richard Whitley.  (2011) Antiviral drugs and antiviral drug resistance. <i><span class="NLM_source">Current Opinion in Virology</span></i><br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.coviro.2011.10.024" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">29</p><p class="content">Gabriella d’Ettorre, Mauro Andreotti, Giancarlo Ceccarelli, Clementina Maria Galluzzo, Alessandra Mallano, Anna Paola Massetti, Francesca Tierno, Stefano Stella, Roberta Amici, Stefano Vella, Claudio M. Mastroianni, Vincenzo Vullo.  (2011) The role of IL-15 in challenging Acquired Immunodeficiency Syndrome. <i><span class="NLM_source">Cytokine</span></i><br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.cyto.2011.09.026" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">30</p><p class="content">Katarzyna Hryckiewicz, Maciej Bura, Arleta Kowala-Piaskowska, Beata Bolewska, Iwona Mozer-Lisewska.  (2011) HIV RNA splicing. <i><span class="NLM_source">HIV &amp; AIDS Review</span></i> <b>10</b>:3, 61-64<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.hivar.2011.05.001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">31</p><p class="content">Mark W. Hull, Julio S. G. Montaner.  (2011) Ritonavir-boosted protease inhibitors in HIV therapy. <i><span class="NLM_source">Annals of Medicine</span></i> <b>43</b>:5, 375-388<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.3109/07853890.2011.572905" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">32</p><p class="content">L. Shen, S. A. Rabi, A. R. Sedaghat, L. Shan, J. Lai, S. Xing, R. F. Siliciano.  (2011) A Critical Subset Model Provides a Conceptual Basis for the High Antiviral Activity of Major HIV Drugs. <i><span class="NLM_source">Science Translational Medicine</span></i> <b>3</b>:91, 91ra63-91ra63<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1126/scitranslmed.3002304" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">33</p><p class="content">Jose M. Almeida, Emilio Letang, Tacilta Nhampossa, Edgar Ayala, Catarina David, Clara Menendez, Joaquim Gascon, Pedro Alonso, Denise Naniche.  (2011) Rapid Suppression of HIV-RNA Is Associated with Improved Control of Immune Activation in Mozambican Adults Initiating Antiretroviral Therapy with Low CD4 Counts. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>27</b>:7, 705-711<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2010.0200" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">34</p><p class="content">Shih-Fen Hsu, Su-Pen Yang, Yu-Jiun Chan, Yung-Wei Wang.  (2011) Clinical manifestations of treatment-naive patients with acquired immunodeficiency syndrome and responses to highly active antiretroviral therapy in the Taipei Veterans General Hospital: A 5-year prospective study. <i><span class="NLM_source">Journal of Microbiology, Immunology and Infection</span></i> <b>44</b>:3, 198-203<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jmii.2011.01.022" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">35</p><p class="content">Arnout R. D. Voet, Marc De Maeyer, Frauke Christ, Zeger Debyser. Targeting Integration beyond Strand Transfer: Development of Second-Generation HIV Integrase Inhibitors. Wiley-VCH Verlag GmbH &amp; Co. KGaA, 2011:51-71.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/9783527635955.ch3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">36</p><p class="content">Gabriella d'Ettorre, Mirko Paiardini, Giancarlo Ceccarelli, Guido Silvestri, Vincenzo Vullo.  (2011) HIV-Associated Immune Activation: From Bench to Bedside. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>27</b>:4, 355-364<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2010.0342" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">37</p><p class="content">Swetha Bollam, Prabhakar Kandadi, Shashank Sridhar Apte, Kishan Veerabrahma.  (2011) Development of Indinavir Submicron Lipid Emulsions Loaded with Lipoamino Acids—In Vivo Pharmacokinetics and Brain-Specific Delivery. <i><span class="NLM_source">AAPS PharmSciTech</span></i> <b>12</b>:1, 422-430<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1208/s12249-011-9604-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">38</p><p class="content">Prabhakar Kandadi, Muzammil Afzal Syed, Surendar Goparaboina, Kishan Veerabrahma.  (2011) Brain specific delivery of pegylated indinavir submicron lipid emulsions. <i><span class="NLM_source">European Journal of Pharmaceutical Sciences</span></i> <b>42</b>:4, 423-432<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.ejps.2011.01.008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">39</p><p class="content">Inmaculada Ferreros, Isabel Hurtado, Julia del Amo, Roberto Muga, Jorge del Romero, Patricia García, Ignacio Alastrué, Josefina Belda, Marcela Guevara, Santiago Pérez.  (2011) Efectividad del tratamiento antirretroviral combinado de gran actividad en eventos recurrentes de sida en una cohorte de seroconvertores al virus de la inmunodeficiencia humana. <i><span class="NLM_source">Enfermedades Infecciosas y Microbiología Clínica</span></i> <b>29</b>:3, 179-184<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.eimc.2010.10.005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">40</p><p class="content">Matthew J. Pace, Luis Agosto, Erin H. Graf, Una O'Doherty.  (2011) HIV reservoirs and latency models. <i><span class="NLM_source">Virology</span></i> <b>411</b>:2, 344-354<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.virol.2010.12.041" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">41</p><p class="content">Tim R Cressey, Saik Urien, Deborah Hirt, Guttiga Halue, Malee Techapornroong, Chureeratana Bowonwatanuwong, Prattana Leenasirimakul, Jean-Marc Treluyer, Gonzague Jourdain, Marc Lallemant.  (2011) Influence of Body Weight on Achieving Indinavir Concentrations Within Its Therapeutic Window in HIV-Infected Thai Patients Receiving Indinavir Boosted With Ritonavir. <i><span class="NLM_source">Therapeutic Drug Monitoring</span></i> <b>33</b>:1, 25-31<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/FTD.0b013e3182057f6f" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">42</p><p class="content">Charles J. Lick, Tom P. Aufderheide, Robert A. Niskanen, Janet E. Steinkamp, Scott P. Davis, Susan D. Nygaard, Kim K. Bemenderfer, Louis Gonzales, Jeffrey A. Kalla, Sarah K. Wald, Debbie L. Gillquist, Michael R. Sayre, Susie Y. Oski Holm, Dana A. Oakes, Terry A. Provo, Ed M. Racht, John D. Olsen, Demetris Yannopoulos, Keith G. Lurie.  (2011) Take Heart America: A comprehensive, community-wide, systems-based approach to the treatment of cardiac arrest*. <i><span class="NLM_source">Critical Care Medicine</span></i> <b>39</b>:1, 26-33<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/CCM.0b013e3181fa7ce4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">43</p><p class="content">Janice E Clements, Lucio Gama, David R Graham, Joseph L Mankowski, MC Zink.  (2011) A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system. <i><span class="NLM_source">Current Opinion in HIV and AIDS</span></i> <b>6</b>:1, 37-42<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/COH.0b013e3283412413" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">44</p><p class="content">Lorna Renner, Meghan Prin, Fang-Yong Li, Bamenla Goka, Veronika Northrup, Elijah Paintsil.  (2011) Time to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana. <i><span class="NLM_source">AIDS Research and Treatment</span></i> <b>2011</b>, 1-9<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1155/2011/896040" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">45</p><p class="content">Elijah Paintsil.  (2011) Monitoring Antiretroviral Therapy in HIV-Infected Children in Resource-Limited Countries: A Tale of Two Epidemics. <i><span class="NLM_source">AIDS Research and Treatment</span></i> <b>2011</b>, 1-9<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1155/2011/280901" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">46</p><p class="content">Viviane D Lima, David R Bangsberg, P Richard Harrigan, Steven G Deeks, Benita Yip, Robert S Hogg, Julio S G Montaner.  (2010) Risk of Viral Failure Declines With Duration of Suppression on Highly Active Antiretroviral Therapy Irrespective of Adherence Level. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>55</b>:4, 460-465<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e3181f2ac87" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">47</p><p class="content">Celine S. Yan, Imelda Hanafi, Anthony D. Kelleher, Andrew D. Carr, Janaki Amin, Leon P. McNally, Philip H. Cunningham.  (2010) Lack of correlation between three commercial platforms for the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of quantification. <i><span class="NLM_source">Journal of Clinical Virology</span></i> <b>49</b>:4, 249-253<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jcv.2010.08.016" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">48</p><p class="content">Jeremiah L. Deneve, Jessica G. Shantha, Andrew J. Page, Amy D. Wyrzykowski, Grace S. Rozycki, David V. Feliciano.  (2010) CD4 count is predictive of outcome in HIV-positive patients undergoing abdominal operations. <i><span class="NLM_source">The American Journal of Surgery</span></i> <b>200</b>:6, 694-700<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.amjsurg.2010.07.030" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">49</p><p class="content">Roy M Gulick.  (2010) Antiretroviral Treatment 2010: Progress and Controversies. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>55</b>, S43-S48<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e3181f9c09e" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">50</p><p class="content">Janet D Siliciano, Robert F Siliciano.  (2010) Biomarkers of HIV replication. <i><span class="NLM_source">Current Opinion in HIV and AIDS</span></i> <b>5</b>:6, 491-497<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/COH.0b013e32833f206f" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">51</p><p class="content">Christopher J. Scott, Clifford C. Taggart.  (2010) Biologic protease inhibitors as novel therapeutic agents. <i><span class="NLM_source">Biochimie</span></i> <b>92</b>:11, 1681-1688<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.biochi.2010.03.010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">52</p><p class="content">Filippa Bonura, Fabio Tramuto, Francesco Vitale, Anna Maria Perna, Enza Viviano, Nino Romano.  (2010) Transmission of Drug-Resistant HIV Type 1 Strains in HAART-Naive Patients: A 5-Year Retrospective Study in Sicily, Italy. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>26</b>:9, 961-965<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2009.0250" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">53</p><p class="content">Brandon DL Marshall, M-J Milloy, Thomas Kerr, Ruth Zhang, Julio SG Montaner, Evan Wood.  (2010) No evidence of increased sexual risk behaviour after initiating antiretroviral therapy among people who inject drugs. <i><span class="NLM_source">AIDS</span></i> <b>24</b>:14, 2271-2278<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e32833dd101" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">54</p><p class="content">Arun K. Ghosh, David D. Anderson, Hiroaki Mitsuya. The FDA Approved HIV-1 Protease Inhibitors for Treatment of HIV/AIDS. In: Burger's Medicinal Chemistry and Drug Discovery. John Wiley &amp; Sons, Inc., 2010.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/0471266949.bmc224" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">55</p><p class="content">Erika Coria-Ramirez, Leopoldo Nieto Cisneros, Sandra Treviño-Perez, Isabel Ibarra-Gonzalez, Jesus Casillas-Rodriguez, Abraham Majluf-Cruz.  (2010) Effect of Highly Active Antiretroviral Therapy on Homocysteine Plasma Concentrations in HIV-1–Infected Patients. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>54</b>:5, 477-481<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e3181d91088" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">56</p><p class="content">Kaori Sango, Aviva Joseph, Mahesh Patel, Kristin Osiecki, Monica Dutta, Harris Goldstein.  (2010) Highly Active Antiretroviral Therapy Potently Suppresses HIV Infection in Humanized Rag2
              <sup>-/-</sup>
              γ
              <sub>c</sub>
              <sup>-/-</sup>
              Mice. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>26</b>:7, 735-746<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2009.0136" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">57</p><p class="content">Tsutomu Murakami, Naoki Yamamoto.  (2010) Role of CXCR4 in HIV infection and its potential as a therapeutic target. <i><span class="NLM_source">Future Microbiology</span></i> <b>5</b>:7, 1025-1039<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2217/fmb.10.67" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">58</p><p class="content"> Meyers ,  Tammy M.  Ndung'u ,  Thumbi .  (2010) Case 18-2010. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>362</b>:24, 2305-2312<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJMcpc1002113">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJMcpc1002113} --></span></p></li><li class="odd"><p class="number">59</p><p class="content">D. L. Wyles, R. T. Schooley.  (2010) Rong's Numbers: Accelerating Progress in HCV Therapeutic Research. <i><span class="NLM_source">Science Translational Medicine</span></i> <b>2</b>:33, 33ps25-33ps25<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1126/scitranslmed.3001183" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">60</p><p class="content">Martin Delaney.  (2010) The Development of Combination Therapies for HIV Infection. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>26</b>:5, 501-509<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2010.0064" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">61</p><p class="content">S. Moreno, J. Lopez Aldeguer, J. R. Arribas, P. Domingo, J. A. Iribarren, E. Ribera, A. Rivero, F. Pulido, .  (2010) The future of antiretroviral therapy: challenges and needs. <i><span class="NLM_source">Journal of Antimicrobial Chemotherapy</span></i> <b>65</b>:5, 827-835<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/jac/dkq061" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">62</p><p class="content">Alexander Monto, Robert T Schooley, Jennifer C Lai, Mark S Sulkowski, Raymond T Chung, Jean-Michel Pawlotsky, John G McHutchison, Ira M Jacobson.  (2010) Lessons From HIV Therapy Applied to Viral Hepatitis Therapy: Summary of a Workshop. <i><span class="NLM_source">The American Journal of Gastroenterology</span></i> <b>105</b>:5, 989-1004<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1038/ajg.2009.726" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">63</p><p class="content">Mehmet Numan Alp, Nurcan Baykam, Gulcan Kural.  (2010) Immune recovery uveitis associated with highly active antiretroviral therapy in a patient with CMV retinitis and AIDS despite a low CD4+ T cell count: case report and a review of the literature. <i><span class="NLM_source">International Ophthalmology</span></i> <b>30</b>:2, 183-189<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10792-009-9303-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">64</p><p class="content">Melissa Morgan, Brenda Bartlett, Clay Cockerell, Philip Cohen. Cutaneous Manifestations of HIV Infection. In: Mucocutaneous Manifestations of Viral Diseases. CRC Press, 2010:263-339.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.3109/9781420073133-15" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">65</p><p class="content">C. B. Bunker, F. Gotch. HIV and the Skin. In: Rook's Textbook of Dermatology. Wiley-Blackwell, 2010:1-47.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/9781444317633.ch35" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">66</p><p class="content">Christian Erikstrup, Gitte Kronborg, Nicolai Lohse, Ostrowski Sisse Rye, Jan Gerstoft, Henrik Ullum.  (2010) T-Cell Dysfunction in HIV-1-Infected Patients With Impaired Recovery of CD4 Cells Despite Suppression of Viral Replication. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>53</b>:3, 303-310<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e3181ca3f7c" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">67</p><p class="content">Min Liang, Masakazu Kamata, Kevin N. Chen, Nonia Pariente, Dong Sung An, Irvin S. Y. Chen.  (2010) Inhibition of HIV-1 infection by a unique short hairpin RNA to chemokine receptor 5 delivered into macrophages through hematopoietic progenitor cell transduction. <i><span class="NLM_source">The Journal of Gene Medicine</span></i> <b>12</b>:3, 255-265<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/jgm.1440" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">68</p><p class="content">Kazuo Suzuki, Anthony D Kelleher.  (2010) Lessons from viral latency in T cells: manipulating HIV-1 transcription by siRNA. <i><span class="NLM_source">HIV Therapy</span></i> <b>4</b>:2, 199-213<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2217/hiv.10.1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">69</p><p class="content">Suely Hiromi Tuboi, Antonio Guilherme Pacheco, Lee H Harrison, Roslyn A Stone, Margaret May, Martin W G Brinkhof, François Dabis, Matthias Egger, Denis Nash, David Bangsberg, Paula Braitstein, Constantin T Yiannoutsos, Robin Wood, Eduardo Sprinz, Mauro Schechter.  (2010) Mortality Associated With Discordant Responses to Antiretroviral Therapy in Resource-Constrained Settings. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>53</b>:1, 70-77<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e3181c22d19" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">70</p><p class="content">Antonio Valentin, Matthew Morrow, Richard H. Poirier, Karen Aleman, Richard Little, Robert Yarchoan, George N. Pavlakis.  (2010) Identification of a Potential Pharmacological Sanctuary for HIV Type 1 in a Fraction of CD4
              <sup>+</sup>
              Primary Cells. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>26</b>:1, 79-88<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2009.0044" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">71</p><p class="content"> (2010) The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. <i><span class="NLM_source">AIDS</span></i> <b>24</b>:1, 123-137<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e3283324283" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">72</p><p class="content">Zhi-wei Ye, Sandrine Camus, Patrick Augustijns, Pieter Annaert.  (2010) Interaction of eight HIV protease inhibitors with the canalicular efflux transporter ABCC2 (MRP2) in sandwich-cultured rat and human hepatocytes. <i><span class="NLM_source">Biopharmaceutics &amp; Drug Disposition</span></i>n/a-n/a<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/bdd.701" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">73</p><p class="content">Annemarie M.J. Wensing, Noortje M. van Maarseveen, Monique Nijhuis.  (2010) Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance. <i><span class="NLM_source">Antiviral Research</span></i> <b>85</b>:1, 59-74<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.antiviral.2009.10.003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">74</p><p class="content">S. R. Cole, L. P. Jacobson, P. C. Tien, L. Kingsley, J. S. Chmiel, K. Anastos.  (2010) Using Marginal Structural Measurement-Error Models to Estimate the Long-term Effect of Antiretroviral Therapy on Incident AIDS or Death. <i><span class="NLM_source">American Journal of Epidemiology</span></i> <b>171</b>:1, 113-122<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/aje/kwp329" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">75</p><p class="content">R.W. Coombs. Human Immunodeficiency Virus Infection and the Acquired Immunodeficiency Syndrome. In: Atlas of Sexually Transmitted Diseases and AIDS. Elsevier, 2010:240-255.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/B978-0-7020-4060-3.00014-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">76</p><p class="content">MARVIN S. REITZ, ROBERT C. GALLO. Human Immunodeficiency Viruses. In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier, 2010:2323-2335.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/B978-0-443-06839-3.00169-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">77</p><p class="content">Matthew D Marsden, Jerome A Zack.  (2010) Establishment and maintenance of HIV latency: model systems and opportunities for intervention. <i><span class="NLM_source">Future Virology</span></i> <b>5</b>:1, 97-109<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2217/fvl.09.70" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">78</p><p class="content">Princy N Kumar, Parul Patel.  (2010) Lamivudine for the treatment of HIV. <i><span class="NLM_source">Expert Opinion on Drug Metabolism &amp; Toxicology</span></i> <b>6</b>:1, 105-114<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/17425250903490418" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">79</p><p class="content">Moira A McMahon, Lin Shen, Robert F Siliciano.  (2009) New approaches for quantitating the inhibition of HIV-1 replication by antiviral drugs in vitro and in vivo. <i><span class="NLM_source">Current Opinion in Infectious Diseases</span></i> <b>22</b>:6, 574-582<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QCO.0b013e328332c54d" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">80</p><p class="content">Lin Shen, S. Alireza Rabi, Robert F. Siliciano.  (2009) A novel method for determining the inhibitory potential of anti-HIV drugs. <i><span class="NLM_source">Trends in Pharmacological Sciences</span></i> <b>30</b>:12, 610-616<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.tips.2009.09.003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">81</p><p class="content">Humphrey J. Shao, John A. Crump, Habib O. Ramadhani, Leonard O. Uiso, Sendui Ole-Nguyaine, Andrew M. Moon, Rehema A. Kiwera, Christopher W. Woods, John F. Shao, John A. Bartlett, Nathan M. Thielman.  (2009) Early versus Delayed Fixed Dose Combination Abacavir/Lamivudine/Zidovudine in Patients with HIV and Tuberculosis in Tanzania. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>25</b>:12, 1277-1285<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2009.0100" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">82</p><p class="content">Julien Paccou, Nathalie Viget, Isabelle Legrout-Gérot, Yazdan Yazdanpanah, Bernard Cortet.  (2009) Bone loss in patients with HIV infection. <i><span class="NLM_source">Joint Bone Spine</span></i> <b>76</b>:6, 637-641<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jbspin.2009.10.003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">83</p><p class="content">David Y.-W. Lee, Xudong Lin, Elena E. Paskaleva, Yanze Liu, Shadakshara S. Puttamadappa, Carol Thornber, James R. Drake, Maja Habulin, Alexander Shekhtman, Mario Canki.  (2009) Palmitic Acid Is a Novel CD4 Fusion Inhibitor That Blocks HIV Entry and Infection. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>25</b>:12, 1231-1241<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2009.0019" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">84</p><p class="content">R. Nageswara Rao, Dhananjay D. Shinde.  (2009) Two-dimensional LC–MS/MS determination of antiretroviral drugs in rat serum and urine. <i><span class="NLM_source">Journal of Pharmaceutical and Biomedical Analysis</span></i> <b>50</b>:5, 994-999<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jpba.2009.07.005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">85</p><p class="content">Piyamat Jinnopat, Panasda Isarangkura-na-ayuthaya, Piraporn Utachee, Yukiko Kitagawa, U Chandimal de Silva, Uamporn Siripanyaphinyo, Yoko Kameoka, Kenzo Tokunaga, Pathom Sawanpanyalert, Kazuyoshi Ikuta, Wattana Auwanit, Masanori Kameoka.  (2009) Impact of Amino Acid Variations in Gag and Protease of HIV Type 1 CRF01_AE Strains on Drug Susceptibility of Virus to Protease Inhibitors. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>52</b>:3, 320-328<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e3181b4b18c" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">86</p><p class="content">Danièle Bentué-Ferrer, Cédric Arvieux, Olivier Tribut, Annick Ruffault, Eric Bellissant.  (2009) Clinical pharmacology, efficacy and safety of atazanavir: a review. <i><span class="NLM_source">Expert Opinion on Drug Metabolism &amp; Toxicology</span></i> <b>5</b>:11, 1455-1468<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/17425250903321514" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">87</p><p class="content"> Landovitz ,  Raphael J. ,  Currier ,  Judith S. , .  (2009) Postexposure Prophylaxis for HIV Infection. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>361</b>:18, 1768-1775<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJMcp0904189">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJMcp0904189} --></span></p></li><li class="even"><p class="number">88</p><p class="content">Walter Jaoko, Tamara Kredo, Walter Jaoko. Boosted protease inhibitor (PI) monotherapy for treating HIV/AIDS. In: Cochrane Database of Systematic Reviews. John Wiley &amp; Sons, Ltd, 2009.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/14651858.CD008171" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">89</p><p class="content">Arnout RD Voet, Marc De Maeyer, Zeger Debyser, Frauke Christ.  (2009) In search of second-generation HIV integrase inhibitors: targeting integration beyond strand transfer. <i><span class="NLM_source">Future Medicinal Chemistry</span></i> <b>1</b>:7, 1259-1274<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.4155/fmc.09.86" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">90</p><p class="content">Mariona Parera, Nuria Perez-Alvarez, Bonaventura Clotet, Miguel Angel Martínez.  (2009) Epistasis among Deleterious Mutations in the HIV-1 Protease. <i><span class="NLM_source">Journal of Molecular Biology</span></i> <b>392</b>:2, 243-250<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jmb.2009.07.015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">91</p><p class="content">Jeffrey B. Bingenheimer, Arline T. Geronimus.  (2009) Behavioral Mechanisms in HIV Epidemiology and Prevention: Past, Present, and Future Roles. <i><span class="NLM_source">Studies in Family Planning</span></i> <b>40</b>:3, 187-204<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1728-4465.2009.00202.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">92</p><p class="content">Libin Rong, Alan S. Perelson.  (2009) Modeling HIV persistence, the latent reservoir, and viral blips. <i><span class="NLM_source">Journal of Theoretical Biology</span></i> <b>260</b>:2, 308-331<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jtbi.2009.06.011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">93</p><p class="content">Kenneth H Fife, Julia W Wu, Kathleen E Squires, D Heather Watts, Janet W Andersen, Darron R Brown.  (2009) Prevalence and Persistence of Cervical Human Papillomavirus Infection in HIV-Positive Women Initiating Highly Active Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>51</b>:3, 274-282<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e3181a97be5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">94</p><p class="content">Karem L. Ortega, Daniela A. Vale, Marina H. C. G. Magalhães.  (2009) Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients. <i><span class="NLM_source">Journal of Oral Pathology &amp; Medicine</span></i> <b>38</b>:6, 489-494<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1600-0714.2009.00783.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">95</p><p class="content">J. B. Dinoso, S. Y. Kim, A. M. Wiegand, S. E. Palmer, S. J. Gange, L. Cranmer, A. O'Shea, M. Callender, A. Spivak, T. Brennan, M. F. Kearney, M. A. Proschan, J. M. Mican, C. A. Rehm, J. M. Coffin, J. W. Mellors, R. F. Siliciano, F. Maldarelli.  (2009) Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. <i><span class="NLM_source">Proceedings of the National Academy of Sciences</span></i> <b>106</b>:23, 9403-9408<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1073/pnas.0903107106" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">96</p><p class="content">Ronald J. Ellis, Patricia Calero, Michael D. Stockin.  (2009) HIV Infection and the Central Nervous System: A Primer. <i><span class="NLM_source">Neuropsychology Review</span></i> <b>19</b>:2, 144-151<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s11065-009-9094-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">97</p><p class="content">Wattana Auwanit, Panasda Isarangkura-Na-Ayuthaya, Dao Kasornpikul, Kazuyoshi Ikuta, Pathom Sawanpanyalert, Masanori Kameoka.  (2009) Detection of Drug Resistance-Associated and Background Mutations in Human Immunodeficiency Virus Type 1 CRF01_AE Protease and Reverse Transcriptase Derived from Drug Treatment-Naive Patients Residing in Central Thailand. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>25</b>:6, 625-631<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2008.0298" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">98</p><p class="content">T. E. Madiba, D. J. J. Muckart, S. R. Thomson.  (2009) Human Immunodeficiency Disease: How Should It Affect Surgical Decision Making?. <i><span class="NLM_source">World Journal of Surgery</span></i> <b>33</b>:5, 899-909<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s00268-009-9969-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">99</p><p class="content">Martin Vogel, Jürgen K Rockstroh.  (2009) Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation. <i><span class="NLM_source">Current Opinion in HIV and AIDS</span></i> <b>4</b>:3, 171-175<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/COH.0b013e328329c602" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">100</p><p class="content">Debra L. Hanson, Christiane Adjé-Touré, N. Talla-Nzussouo, Pascal Eby, Marie-Yolande Borget, Léonard Ya Kouadio, Bile Ebi Celestin, Odette Tossou, Serge Eholie, Auguste Kadio, Terence Chorba, John N. Nkengasong.  (2009) HIV Type 1 Drug Resistance in Adults Receiving Highly Active Antiretroviral Therapy in Abidjan, Côte d'Ivoire. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>25</b>:5, 489-495<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2008.0273" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">101</p><p class="content">Jerrome K. Percus, Ora E. Percus, Michele Di Mascio.  (2009) The amplitudes of viral blips in HIV-1 infected patients treated with antiretroviral therapy are power-law distributed. <i><span class="NLM_source">Journal of Theoretical Biology</span></i> <b>257</b>:3, 454-459<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jtbi.2008.12.034" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">102</p><p class="content">Ramakrishna Nirogi, Gopinadh Bhyrapuneni, Vishwottam Kandikere, Koteshwara Mudigonda, Prashanth Komarneni, Raghupathi Aleti, K. Mukkanti.  (2009) Simultaneous quantification of a non-nucleoside reverse transcriptase inhibitor efavirenz, a nucleoside reverse transcriptase inhibitor emtricitabine and a nucleotide reverse transcriptase inhibitor tenofovir in plasma by liquid chromatography positive ion electrospray tandem mass spectrometry. <i><span class="NLM_source">Biomedical Chromatography</span></i> <b>23</b>:4, 371-381<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/bmc.1125" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">103</p><p class="content">Hans S L M Nottet, Sabine J van Dijk, Ewout B Fanoy, Irma W Goedegebuure, Dorien de Jong, Nienke Vrisekoop, Debbie van Baarle, Valerie Boltz, Sarah Palmer, Jan C C Borleffs, Charles A B Boucher.  (2009) HIV-1 Can Persist in Aged Memory CD4+ T Lymphocytes With Minimal Signs of Evolution After 8.3 Years of Effective Highly Active Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>50</b>:4, 345-353<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e318197eb04" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">104</p><p class="content">Gautam K. Sahu, David Paar, Simon D.W. Frost, Melissa M. Smith, Scott Weaver, Miles W. Cloyd.  (2009) Low-level plasma HIVs in patients on prolonged suppressive highly active antiretroviral therapy are produced mostly by cells other than CD4 T-cells. <i><span class="NLM_source">Journal of Medical Virology</span></i> <b>81</b>:1, 9-15<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/jmv.21366" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">105</p><p class="content">Jean-Philippe Herbeuval, Jakob Nilsson, Adriano Boasso, Andrew W Hardy, Monica Vaccari, Valentina Cecchinato, Valerio Valeri, Genoveffa Franchini, Jan Andersson, Gene M Shearer.  (2009) HAART reduces death ligand but not death receptors in lymphoid tissue of HIV-infected patients and simian immunodeficiency virus-infected macaques. <i><span class="NLM_source">AIDS</span></i> <b>23</b>:1, 35-40<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e32831cb907" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">106</p><p class="content">Zhi-wei Ye, Jos Van Pelt, Sandrine Camus, Jan Snoeys, Patrick Augustijns, Pieter Annaert.  (2009) Species-specific interaction of HIV protease inhibitors with accumulation of cholyl-glycylamido-fluorescein (CGamF) in sandwich-cultured hepatocytes. <i><span class="NLM_source">Journal of Pharmaceutical Sciences</span></i>n/a-n/a<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/jps.22018" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">107</p><p class="content">Andros Theo, Tracy Masebe, Yasuhiro Suzuki, Haruhisa Kikuchi, Shoko Wada, Chikwelu Larry Obi, Pascal Obong Bessong, Motoki Usuzawa, Yoshiteru Oshima, Toshio Hattori.  (2009) Peltophorum Africanum, a Traditional South African Medicinal Plant, Contains an Anti HIV-1 Constituent, Betulinic Acid. <i><span class="NLM_source">The Tohoku Journal of Experimental Medicine</span></i> <b>217</b>:2, 93-99<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1620/tjem.217.93" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">108</p><p class="content">Salim S Abdool Karim, Cheryl Baxter.  (2009) Antiretroviral prophylaxis for the prevention of HIV infection: future implementation challenges. <i><span class="NLM_source">HIV Therapy</span></i> <b>3</b>:1, 3-6<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2217/17584310.3.1.3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">109</p><p class="content">Timothy&nbsp;J. Wilkin, Roy&nbsp;M. Gulick.  (2008) HIV/AIDS: When to Start Antiretroviral Therapy?. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>47</b>:12, 1580-1586<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/593311" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">110</p><p class="content">Robin Wood.  (2008) Atazanavir: its role in HIV treatment. <i><span class="NLM_source">Expert Review of Anti-infective Therapy</span></i> <b>6</b>:6, 785-796<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1586/14787210.6.6.785" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">111</p><p class="content">Nikos Pantazis, Giota Touloumi, Philippe Vanhems, John Gill, Heiner C Bucher, Kholoud Porter.  (2008) The effect of antiretroviral treatment of different durations in primary HIV infection. <i><span class="NLM_source">AIDS</span></i> <b>22</b>:18, 2441-2450<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e328319ea4e" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">112</p><p class="content">Mohamed G. Atta, Gilbert Deray, Gregory M. Lucas.  (2008) Antiretroviral Nephrotoxicities. <i><span class="NLM_source">Seminars in Nephrology</span></i> <b>28</b>:6, 563-575<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.semnephrol.2008.08.009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">113</p><p class="content">Devon J. Shedlock, Daniel Hwang, Andy Y. Choo, Christopher W. Chung, Karuppiah Muthumani, David B. Weiner.  (2008) HIV-1 viral genes and mitochondrial apoptosis. <i><span class="NLM_source">Apoptosis</span></i> <b>13</b>:9, 1088-1099<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10495-008-0239-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">114</p><p class="content">Yefei Han, Yijie B. Lin, Wenfeng An, Jie Xu, Hung-Chih Yang, Karen O'Connell, Dominic Dordai, Jef D. Boeke, Janet D. Siliciano, Robert F. Siliciano.  (2008) Orientation-Dependent Regulation of Integrated HIV-1 Expression by Host Gene Transcriptional Readthrough. <i><span class="NLM_source">Cell Host &amp; Microbe</span></i> <b>4</b>:2, 134-146<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.chom.2008.06.008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">115</p><p class="content">Zhijian Lu.  (2008) Second generation HIV protease inhibitors against resistant virus. <i><span class="NLM_source">Expert Opinion on Drug Discovery</span></i> <b>3</b>:7, 775-786<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/17460441.3.7.775" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">116</p><p class="content">Lin Shen, Robert F. Siliciano.  (2008) Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection. <i><span class="NLM_source">Journal of Allergy and Clinical Immunology</span></i> <b>122</b>:1, 22-28<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jaci.2008.05.033" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">117</p><p class="content">Elijah Paintsil, Musie Ghebremichael, Sostena Romano, Warren A. Andiman.  (2008) Absolute CD4+ T-Lymphocyte Count as a Surrogate Marker of Pediatric Human Immunodeficiency Virus Disease Progression. <i><span class="NLM_source">The Pediatric Infectious Disease Journal</span></i> <b>27</b>:7, 629-635<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/INF.0b013e3181693892" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">118</p><p class="content">Lin Shen, Susan Peterson, Ahmad R Sedaghat, Moira A McMahon, Marc Callender, Haili Zhang, Yan Zhou, Eleanor Pitt, Karen S Anderson, Edward P Acosta, Robert F Siliciano.  (2008) Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs. <i><span class="NLM_source">Nature Medicine</span></i> <b>14</b>:7, 762-766<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1038/nm1777" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">119</p><p class="content">Patrick J. Collins, Lesley F. Haire, Yi Pu Lin, Junfeng Liu, Rupert J. Russell, Philip A. Walker, John J. Skehel, Stephen R. Martin, Alan J. Hay, Steven J. Gamblin.  (2008) Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. <i><span class="NLM_source">Nature</span></i> <b>453</b>:7199, 1258-1261<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1038/nature06956" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">120</p><p class="content">Nancy M Archin, Joseph J Eron, Sarah Palmer, Anne Hartmann-Duff, Jeffery A Martinson, Ann Wiegand, Nicholas Bandarenko, John L Schmitz, Ronald J Bosch, Alan L Landay, John M Coffin, David M Margolis.  (2008) Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells. <i><span class="NLM_source">AIDS</span></i> <b>22</b>:10, 1131-1135<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e3282fd6df4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">121</p><p class="content">Davey M. Smith, Robert T. Schooley.  (2008) Running with Scissors: Using Antiretroviral Therapy without Monitoring Viral Load. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>46</b>:10, 1598-1600<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/587110" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">122</p><p class="content">John H. Elder, Magnus Sundstrom, Sohela de Rozieres, Aymeric de Parseval, Chris K. Grant, Ying-Chuan Lin.  (2008) Molecular mechanisms of FIV infection. <i><span class="NLM_source">Veterinary Immunology and Immunopathology</span></i> <b>123</b>:1-2, 3-13<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.vetimm.2008.01.007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">123</p><p class="content">Jeffrey A. Anderson, Hongyu Jiang, Xiao Ding, Leslie Petch, Terri Journigan, Susan A. Fiscus, Richard Haubrich, David Katzenstein, Ronald Swanstrom, Roy M. Gulick.  (2008) Genotypic Susceptibility Scores and HIV Type 1 RNA Responses in Treatment-Experienced Subjects with HIV Type 1 Infection. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>24</b>:5, 685-694<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2007.0127" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">124</p><p class="content">A. R. Sedaghat, J. B. Dinoso, L. Shen, C. O. Wilke, R. F. Siliciano.  (2008) Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle. <i><span class="NLM_source">Proceedings of the National Academy of Sciences</span></i> <b>105</b>:12, 4832-4837<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1073/pnas.0711372105" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">125</p><p class="content">Jason T. Blackard, Seth L. Welles, Avra Ackerman, Nimisha Kalia, Daniel E. Cohen, Kenneth H. Mayer.  (2008) Immunological Rebound after Initiation of Highly Active Antiretroviral Therapy in Treatment-Naive Patients. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>24</b>:3, 499-504<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2007.0099" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">126</p><p class="content">Kersten&nbsp;K. Koelsch, Lin Liu, Richard Haubrich, Susanne May, Diane Havlir, Huldrych&nbsp;F. Günthard, Caroline&nbsp;C. Ignacio, Paula Campos‐Soto, Susan&nbsp;J. Little, Robert Shafer, Gregory&nbsp;K. Robbins, Richard&nbsp;T. D’Aquila, Yuji Kawano, Karen Young, Phillip Dao, Celsa&nbsp;A. Spina, Douglas&nbsp;D. Richman, Joseph&nbsp;K. Wong.  (2008) Dynamics of Total, Linear Nonintegrated, and Integrated HIV‐1 DNA In Vivo and In Vitro. <i><span class="NLM_source">The Journal of Infectious Diseases</span></i> <b>197</b>:3, 411-419<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/525283" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">127</p><p class="content">Luc Geeraert, Günter Kraus, Roger J. Pomerantz.  (2008) Hide-and-Seek: The Challenge of Viral Persistence in HIV-1 Infection. <i><span class="NLM_source">Annual Review of Medicine</span></i> <b>59</b>:1, 487-501<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1146/annurev.med.59.062806.123001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">128</p><p class="content">Shiro Ibe, Junko Hattori, Seiichiro Fujisaki, Urara Shigemi, Saeko Fujisaki, Kayoko Shimizu, Kazuyo Nakamura, Takejiro Kazumi, Yoshiyuki Yokomaku, Naoto Mamiya, Motohiro Hamaguchi, Tsuguhiro Kaneda.  (2008) Trend of Drug-Resistant HIV Type 1 Emergence among Therapy-Naive Patients in Nagoya, Japan: An 8-Year Surveillance from 1999 to 2006. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>24</b>:1, 7-14<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2007.0129" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">129</p><p class="content">Toru Murakami, Hideki Harada, Mary Ann Suico, Tsuyoshi Shuto, Shinya Suzu, Hirofumi Kai, Seiji Okada.  (2008) Ephedrae Herba, a Component of Japanese Herbal Medicine Mao-to, Efficiently Activates the Replication of Latent Human Immunodeficiency Virus Type 1 (HIV-1) in a Monocytic Cell Line. <i><span class="NLM_source">Biological &amp; Pharmaceutical Bulletin</span></i> <b>31</b>:12, 2334-2337<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1248/bpb.31.2334" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">130</p><p class="content">Heidi M. Crane, Stephen E. Van Rompaey, Mari M. Kitahata.  (2007) Initiating Highly Active Antiretroviral Therapy with Newer Protease Inhibitors Is Associated with Better Survival Compared to First-Generation Protease Inhibitors or Nevirapine. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>21</b>:12, 920-929<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/apc.2007.0020" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">131</p><p class="content">Ren-rong Tian, Qing-jiao Liao, Xu-lin Chen.  (2007) Current status of targets and assays for anti-HIV drug screening. <i><span class="NLM_source">Virologica Sinica</span></i> <b>22</b>:6, 476-485<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s12250-007-0049-5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">132</p><p class="content">Dean G. Cruess, Sarah Minor, Michael H. Antoni, Theodore Millon.  (2007) Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to Predict Adherence to Highly Active Antiretroviral Therapy (HAART) Medication Regimens Among HIV-Positive Men and Women. <i><span class="NLM_source">Journal of Personality Assessment</span></i> <b>89</b>:3, 277-290<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1080/00223890701629805" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">133</p><p class="content">Anita A Mathias, John Hinkle, Mark Menning, James Hui, Sanjeev Kaul, Brian P Kearney.  (2007) Bioequivalence of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>46</b>:2, 167-173<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e3181427835" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">134</p><p class="content">Mehrdad Hamidi.  (2007) Central nervous system distribution kinetics of indinavir in rats. <i><span class="NLM_source">Journal of Pharmacy and Pharmacology</span></i> <b>59</b>:8, 1077-1085<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1211/jpp.59.8.0004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">135</p><p class="content">I. Sarkar, I. Hauber, J. Hauber, F. Buchholz.  (2007) HIV-1 Proviral DNA Excision Using an Evolved Recombinase. <i><span class="NLM_source">Science</span></i> <b>316</b>:5833, 1912-1915<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1126/science.1141453" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">136</p><p class="content">Tim R Cressey, Nottasorn Plipat, Federica Fregonese, Kulkanya Chokephaibulkit.  (2007) Indinavir/ritonavir remains an important component of HAART for the treatment of HIV/AIDS, particularly in resource-limited settings. <i><span class="NLM_source">Expert Opinion on Drug Metabolism &amp; Toxicology</span></i> <b>3</b>:3, 347-361<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/17425255.3.3.347" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">137</p><p class="content">Suely H Tuboi, Martin W G Brinkhof, Matthias Egger, Roslyn A Stone, Paula Braitstein, Denis Nash, Eduardo Sprinz, Fran??ois Dabis, Lee H Harrison, Mauro Schechter.  (2007) Discordant Responses to Potent Antiretroviral Treatment in Previously Naive HIV-1-Infected Adults Initiating Treatment in Resource-Constrained Countries. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>45</b>:1, 52-59<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e318042e1c3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">138</p><p class="content">Joel E. Gallant.  (2007) Should antiretroviral therapy be started earlier?. <i><span class="NLM_source">Current HIV/AIDS Reports</span></i> <b>4</b>:2, 53-59<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s11904-007-0008-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">139</p><p class="content">M. Vogel, J.K. Rockstroh.  (2007) Chronische HIV-Infektion. <i><span class="NLM_source">Der Internist</span></i> <b>48</b>:5, 519-526<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s00108-007-1845-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">140</p><p class="content">JJ Laurichesse, A Persoz, I Theodorou, C Rouzioux, JF Delfraissy, L Meyer.  (2007) Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 ?32 deletion. <i><span class="NLM_source">HIV Medicine</span></i> <b>8</b>:4, 213-219<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1468-1293.2007.00455.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">141</p><p class="content">Mark Boyd.  (2007) Indinavir: the forgotten HIV-protease inhibitor. Does it still have a role?. <i><span class="NLM_source">Expert Opinion on Pharmacotherapy</span></i> <b>8</b>:7, 957-964<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/14656566.8.7.957" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">142</p><p class="content">Sonia Napravnik, Jessica R Keys, E Byrd Quinlivan, David A Wohl, Oksana V Mikeal, Joseph J Eron.  (2007) Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>21</b>:7, 825-834<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e32805e8764" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">143</p><p class="content">Roy M Gulick, Christina M Lalama, Heather J Ribaudo, Cecilia M Shikuma, Bruce R Schackman, Jeffrey Schouten, Kathleen E Squires, Susan L Koletar, Christopher D Pilcher, Richard C Reichman, Karin L Klingman, Daniel R Kuritzkes.  (2007) Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression. <i><span class="NLM_source">AIDS</span></i> <b>21</b>:7, 813-823<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e32805e8753" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">144</p><p class="content">Rodger D MacArthur.  (2007) Darunavir: promising initial results. <i><span class="NLM_source">The Lancet</span></i> <b>369</b>:9568, 1143-1144<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(07)60499-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">145</p><p class="content">Roy M. Gulick.  (2007) Antiretroviral Management of Treatment-Naive Patients. <i><span class="NLM_source">Infectious Disease Clinics of North America</span></i> <b>21</b>:1, 71-84<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.idc.2007.01.002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">146</p><p class="content">Deborah Persaud, Stuart C. Ray, Joleen Kajdas, Aima Ahonkhai, George K. Siberry, Kimberly Ferguson, Carrie Ziemniak, Thomas C. Quinn, Joseph P. Casazza, Steven Zeichner, Stephen J. Gange, Douglas C. Watson.  (2007) Slow Human Immunodeficiency Virus Type 1 Evolution in Viral Reservoirs in Infants Treated with Effective Antiretroviral Therapy. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>23</b>:3, 381-390<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2006.0175" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">147</p><p class="content">Laurent Balvay, Marcelo Lopez Lastra, Bruno Sargueil, Jean-Luc Darlix, Théophile Ohlmann.  (2007) Translational control of retroviruses. <i><span class="NLM_source">Nature Reviews Microbiology</span></i> <b>5</b>:2, 128-140<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1038/nrmicro1599" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">148</p><p class="content">Masaki Imai, Lajos Baranyi, Noriko Okada, Hidechika Okada.  (2007) Inhibition of HIV-1 infection by synthetic peptides derived CCR5 fragments. <i><span class="NLM_source">Biochemical and Biophysical Research Communications</span></i> <b>353</b>:4, 851-856<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.bbrc.2006.12.084" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">149</p><p class="content">Ting Zhang, Yuan Li, Yan-Jian Wang, Xu Wang, Mike Young, Steven D. Douglas, Wen-Zhe Ho.  (2007) Natural killer cell inhibits human immunodeficiency virus replication in chronically infected immune cells. <i><span class="NLM_source">Antiviral Research</span></i> <b>73</b>:2, 132-139<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.antiviral.2006.08.006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">150</p><p class="content">Carlos Alberto Zaccarelli-Filho, Erika Ono, Daisy Maria Machado, Milena Brunialti, Regina Célia de Menezes Succi, Reinaldo Salomão, Esper Georges Kallás, Maria Isabel de Moraes-Pinto.  (2007) HIV-1-infected children on HAART: Immunologic features of three different levels of viral suppression. <i><span class="NLM_source">Cytometry Part B: Clinical Cytometry</span></i> <b>72B</b>:1, 14-21<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/cyto.b.20152" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">151</p><p class="content">Tsuyoshi Yoshida, Vickie C Jones, Makiko Kobayashi, Xiao-Dong Li, Richard B Pollard, Fujio Suzuki.  (2007) Acceleration of R5 HIV replication by polymorphonuclear neutrophils in cultures of macrophages. <i><span class="NLM_source">Immunology and Cell Biology</span></i><br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1038/sj.icb.7100024" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">152</p><p class="content">Sylvain Thierry, Joël Gozlan, Amandine Jaulmes, Rachel Boniface, Nadine Nasreddine, François Strauss, Vincent Maréchal.  (2007) High-mobility group box 1 protein induces HIV-1 expression from persistently infected cells. <i><span class="NLM_source">AIDS</span></i> <b>21</b>:3, 283-292<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e3280115b50" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">153</p><p class="content">Margaret A Fischl, Ann C Collier, A Lisa Mukherjee, Judith E Feinberg, Lisa M Demeter, Pablo Tebas, Marina Giuliano, Marjorie Dehlinger, Kevin Garren, Barbara Brizz, Roland Bassett.  (2007) Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen. <i><span class="NLM_source">AIDS</span></i> <b>21</b>:3, 325-333<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e328011ddfa" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">154</p><p class="content">Sidney A. Houff, Eugene O. Major. Neuropharmacology of HIV/AIDS. Elsevier, 2007:319-364.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0072-9752(07)85019-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">155</p><p class="content">Anton Pozniak.  (2006) Initiation of antiretroviral therapy. <i><span class="NLM_source">Current Opinion in Internal Medicine</span></i> <b>5</b>:6, 594-604<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.COH.0000239852.22614.b1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">156</p><p class="content">Douglas L. Mayers, Jain Chung, Veronika M. Kohlbrenner, David B. Hall, Ralph A. DeMasi, Dietmar Neubacher, Neil E. Buss, Miklos P. Salgo.  (2006) Seeking Ethical Designs for HIV Clinical Trials in Treatment-Experienced Patients: An Industry Perspective. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>22</b>:11, 1110-1112<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2006.22.1110" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">157</p><p class="content">S. Esser.  (2006) Antiretrovirale Therapieregime. <i><span class="NLM_source">Der Hautarzt</span></i> <b>57</b>:11, 961-968<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s00105-006-1224-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">158</p><p class="content">D. Foschi, P. Cellerino, F. Corsi, A. Casali, A. Rizzi, I. Righi, E. Trabucchi.  (2006) Impact of highly active antiretroviral therapy on outcome of cholecystectomy in patients with human immunodeficiency virus infection. <i><span class="NLM_source">British Journal of Surgery</span></i> <b>93</b>:11, 1383-1389<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/bjs.5527" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">159</p><p class="content">M. Hartmann.  (2006) Arzneimittelnebenwirkungen bei antiretroviraler Therapie. <i><span class="NLM_source">Der Hautarzt</span></i> <b>57</b>:11, 969-974<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s00105-006-1240-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">160</p><p class="content">Toks Akerele, Grazyna Galatowicz, Catey Bunce, Virginia Calder, William A. Lynn, Susan Lightman.  (2006) Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy. <i><span class="NLM_source">Clinical Immunology</span></i> <b>121</b>:2, 191-197<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.clim.2006.07.008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">161</p><p class="content">Roy M. Gulick.  (2006) <i>Editorial Commentary:</i>
              Adherence to Antiretroviral Therapy: How Much Is Enough?. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>43</b>:7, 942-944<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/507549" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">162</p><p class="content">Andrew M. L. Lever. AIDS/HIV, Molecular and Cell Biology. In: Encyclopedia of Molecular Cell Biology and Molecular Medicine. Wiley-VCH Verlag GmbH &amp; Co. KGaA, 2006.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/3527600906.mcb.200300043" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">163</p><p class="content">Arun K. Ghosh, Perali Ramu Sridhar, Nagaswamy Kumaragurubaran, Yasuhiro Koh, Irene T. Weber, Hiroaki Mitsuya.  (2006) Bis-Tetrahydrofuran: a Privileged Ligand for Darunavir and a New Generation of HIV Protease Inhibitors That Combat Drug Resistance. <i><span class="NLM_source">ChemMedChem</span></i> <b>1</b>:9, 939-950<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/cmdc.200600103" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">164</p><p class="content">Ellen M. Tedaldi, John T. Brooks, Paul J. Weidle, James T. Richardson, Rose K. Baker, Kate Buchacz, Anne C. Moorman, Kathleen C. Wood, Scott D. Holmberg.  (2006) Increased Body Mass Index Does Not Alter Response to Initial Highly Active Antiretroviral Therapy in HIV-1-Infected Patients. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>43</b>:1, 35-41<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000234084.11291.d4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">165</p><p class="content">Douglas D. Richman.  (2006) Antiviral drug resistance. <i><span class="NLM_source">Antiviral Research</span></i> <b>71</b>:2-3, 117-121<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.antiviral.2006.03.004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">166</p><p class="content">Won Hee Kim, Han Byul Chung, Chung Choo Chung.  (2006) Optimal Switching In Structured Treatment Interruption For Hiv Therapy. <i><span class="NLM_source">Asian Journal of Control</span></i> <b>8</b>:3, 290-296<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1934-6093.2006.tb00280.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">167</p><p class="content">A. Mocroft, C. A. Sabin, M. Youle, S. Madge, M. Tyrer, H. Devereux, J. Deayton, A. Dykhoff, M. C. I. Lipman, A. N. Phillips, M. A. Johnson.  (2006) Changes in AIDS-Defining Illnesses in a London Clinic, 1987???1998. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>21</b>:5, 401<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.pas.0000213299.11649.106" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">168</p><p class="content">Mehrdad Hamidi.  (2006) Role of P-glycoprotein in tissue uptake of indinavir in rat. <i><span class="NLM_source">Life Sciences</span></i> <b>79</b>:10, 991-998<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.lfs.2006.05.010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">169</p><p class="content">Line Labbé, Davide Verotta.  (2006) A Non-linear Mixed Effect Dynamic Model Incorporating Prior Exposure and Adherence to Treatment to Describe Long-term Therapy Outcome in HIV-patients. <i><span class="NLM_source">Journal of Pharmacokinetics and Pharmacodynamics</span></i> <b>33</b>:4, 519-542<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10928-006-9022-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">170</p><p class="content">Linda Gorgos, Erica Avery, Keith Bletzer, Charlton Wilson.  (2006) Determinants of Survival for Native American Adults with HIV Infection. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>20</b>:8, 586-594<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/apc.2006.20.586" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">171</p><p class="content">Santiago Pérez-Hoyos.  (2006) Efecto del tratamiento antirretroviral de gran eficacia en la infección por el VIH: papel de los estudios epidemiológicos. <i><span class="NLM_source">Medicina Clínica</span></i> <b>127</b>:5, 175-176<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1157/13090711" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">172</p><p class="content">Alain Makinson, Bernard Masquelier, Audrey Taieb, Gilles Peytavin, Anne Waldner-Combernoux, Gilles Collin, Genevieve Chêne, Françoise Brun-Vézinet, François Raffi, Vincent Le Moing, Catherine Leport, Diane Descamps.  (2006) Presence of numerous stop codons in HIV-1 reverse transcriptase proviral DNA sequences from patients with virological response to HAART. <i><span class="NLM_source">AIDS</span></i> <b>20</b>:9, 1327-1329<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.aids.0000232242.51286.7b" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">173</p><p class="content">Wendy P. Bannister, Ole Kirk, Jose M. Gatell, Brygida Knysz, Jean-Paul Viard, Helene Mens, Antonella D'Arminio Monforte, Andrew N. Phillips, Amanda Mocroft, Jens D. Lundgren.  (2006) Regional Changes Over Time in Initial Virologic Response Rates to Combination Antiretroviral Therapy Across Europe. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>42</b>:2, 229-237<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000214815.95786.31" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">174</p><p class="content">Steven G Deeks.  (2006) The risk of treatment versus the risk of HIV replication. <i><span class="NLM_source">The Lancet</span></i> <b>367</b>:9527, 1955-1956<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(06)68857-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">175</p><p class="content">R. Bruno, P. Sacchi, L. Maiocchi, S. Patruno, G. Filice.  (2006) Hepatotoxicity and antiretroviral therapy with protease inhibitors: A review. <i><span class="NLM_source">Digestive and Liver Disease</span></i> <b>38</b>:6, 363-373<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.dld.2006.01.020" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">176</p><p class="content">Rafik Samuel, Robert Bettiker, Byungse Suh.  (2006) Antiretroviral therapy 2006: Pharmacology, applications, and special situations. <i><span class="NLM_source">Archives of Pharmacal Research</span></i> <b>29</b>:6, 431-458<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF02969415" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">177</p><p class="content">Christopher S. Krawczyk, Ellen Funkhouser, J Michael Kilby, Richard A. Kaslow, Amita K. Bey, Sten H. Vermund.  (2006) Factors Associated with Delayed Initiation of HIV Medical Care Among Infected Persons Attending a Southern HIV/AIDS Clinic. <i><span class="NLM_source">Southern Medical Journal</span></i> <b>99</b>:5, 472-481<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.smj.0000215639.59563.83" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">178</p><p class="content">Mark A. Boyd, Preeyaporn Srasuebkul, Kiat Ruxrungtham, Peter I. Mackenzie, Verawan Uchaipichat, Michael Stek, Joep M.A. Lange, Praphan Phanuphak, David A. Cooper, Wandee Udomuksorn, John O. Miners.  (2006) Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir. <i><span class="NLM_source">Pharmacogenetics and Genomics</span></i> <b>16</b>:5, 321-329<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.fpc.0000197465.14340.d4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">179</p><p class="content">Manuel Battegay, Reto Nüesch, Bernard Hirschel, Gilbert R Kaufmann.  (2006) Immunological recovery and antiretroviral therapy in HIV-1 infection. <i><span class="NLM_source">The Lancet Infectious Diseases</span></i> <b>6</b>:5, 280-287<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1473-3099(06)70463-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">180</p><p class="content">Niloufar Ameli, Peter Bacchetti, Rhoda Ashley Morrow, Nancy A Hessol, Timothy Wilkin, Mary Young, Mardge Cohen, Howard Minkoff, Stephen J Gange, Ruth M Greenblatt.  (2006) Herpes simplex virus infection in women in the WIHS: Epidemiology and effect of antiretroviral therapy on clinical manifestations. <i><span class="NLM_source">AIDS</span></i> <b>20</b>:7, 1051-1058<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.aids.0000222078.75867.77" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">181</p><p class="content">Rachael Jones, Brian Gazzard.  (2006) HIV/AIDS pathogenesis and treatment options focusing on the viral entry inhibitors. <i><span class="NLM_source">Expert Review of Anti-infective Therapy</span></i> <b>4</b>:2, 303-312<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1586/14787210.4.2.303" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">182</p><p class="content">Mehrdad Hamidi.  (2006) Simple and sensitive high-performance liquid chromatography method for the quantitation of indinavir in rat plasma and central nervous system. <i><span class="NLM_source">Journal of Separation Science</span></i> <b>29</b>:5, 620-627<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/jssc.200500328" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">183</p><p class="content">V. V. Velichenko, D. A. Pritykin.  (2006) Control of the medical treatment of AIDS. <i><span class="NLM_source">Automation and Remote Control</span></i> <b>67</b>:3, 493-511<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1134/S0005117906030131" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">184</p><p class="content">Antigoni Katsoulidou, Maria Petrodaskalaki, Vana Sypsa, Eleni Papachristou, Cleo G. Anastassopoulou, Panagiotis Gargalianos, Anastasia Karafoulidou, Marios Lazanas, Theodoros Kordossis, Anastasia Andoniadou, Angelos Hatzakis.  (2006) Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays—LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 Monitor v1.5. <i><span class="NLM_source">Journal of Virological Methods</span></i> <b>131</b>:2, 168-174<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jviromet.2005.07.014" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">185</p><p class="content">M.P. Geijo Martínez, M.Á. Maciá Martínez, J. Solera Santos, J.R. Barberá Farré, M. Rodríguez Zapata, F. Marcos Sánchez, E. Martínez Alfaro, F. Cuadra García-Tenorio, J. Sanz Moreno, J.M. Moreno Mendaña, J.L. Beato Pérez, J. Sanz Sanz.  (2006) Ensayo clínico comparativo de eficacia y seguridad de cuatro pautas de tratamiento antirretroviral de alta eficacia (TARGA) en pacientes naive con infección por VIH avanzada. <i><span class="NLM_source">Revista Clínica Española</span></i> <b>206</b>:2, 67-76<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1157/13085355" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">186</p><p class="content">Robert F Siliciano. Acquired Immune Deficiency Syndrome (AIDS). In: Encyclopedia of Life Sciences. John Wiley &amp; Sons, Ltd, 2006.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1038/npg.els.0003998" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">187</p><p class="content">Stefano Rusconi, Ottavia Vigano.  (2006) New HIV protease inhibitors for drug-resistant viruses. <i><span class="NLM_source">Therapy</span></i> <b>3</b>:1, 79-88<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1586/14750708.3.1.79" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">188</p><p class="content">Steve A Castillo, Jaime E Hernandez, Cindy H Brothers.  (2006) Long-Term Safety and Tolerability of the Lamivudine/Abacavir Combination as Components of Highly Active Antiretroviral Therapy. <i><span class="NLM_source">Drug Safety</span></i> <b>29</b>:9, 811-826<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2165/00002018-200629090-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">189</p><p class="content">Emmanouil Papasavvas, Jay R. Kostman, Brian Thiel, Maxwell Pistilli, Agnieszka Mackiewicz, Andrea Foulkes, Robert Gross, Kimberly A. Jordan, Douglas F. Nixon, Robert Grant, Jean-francois Poulin, Joseph M. Mccune, Karam Mounzer, Luis J. Montaner.  (2006) HIV-1-Specific CD4+ T Cell Responses in Chronically HIV-1 Infected Blippers on Antiretroviral Therapy in Relation to Viral Replication Following Treatment Interruption. <i><span class="NLM_source">Journal of Clinical Immunology</span></i> <b>26</b>:1, 40-54<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10875-006-7518-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">190</p><p class="content">DALMO CORREIA, LUIZ ANTONIO PERTILLI RODRIGUES DE RESENDE, RODRIGO JULIANO MOLINA, BRUNO DORIGUETTO COUTO FERREIRA, FERNANDO COLOMBARI, CARLOS JOSE DORNAS G. BARBOSA, VALDO JOSE DIAS DA SILVA, ALUIZIO PRATA.  (2006) Power Spectral Analysis of Heart Rate Variability in HIV-Infected and AIDS Patients. <i><span class="NLM_source">Pacing and Clinical Electrophysiology</span></i> <b>29</b>:1, 53-58<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1540-8159.2006.00297.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">191</p><p class="content">Stefano Rusconi, Ottavia Viganò.  (2006) New HIV protease inhibitors for drug-resistant viruses. <i><span class="NLM_source">Therapy</span></i> <b>3</b>:1, 79-88<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2217/14750708.3.1.79" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">192</p><p class="content">Norbert Bräu, Mirella Salvatore, Carlos F. Ríos-Bedoya, Alberto Fernández-Carbia, Fiorenzo Paronetto, José F. Rodríguez-Orengo, Maribel Rodríguez-Torres.  (2006) Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. <i><span class="NLM_source">Journal of Hepatology</span></i> <b>44</b>:1, 47-55<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jhep.2005.07.006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">193</p><p class="content"> Severe ,  Patrice ,  Leger ,  Paul ,  Charles ,  Macarthur ,  Noel ,  Francine ,  Bonhomme ,  Gerry ,  Bois ,  Gyrlande ,  George ,  Erik ,  Kenel-Pierre ,  Stefan ,  Wright ,  Peter F. ,  Gulick ,  Roy ,  Johnson ,  Warren D.   Jr. ,  Pape ,  Jean William ,  Fitzgerald ,  Daniel W. , .  (2005) Antiretroviral Therapy in a Thousand Patients with AIDS in Haiti. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>353</b>:22, 2325-2334<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJMoa051908">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJMoa051908} --></span></p></li><li class="even"><p class="number">194</p><p class="content">Roger Pomerantz, Giuseppe Nunnari. HIV-1 Reservoirs and Residual Viral Replication during Highly Active Antiretroviral Therapy. In: Cell Death During HIV Infection. CRC Press, 2005:457-474.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1201/9781420038156.ch26" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">195</p><p class="content">Gerd Fätkenheuer, Anton L Pozniak, Margaret A Johnson, Andreas Plettenberg, Schlomo Staszewski, Andy I M Hoepelman, Michael S Saag, Frank D Goebel, Jürgen K Rockstroh, Bruce J Dezube, Tim M Jenkins, Christine Medhurst, John F Sullivan, Caroline Ridgway, Samantha Abel, Ian T James, Mike Youle, Elna van der Ryst.  (2005) Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1. <i><span class="NLM_source">Nature Medicine</span></i> <b>11</b>:11, 1170-1172<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1038/nm1319" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">196</p><p class="content">Samantha Willey, Paul J. Peters, W. Matthew Sullivan, Patrick Dorr, Manos Perros, Paul R. Clapham.  (2005) Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: Effects of viral diversity, target cell and receptor density. <i><span class="NLM_source">Antiviral Research</span></i> <b>68</b>:2, 96-108<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.antiviral.2005.07.006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">197</p><p class="content">Michael F Schneider, Stephen J Gange, Carolyn M Williams, Kathryn Anastos, Ruth M Greenblatt, Lawrence Kingsley, Roger Detels, Alvaro Muñoz.  (2005) Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984–2004. <i><span class="NLM_source">AIDS</span></i> <b>19</b>:17, 2009-2018<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.aids.0000189864.90053.22" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">198</p><p class="content">M. Arnedo-Valero, F. Garcia, C. Gil, T. Guila, E. Fumero, P. Castro, J. L. Blanco, J. M. Miro, T. Pumarola, J. M. Gatell.  (2005) Risk of Selecting De Novo Drug-Resistance Mutations during Structured Treatment Interruptions in Patients with Chronic HIV Infection. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>41</b>:6, 883-890<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/432881" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">199</p><p class="content">Richard M. Rutstein, Kelly A. Gebo, Patricia M. Flynn, John A. Fleishman, Victoria L. Sharp, George K. Siberry, Stephen A. Spector.  (2005) Immunologic Function and Virologic Suppression Among Children With Perinatally Acquired HIV Infection on Highly Active Antiretroviral Therapy. <i><span class="NLM_source">Medical Care</span></i> <b>43</b>:suppl, III-15-III-22<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.mlr.0000175636.34524.b9" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">200</p><p class="content">M.J. Muñoz, M. Merino-Sanjuán, R. Lledó-García, V.G. Casabó, F.J. Máñez-Castillejo, A. Nácher.  (2005) Use of nonlinear mixed effect modeling for the intestinal absorption data: Application to ritonavir in the rat. <i><span class="NLM_source">European Journal of Pharmaceutics and Biopharmaceutics</span></i> <b>61</b>:1-2, 20-26<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.ejpb.2005.03.008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">201</p><p class="content">Eric Ashton, Mark Vosvick, Margaret Chesney, Cheryl Gore-Felton, Cheryl Koopman, Kristen O'shea, José Maldonado, Michael H. Bachmann, Dennis Israelski, Jason Flamm, David Spiegel.  (2005) Social Support and Maladaptive Coping as Predictors of the Change in Physical Health Symptoms among Persons Living with HIV/AIDS. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>19</b>:9, 587-598<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/apc.2005.19.587" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">202</p><p class="content">Veronica Svedhem, A. Lindkvist, T. Bergroth, Lidman Knut, A. Sönnerborg.  (2005) Diverse pattern of protease inhibitor resistance mutations in HIV-1 infected patients failing nelfinavir. <i><span class="NLM_source">Journal of Medical Virology</span></i> <b>76</b>:4, 447-451<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/jmv.20381" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">203</p><p class="content">Karen Cohen, Ushma Mehta, Donovan Hiss, Gary Maartens, Jennifer Pitt, Karen Cohen. Ritonavir-boosted protease inhibitor-containing regimens versus non-boosted protease-inhibitor-containing regimens for reducing morbidity and mortality in people with HIV/AIDS. In: Cochrane Database of Systematic Reviews. John Wiley &amp; Sons, Ltd, 2005.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/14651858.CD005418" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">204</p><p class="content">M.D. Prasanna, Jiri Vondrasek, Alexander Wlodawer, T.N. Bhat.  (2005) Application of InChI to curate, index, and query 3-D structures. <i><span class="NLM_source">Proteins: Structure, Function, and Bioinformatics</span></i> <b>60</b>:1, 1-4<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/prot.20469" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">205</p><p class="content">DANIEL E. GOLDBERG, LINDSAY M. SMITHEN, ALLISON ANGELILLI, WILLIAM R. FREEMAN.  (2005) HIV-ASSOCIATED RETINOPATHY IN THE HAART ERA. <i><span class="NLM_source">Retina</span></i> <b>25</b>:5, 633-649<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00006982-200507000-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">206</p><p class="content">Martin Markowitz, Christina Hill-Zabala, Joseph Lang, Edwin DeJesus, Qiming Liao, E Randall Lanier, E Anne Davis, Mark Shaefer.  (2005) Induction With Abacavir/Lamivudine/Zidovudine Plus Efavirenz for 48 Weeks Followed by 48-Week Maintenance With Abacavir/Lamivudine/Zidovudine Alone in Antiretroviral-Naive HIV-1-Infected Patients. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>39</b>:3, 257-264<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000169664.15536.20" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">207</p><p class="content">Mark A Perazella.  (2005) Drug-induced nephropathy: an update. <i><span class="NLM_source">Expert Opinion on Drug Safety</span></i> <b>4</b>:4, 689-706<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/14740338.4.4.689" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">208</p><p class="content">Jennifer E. Cook, Somsankar Dasgupta, Lawrence D. Middaugh, Elaine C. Terry, Paul R. Gorry, Steven L. Wesselingh, William R. Tyor.  (2005) Highly active antiretroviral therapy and human immunodeficiency virus encephalitis. <i><span class="NLM_source">Annals of Neurology</span></i> <b>57</b>:6, 795-803<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/ana.20479" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">209</p><p class="content">Hema Viswanathan, Rodney Anderson, Joseph Thomas.  (2005) Evaluation of an Antiretroviral Medication Attitude Scale and Relationships Between Medication Attitudes and Medication Nonadherence. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>19</b>:5, 306-316<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/apc.2005.19.306" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">210</p><p class="content">Diane Descamps, Marie-Laure Chaix, Patrice Andr??, V??ronique Brodard, Jacqueline Cottalorda, Christiane Deveau, Martine Harzic, Didier Ingrand, Jacques Izopet, Evelyne Kohli, Bernard Masquelier, Said Mouajjah, Pierre Palmer, Isabelle Pellegrin, Jean-Christophe Plantier, C??cile Poggi, Sylvie Rogez, Annick Ruffault, V??ronique Schneider, Anne Signori-Schm??ck, Catherine Tamalet, Marc Wirden, Christine Rouzioux, Fran??oise Brun-Vezinet, Laurence Meyer, Dominique Costagliola.  (2005) French National Sentinel Survey of Antiretroviral Drug Resistance in Patients With HIV-1 Primary Infection and in Antiretroviral-Naive Chronically Infected Patients in 2001-2002. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>38</b>:5, 545-552<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000155201.51232.2e" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">211</p><p class="content">Mireia Arnedo-Valero, Tomàs Pumarola.  (2005) HIV-1 genotypic resistance in structured treatment interruptions. <i><span class="NLM_source">Reviews in Medical Microbiology</span></i> <b>16</b>:2, 33-38<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.revmedmi.0000166858.91649.82" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">212</p><p class="content">Carmem Beatriz Wagner Giacoia-Gripp, Ivan Neves, Maria Clara Galhardo, Mariza Gon<img src="untitled" alt="" class="entityD">alves Morgado.  (2005) Flow Cytometry Evaluation of the T-Cell ReceptorV? Repertoire Among HIV-1 Infected Individuals Before and After Antiretroviral Therapy. <i><span class="NLM_source">Journal of Clinical Immunology</span></i> <b>25</b>:2, 116-126<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10875-005-2817-z" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">213</p><p class="content">Bradford A. Navia, Kevin Rostasy.  (2005) The AIDS dementia complex: Clinical and basic Neuroscience with implications for novel molecular therapies. <i><span class="NLM_source">Neurotoxicity Research</span></i> <b>8</b>:1-2, 3-24<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF03033817" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">214</p><p class="content">Rafael E Campo, Rose Lalanne, Thomas J Tanner, Dushyantha T Jayaweera, Allan E Rodriguez, Lunie Fontaine, Michael A Kolber.  (2005) Lopinavir/ritonavir maintenance monotherapy after successful viral suppression with standard highly active antiretroviral therapy in HIV-1-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>19</b>:4, 447-449<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.aids.0000161777.38438.ed" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">215</p><p class="content"> Sanders ,  Gillian D. ,  Bayoumi ,  Ahmed M. ,  Sundaram ,  Vandana ,  Bilir ,  S. Pinar ,  Neukermans ,  Christopher P. ,  Rydzak ,  Chara E. ,  Douglass ,  Lena R. ,  Lazzeroni ,  Laura C. ,  Holodniy ,  Mark ,  Owens ,  Douglas K. , .  (2005) Cost-Effectiveness of Screening for HIV in the Era of Highly Active Antiretroviral Therapy. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>352</b>:6, 570-585<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJMsa042657">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJMsa042657} --></span></p></li><li class="even"><p class="number">216</p><p class="content">Xavier Duval, France Mentr??, Claire Lamotte, Genevieve Ch??ne, Bruno Spire, Pierre Dellamonica, Xavi??re Panhard, Dominique Salmon, Fran??ois Raffi, Gilles Peytavin, Catherine Leport.  (2005) Indinavir Plasma Concentration and Adherence Score Are Codeterminant of Early Virologic Response in HIV-Infected Patients of the APROCO Cohort. <i><span class="NLM_source">Therapeutic Drug Monitoring</span></i> <b>27</b>:1, 63-70<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00007691-200502000-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">217</p><p class="content">Ilona Hauber, Dorian Bevec, Jochen Heukeshoven, Friedrich Krätzer, Florian Horn, Axel Choidas, Thomas Harrer, Joachim Hauber.  (2005) Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy. <i><span class="NLM_source">Journal of Clinical Investigation</span></i> <b>115</b>:1, 76-85<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1172/JCI200521949" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">218</p><p class="content">Ilona Hauber, Dorian Bevec, Jochen Heukeshoven, Friedrich Krätzer, Florian Horn, Axel Choidas, Thomas Harrer, Joachim Hauber.  (2005) Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy. <i><span class="NLM_source">Journal of Clinical Investigation</span></i> <b>115</b>:1, 76-85<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1172/JCI21949" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">219</p><p class="content">Martin Stürmer, Annemarie Berger, Wolfgang Preiser, Hans Wilhelm Doerr.  (2005) Kommerzielle Systeme zur Genotypisierung von humanen Immundefizienzviren Typ 1: Vergleich von ViroSeq (Abbott) und TruGene (Bayer). Commercially available assays for genotyping of human immunodeficiency virus type 1: Comparison of ViroSeq (Abbott) and TruGene (Bayer). <i><span class="NLM_source">LaboratoriumsMedizin</span></i> <b>29</b>:1, 50-62<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1515/JLM.2005.008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">220</p><p class="content">Shizuko Sei.  (2005) Peptide nucleic acids as epigenetic inhibitors of HIV-1. <i><span class="NLM_source">International Journal of Peptide Research and Therapeutics</span></i> <b>10</b>:3, 269-286<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10989-005-4925-2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">221</p><p class="content">Glen S. Markowitz, Mark A. Perazella.  (2005) Drug-induced renal failure: a focus on tubulointerstitial disease. <i><span class="NLM_source">Clinica Chimica Acta</span></i> <b>351</b>:1-2, 31-47<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.cccn.2004.09.005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">222</p><p class="content">Hannele Yki‐Järvinen.  (2005) Fat in the liver and insulin resistance. <i><span class="NLM_source">Annals of Medicine</span></i> <b>37</b>:5, 347-356<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1080/07853890510037383" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">223</p><p class="content">K JEROME.  (2005) The road to new antiviral therapies. <i><span class="NLM_source">Clinical and Applied Immunology Reviews</span></i> <b>5</b>:1, 65-76<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.cair.2004.10.002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">224</p><p class="content">Günal Kahraman, Katharina Krepler, Carmen Franz, Eva Ries, Noemi Maar, Andreas Wedrich, Armin Rieger, Irene Dejaco-Ruhswurm.  (2005) Seven Years of HAART Impact on Ophthalmic Management of HIV-Infected Patients. <i><span class="NLM_source">Ocular Immunology and Inflammation</span></i> <b>13</b>:2-3, 213-218<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1080/09273940490912443" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">225</p><p class="content">Zita Lazzarini, Jonathan E Von Kohorn. Medical Ethics and the Law. In: The AIDS Pandemic. Elsevier, 2005:488-510.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/B978-012465271-2/50022-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">226</p><p class="content">Y. H. Joshua Chen, Michael L. Nessly, Balasamy Thiyagarajan.  (2004) Incorporating Durability Information in the Comparison of Proportions of Patients with HIV Suppression. <i><span class="NLM_source">Journal of Biopharmaceutical Statistics</span></i> <b>14</b>:3, 741-755<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1081/BIP-200025683" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">227</p><p class="content">Felix Grases, Ram n Gare a-Gonz lez, Enrique Redondo, Antonia Costa-Bauz, Bartolom M. Simonet, Raquel P. Sartini, Antoni Bassa, Carmen Gallegos, Antoni Payeras, Dulce Saro, Ana-Isabel Martinez, Carmen Cifuentes, Francisco Homar, Jos A. Murillo, Cristina Fern ndez, Melchor Riera, Antonio Conte.  (2004) Effects of escin on indinavir crystallization time in the urine of patients with HIV-I infection: A multicenter, randomized, open-label, controlled, four-period crossover trial. <i><span class="NLM_source">Clinical Therapeutics</span></i> <b>26</b>:12, 2045-2055<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.clinthera.2004.12.014" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">228</p><p class="content">Andrew V. Albright, Francisco González-Scarano.  (2004) Microarray analysis of activated mixed glial (microglia) and monocyte-derived macrophage gene expression. <i><span class="NLM_source">Journal of Neuroimmunology</span></i> <b>157</b>:1-2, 27-38<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jneuroim.2004.09.007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">229</p><p class="content">Hans Henriklarsen, Henry Masur, Joseph Kovacs. Current Regimens for Treatment and Prophylaxis of Pneumocystis jirovecii Pneumonia. CRC Press, 2004:505-538.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1201/b14162-21" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">230</p><p class="content">Jodi K. Craigo, Bruce K. Patterson, Shirish Paranjpe, Kathy Kulka, Ming Ding, John Mellors, Ronald C. Montelaro, Phalguni Gupta.  (2004) Persistent HIV Type 1 Infection in Semen and Blood Compartments in Patients after Long-Term Potent Antiretroviral Therapy. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>20</b>:11, 1196-1209<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2004.20.1196" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">231</p><p class="content">Daniel S. Stein, Yu Lou, Mark Johnson, Sharon Randall, Stephane Blanche, .  (2004) Pharmacokinetic and Pharmacodynamic Analysis of Amprenavir-Containing Combination Therapy in HIV-1-Infected Children. <i><span class="NLM_source">The Journal of Clinical Pharmacology</span></i> <b>44</b>:11, 1301-1308<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1177/0091270004269561" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">232</p><p class="content">Paolo Monini, Cecilia Sgadari, Elena Toschi, Giovanni Barillari, Barbara Ensoli.  (2004) Antitumour effects of antiretroviral therapy. <i><span class="NLM_source">Nature Reviews Cancer</span></i> <b>4</b>:11, 861-875<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1038/nrc1479" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">233</p><p class="content">Galit Alter, Christos Micheal Tsoukas, Danielle Rouleau, Pierre Côté, Jean-Pierre Routy, Rafik-Pierre Sékaly, Nicole Flore Bernard.  (2004) Assessment of longitudinal changes in HIV-specific effector activity in subjects undergoing untreated primary HIV infection. <i><span class="NLM_source">AIDS</span></i> <b>18</b>:15, 1979-1989<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200410210-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">234</p><p class="content">Antigoni Katsoulidou, Eleni Papachristou, Maria Petrodaskalaki, Vana Sypsa, Cleo G. Anastassopoulou, Panagiotis Gargalianos, Anastasia Karafoulidou, Marios Lazanas, Theodoros Kordossis, Anastasia Andoniadou, Angelos Hatzakis.  (2004) Comparison of three current viral load assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. <i><span class="NLM_source">Journal of Virological Methods</span></i> <b>121</b>:1, 93-99<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jviromet.2004.06.007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">235</p><p class="content">Benjamin Young.  (2004) The Role of Nucleoside and Nucleotide Reverse Transcriptase Inhibitor Backbones in Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>37</b>:Supplement 1, S13-S20<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000137002.17634.4e" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">236</p><p class="content">R. M. Viani, M. R. G. Araneta, J. G. Deville, S. A. Spector.  (2004) Decrease in Hospitalization and Mortality Rates among Children with Perinatally Acquired HIV Type 1 Infection Receiving Highly Active Antiretroviral Therapy. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>39</b>:5, 725-731<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/423178" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">237</p><p class="content">Stephen P Raffanti, Jennifer S Fusco, Beth H Sherrill, Nellie I Hansen, Amy C Justice, Richard D???Aquila, Wendy J Mangialardi, Gregory P Fusco.  (2004) Effect of Persistent Moderate Viremia on Disease Progression During HIV Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>37</b>:1, 1147-1154<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000136738.24090.d0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">238</p><p class="content">Marina B Klein, Patrick Willemot, Tanya Murphy, Richard G Lalonde.  (2004) The impact of initial highly active antiretroviral therapy on future treatment sequences in HIV infection. <i><span class="NLM_source">AIDS</span></i> <b>18</b>:14, 1895-1904<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200409240-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">239</p><p class="content">Ryan A Reinke, Deborah J Lee, Brenda R McDougall, Peter J King, Joseph Victoria, Yingqun Mao, Xiangyang Lei, Manfred G Reinecke, W.Edward Robinson.  (2004) l-Chicoric acid inhibits human immunodeficiency virus type 1 integration in vivo and is a noncompetitive but reversible inhibitor of HIV-1 integrase in vitro. <i><span class="NLM_source">Virology</span></i> <b>326</b>:2, 203-219<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.virol.2004.06.005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">240</p><p class="content">Andrew V. Albright, Robin M. Vos, Francisco González-Scarano.  (2004) Low-level HIV replication in mixed glial cultures is associated with alterations in the processing of p55Gag. <i><span class="NLM_source">Virology</span></i> <b>325</b>:2, 328-339<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.virol.2004.04.028" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">241</p><p class="content">X. Duval, V. Journot, C. Leport, G. Chene, M. Dupon, L. Cuzin, T. May, P. Morlat, A. Waldner, R. Salamon, F. Raffi, .  (2004) Incidence of and Risk Factors for Adverse Drug Reactions in a Prospective Cohort of HIV-Infected Adults Initiating Protease Inhibitor--Containing Therapy. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>39</b>:2, 248-255<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/422141" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">242</p><p class="content">Douglas D Richman, Sally C Morton, Terri Wrin, Nicholas Hellmann, Sandra Berry, Martin F Shapiro, Samuel A Bozzette.  (2004) The prevalence of antiretroviral drug resistance in the United States. <i><span class="NLM_source">AIDS</span></i> <b>18</b>:10, 1393-1401<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.aids.0000131310.52526.c7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">243</p><p class="content">Antonio Pires, Gareth Hardy, Brian Gazzard, Frances Gotch, Nesrina Imami.  (2004) Initiation of Antiretroviral Therapy During Recent HIV-1 Infection Results in Lower Residual Viral Reservoirs. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>36</b>:3, 783-790<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200407010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">244</p><p class="content">X Duval, G Peytavin, I Albert, S Benoliel, J-L Ecobichon, F Brun-Vezinet, F Mentre, C Leport, J-L Vilde.  (2004) Determination of indinavir and nelfinavir trough plasma concentration efficacy thresholds according to virological response in HIV-infected patients. <i><span class="NLM_source">HIV Medicine</span></i> <b>5</b>:4, 307-313<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1468-1293.2004.00226.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">245</p><p class="content">Wayne TA Enanoria, Cherie Ng, Sona R Saha, John M Colford Jr.  (2004) Treatment outcomes after highly active antiretroviral therapy: a meta-analysis of randomised controlled trials. <i><span class="NLM_source">The Lancet Infectious Diseases</span></i> <b>4</b>:7, 414-425<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1473-3099(04)01057-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">246</p><p class="content">C Lynn Besch.  (2004) Antiretroviral Therapy in Drug-Naive Patients Infected with Human Immunodeficiency Virus. <i><span class="NLM_source">The American Journal of the Medical Sciences</span></i> <b>328</b>:1, 3-9<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00000441-200407000-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">247</p><p class="content">Grissell Tirado, Gloria Jove, Rakesh Kumar, Richard J Noel, Evelyn Reyes, Gladys Sepulveda, Y Yamamura, Anil Kumar.  (2004) Differential virus evolution in blood and genital tract of HIV-infected females: evidence for the involvement of drug and non-drug resistance-associated mutations. <i><span class="NLM_source">Virology</span></i> <b>324</b>:2, 577-586<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.virol.2004.04.013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">248</p><p class="content">Archana Rao, Susana D’Amico, Ashok Balasubramanyam, Mario Maldonado.  (2004) Fenofibrate Is Effective in Treating Hypertriglyceridemia Associated with HIV Lipodystrophy. <i><span class="NLM_source">The American Journal of the Medical Sciences</span></i> <b>327</b>:6, 315-318<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00000441-200406000-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">249</p><p class="content">H. Choremi-Papadopoulou, K. Tsalimalma, U. Dafni, A. Dimitracopoulou, T. Kordossis.  (2004) Limited long-term naive CD4+ T cell reconstitution in patients experiencing viral load rebounds during HAART. <i><span class="NLM_source">Journal of Medical Virology</span></i> <b>73</b>:2, 235-243<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/jmv.20081" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">250</p><p class="content">Wendy B. Bernstein, Josephine H. Cox, Naomi E. Aronson, LaRee Tracy, Katia Schlienger, Silvia Ratto-Kim, Robin Garner, Julio Cotte, Zhaohui Zheng, Lena Winestone, Caroline Liebig, Lynee M. Galley, Mark Connors, Deborah L. Birx, Richard G. Carroll, Bruce L. Levine.  (2004) Immune reconstitution following autologous transfers of CD3/CD28 stimulated CD4+ T cells to HIV-infected persons. <i><span class="NLM_source">Clinical Immunology</span></i> <b>111</b>:3, 262-274<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.clim.2004.03.004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">251</p><p class="content">Andrew M. Tershakovec, Ian Frank, Daniel Rader.  (2004) HIV-related lipodystrophy and related factors. <i><span class="NLM_source">Atherosclerosis</span></i> <b>174</b>:1, 1-10<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0021-9150(03)00246-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">252</p><p class="content">A Gayet-Ageron, D Baratin, E Marceillac, R Allard, D Peyramond, C Chidiac, C Trepo, J-M Livrozet, J-L Touraine, J Ritter, M Sepetjan, J Fabry, P Vanhems.  (2004) The AIDS epidemic in Lyon: patient characteristics and defining illnesses between 1985 and 2000. <i><span class="NLM_source">HIV Medicine</span></i> <b>5</b>:3, 163-170<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1468-1293.2004.00205.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">253</p><p class="content">Martin Stürmer, Annemarie Berger, Wolfgang Preiser.  (2004) HIV-1 genotyping: comparison of two commercially available assays. <i><span class="NLM_source">Expert Review of Molecular Diagnostics</span></i> <b>4</b>:3, 281-291<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1586/14737159.4.3.281" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">254</p><p class="content"> Gulick ,  Roy M. ,  Ribaudo ,  Heather J. ,  Shikuma ,  Cecilia M. ,  Lustgarten ,  Stephanie ,  Squires ,  Kathleen E. ,  Meyer ,  William A.   III ,  Acosta ,  Edward P. ,  Schackman ,  Bruce R. ,  Pilcher ,  Christopher D. ,  Murphy ,  Robert L. ,  Maher ,  William E. ,  Witt ,  Mallory D. ,  Reichman ,  Richard C. ,  Snyder ,  Sally ,  Klingman ,  Karin L. ,  Kuritzkes ,  Daniel R. , .  (2004) Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>350</b>:18, 1850-1861<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJMoa031772">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJMoa031772} --></span></p></li><li class="odd"><p class="number">255</p><p class="content">Roger J. Pomerantz.  (2004) Effects of HIV-1 Vpr on Neuroinvasion and Neuropathogenesis. <i><span class="NLM_source">DNA and Cell Biology</span></i> <b>23</b>:4, 227-238<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/104454904773819815" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">256</p><p class="content"> Clavel ,  François ,  Hance ,  Allan J. , .  (2004) HIV Drug Resistance. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>350</b>:10, 1023-1035<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJMra025195">Full Text</a><!-- ${xml_link: 10.1056%2FNEJMra025195} --></span></p></li><li class="odd"><p class="number">257</p><p class="content">Wei Song, Yosuke Maeda, Akira Tenpaku, Shinji Harada, Keisuke Yusa.  (2004) Persistence of mutations during replication of an HIV library containing combinations of selected protease mutations. <i><span class="NLM_source">Antiviral Research</span></i> <b>61</b>:3, 173-180<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.antiviral.2003.10.001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">258</p><p class="content">Charles Hicks, Martin S King, Roy M Gulick, A Clinton White Jr, Joseph J Eron Jr, Harold A Kessler, Constance Benson, Kathryn R King, Robert L Murphy, Scott C Brun.  (2004) Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients. <i><span class="NLM_source">AIDS</span></i> <b>18</b>:5, 775-779<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200403260-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">259</p><p class="content">Don E Smith, Bruce D Walker, David A Cooper, Eric S Rosenberg, John M Kaldor.  (2004) Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence?. <i><span class="NLM_source">AIDS</span></i> <b>18</b>:5, 709-718<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200403260-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">260</p><p class="content">Walter K. Kraft, Jacqueline B. McCrea, Gregory A. Winchell, Alexandra Carides, Richard Lowry, Eric J. Woolf, Sandra E. Kusma, Paul J. Deutsch, Howard E. Greenberg, Scott A. Waldman.  (2004) Indinavir and Rifabutin Drug Interactions in Healthy Volunteers. <i><span class="NLM_source">The Journal of Clinical Pharmacology</span></i> <b>44</b>:3, 305-313<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1177/0091270003262807" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">261</p><p class="content">Mahmoud Sadeghi, Volker Daniel, Cord Naujokat, Caner Süsal, Rolf Weimer, Angela Huth-Kühne, Rainer Zimmermann, Gerhard Opelz.  (2004) Dissociation of CD4+ cell counts from viral load and association with immune complexes in HIV+ hemophilia patients. <i><span class="NLM_source">Immunology Letters</span></i> <b>91</b>:1, 23-32<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.imlet.2003.09.009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">262</p><p class="content">C Manegold, S Thomas, H Jablonowski, CB Chiwakata, M Alwazzeh, O Adams, M Dietrich, D Haussinger.  (2004) Determinants of long-term highly active antiretroviral treatment efficacy. <i><span class="NLM_source">HIV Medicine</span></i> <b>5</b>:1, 40-49<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1468-1293.2004.00184.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">263</p><p class="content">Roberto Manfredi.  (2004) HIV infection and advanced age. <i><span class="NLM_source">Ageing Research Reviews</span></i> <b>3</b>:1, 31-54<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.arr.2003.07.001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">264</p><p class="content">Viviana Simon, David D. Ho.  (2003) HIV-1 dynamics in vivo: implications for therapy. <i><span class="NLM_source">Nature Reviews Microbiology</span></i> <b>1</b>:3, 181-190<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1038/nrmicro772" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">265</p><p class="content">P??l Voltersvik, Grethe Albrektsen, Elling Ulvestad, Anne Dyrhol-Riise, Birger S??rensen, Birgitta ???sj??.  (2003) Changes in Immunoglobulin Isotypes and Immunoglobulin G (IgG) Subclasses During Highly Active Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>34</b>:4, 358-367<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200312010-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">266</p><p class="content">Roy M Gulick, Anne Meibohm, Diane Havlir, Joseph J Eron, Audrey Mosley, Jeffrey A Chodakewitz, Robin Isaacs, Charles Gonzalez, Deborah McMahon, Douglas D Richman, Michael Robertson, John W Mellors.  (2003) Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine. <i><span class="NLM_source">AIDS</span></i> <b>17</b>:16, 2345-2349<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200311070-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">267</p><p class="content">George Rutherford, Prerana Sangani, Gail E Kennedy, George Rutherford. Three- or four- versus two-drug antiretroviral maintenance regimens for HIV infection. In: Cochrane Database of Systematic Reviews. John Wiley &amp; Sons, Ltd, 2003.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/14651858.CD002037" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">268</p><p class="content">M. S. Hirsch, R. T. Steigbigel, S. Staszewski, D. McMahon, M. A. Fischl, B. Hirschel, K. Squires, M. J. DiNubile, C. M. Harvey, J. Chen, R. Y. Leavitt, .  (2003) Long-Term Efficacy, Safety, and Tolerability of Indinavir-Based Therapy in Protease Inhibitor--Naive Adults with Advanced HIV Infection. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>37</b>:8, 1119-1124<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/378063" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">269</p><p class="content"> (2003) British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. <i><span class="NLM_source">HIV Medicine</span></i> <b>4</b>:S1, 1-41<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1468-1293.4.s1.3.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">270</p><p class="content"> (2003) Estimating the effect of antiretroviral treatment during HIV seroconversion: impact of confounding in observational data. <i><span class="NLM_source">HIV Medicine</span></i> <b>4</b>:4, 332-337<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1468-1293.2003.00168.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">271</p><p class="content">Pierre Cordelier, Sandra A. Calarota, Roger J. Pomerantz, Jiang Xiaoshan, David S. Strayer.  (2003) Inhibition of HIV-1 in the Central Nervous System by IFN-
              <i>α</i>
              2 Delivered by an SV40 Vector. <i><span class="NLM_source">Journal of Interferon &amp; Cytokine Research</span></i> <b>23</b>:9, 477-488<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/10799900360708605" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">272</p><p class="content">Anna M. Iorio, Daniela Francisci, Barbara Camilloni, Giuliano Stagni, Matteo De Martino, Daniela Toneatto, Roberto Bugarini, Mariella Neri, Audino Podda.  (2003) Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy. <i><span class="NLM_source">Vaccine</span></i> <b>21</b>:25-26, 3629-3637<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0264-410X(03)00408-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">273</p><p class="content">Ananthalakshmi Poluri, Marc van Maanen, Richard E Sutton.  (2003) Genetic therapy for HIV/AIDS. <i><span class="NLM_source">Expert Opinion on Biological Therapy</span></i> <b>3</b>:6, 951-963<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/14712598.3.6.951" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">274</p><p class="content">Joseph Kulkosky, Julie Sullivan, Yan Xu, Anne Malin-Markham, Miguel Otero, Sandra Calarota, Jennifer Zielinski, Derek M Culnan, Roger J Pomerantz.  (2003) Genotypic alteration of HAART-persistent HIV-1 reservoirs in vivo. <i><span class="NLM_source">Virology</span></i> <b>314</b>:2, 617-629<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0042-6822(03)00464-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">275</p><p class="content">C??dric Carbonneil, Albertine Aouba, Marianne Burgard, Sylvain Cardinaud, Christine Rouzioux, Pierre Langlade-Demoyen, Laurence Weiss.  (2003) Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-?? are potent inducers of HIV-specific CD8 T cells. <i><span class="NLM_source">AIDS</span></i> <b>17</b>:12, 1731-1740<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200308150-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">276</p><p class="content">James Tesoriero, Tyler French, Linda Weiss, Mark Waters, Ruth Finkelstein, Bruce Agins.  (2003) Stability of Adherence to Highly Active Antiretroviral Therapy Over Time Among Clients Enrolled in the Treatment Adherence Demonstration Project. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>33</b>:4, 484-493<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200308010-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">277</p><p class="content">Peter J. Piliero, Joseph P. Colagreco.  (2003) Simplified Regimens for Treating HIV Infection and AIDS. <i><span class="NLM_source">Journal of the American Academy of Nurse Practitioners</span></i> <b>15</b>:7, 353-360<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1745-7599.2003.tb00403.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">278</p><p class="content">Stéphania Koblavi-Dème, Matthieu Maran, Nguessan Kabran, Marie Yolande Borget, Mireille Kalou, Luc Kestens, Chantal Maurice, Madeleine Sassan-Morokro, Ehounou R. Ekpini, Thierry H. Roels, Terence Chorba, John N. Nkengasong.  (2003) Changes in levels of immune activation and reconstitution markers among HIV-1-infected Africans receiving antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>17</b>, S17-S22<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200317003-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">279</p><p class="content">Ferdinand W. N. M. Wit, Peter Reiss.  (2003) When to start antiretroviral therapy and what to start with—a European perspective. <i><span class="NLM_source">Current Infectious Disease Reports</span></i> <b>5</b>:4, 349-357<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s11908-003-0013-y" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">280</p><p class="content">Naser L. Rezk, Richard R. Tidwell, Angela D.M. Kashuba.  (2003) Simultaneous determination of six HIV nucleoside analogue reverse transcriptase inhibitors and nevirapine by liquid chromatography with ultraviolet absorbance detection. <i><span class="NLM_source">Journal of Chromatography B</span></i> <b>791</b>:1-2, 137-147<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1570-0232(03)00224-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">281</p><p class="content">Peter J. Piliero, Joseph P. Colagreco.  (2003) Simplified Regimens for Treating HIV Infection and AIDS. <i><span class="NLM_source">Journal of the American Academy of Nurse Practitioners</span></i> <b>15</b>:7, 305-312<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1745-7599.2003.tb01313.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">282</p><p class="content">Paul M. Coplan, Alexander Nikas, Anthony Japour, Karen Cormier, Hilal Maradit-Kremers, Ron Lewis, Yi Xu, Mark J. DiNubile.  (2003) Incidence of Myocardial Infarction in Randomized Clinical Trials of Protease Inhibitor-Based Antiretroviral Therapy: An Analysis of Four Different Protease Inhibitors. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>19</b>:6, 449-455<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922203766774487" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">283</p><p class="content">Shizuko Sei.  (2003) Peptide nucleic acids as epigenetic inhibitors of HIV-1. <i><span class="NLM_source">International Journal of Peptide Research and Therapeutics</span></i> <b>10</b>:3-4, 269-286<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10989-004-4925-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">284</p><p class="content">Calvin Cohen.  (2003) First-line Treatment in HIV. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>33</b>:Supplement 1, S29???S38<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200306011-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">285</p><p class="content">Mark A. Perazella.  (2003) Drug-Induced Renal Failure: Update on New Medications and Unique Mechanisms of Nephrotoxicity. <i><span class="NLM_source">The American Journal of the Medical Sciences</span></i> <b>325</b>:6, 349-362<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00000441-200306000-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">286</p><p class="content">Jim A Turpin.  (2003) The next generation of HIV/AIDS drugs: novel and developmental antiHIV drugs and targets. <i><span class="NLM_source">Expert Review of Anti-infective Therapy</span></i> <b>1</b>:1, 97-128<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1586/14787210.1.1.97" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">287</p><p class="content">Marina B Klein, Nadia Campeol, Richard G Lalonde, Bluma Brenner, Mark A Wainberg.  (2003) Didanosine, interferon-alfa and ribavirin. <i><span class="NLM_source">AIDS</span></i> <b>17</b>:7, 1001-1008<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200305020-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">288</p><p class="content">Damien Arnoult, Frédéric Petit, Jean-Daniel Lelièvre, Jérôme Estaquier.  (2003) Mitochondria in HIV-1-induced apoptosis. <i><span class="NLM_source">Biochemical and Biophysical Research Communications</span></i> <b>304</b>:3, 561-574<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0006-291X(03)00629-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">289</p><p class="content">Remko van Leeuwen, Christine Katlama, Robert L Murphy, Kathleen Squires, José Gatell, Andrej Horban, Bonaventura Clotet, Shlomo Staszewski, Arne van Eeden, Nathan Clumeck, Mauro Moroni, Andrew T Pavia, Reinhold E Schmidt, Juan Gonzalez-Lahoz, Julio Montaner, Francisco Antunes, Robert Gulick, Dénes Bánhegyi, Marc van der Valk, Peter Reiss, Liesbeth van Weert, Frank van Leth, Victoria A Johnson, Jean-Pierre Sommadossi, Joep MA Lange.  (2003) A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>17</b>:7, 987-999<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200305020-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">290</p><p class="content">Michael Louie, Christine Hogan, Arlene Hurley, Viviana Simon, Chris Chung, Neal Padte, Patrick Lamy, John Flaherty, Dion Coakley, Michele Di Mascio, Alan S Perelson, Martin Markowitz.  (2003) Determining the antiviral activity of tenofovir disoproxil fumarate in treatment-naive chronically HIV-1-infected individuals. <i><span class="NLM_source">AIDS</span></i> <b>17</b>:8, 1151-1156<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200305230-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">291</p><p class="content">Heike Gehringer, Klaus Von der Helm, Sigrid Seelmeir, Benedikt Weißbrich, Josef Eberle, Hans Nitschko.  (2003) Development and evaluation of a phenotypic assay monitoring resistance formation to protease inhibitors in HIV-1-infected patients. <i><span class="NLM_source">Journal of Virological Methods</span></i> <b>109</b>:2, 143-152<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0166-0934(03)00065-X" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">292</p><p class="content">Shizuko Sei.  (2003) Peptide nucleic acids as epigenetic inhibitors of HIV-1. <i><span class="NLM_source">Letters in Peptide Science</span></i> <b>10</b>:3-4, 269-286<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF02484563" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">293</p><p class="content">Michael P. Carey, Peter A. Vanable. AIDS/HIV. In: Handbook of Psychology. John Wiley &amp; Sons, Inc., 2003.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/0471264385.wei0910" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">294</p><p class="content">M. C. Strain, H. F. Gunthard, D. V. Havlir, C. C. Ignacio, D. M. Smith, A. J. Leigh-Brown, T. R. Macaranas, R. Y. Lam, O. A. Daly, M. Fischer, M. Opravil, H. Levine, L. Bacheler, C. A. Spina, D. D. Richman, J. K. Wong.  (2003) Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: Intrinsic stability predicts lifelong persistence. <i><span class="NLM_source">Proceedings of the National Academy of Sciences</span></i> <b>100</b>:8, 4819-4824<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1073/pnas.0736332100" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">295</p><p class="content">Juan A Arnaiz, Josep Mallolas, Daniel Podzamczer, Jan Gerstoft, Jens D Lundgren, Pedro Cahn, Gerd Fätkenheuer, Antonella D'Arminio-Monforte, Arnaldo Casiró, Peter Reiss, David M Burger, Michael Stek, José M Gatell.  (2003) Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load. <i><span class="NLM_source">AIDS</span></i> <b>17</b>:6, 831-840<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200304110-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">296</p><p class="content">Paulo F. Barroso, Mauro Schechter, Phalguni Gupta, Clarisse Bressan, Antonieta Bomfim, Lee H. Harrison.  (2003) Adherence to Antiretroviral Therapy and Persistence of HIV RNA in Semen. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>32</b>:4, 435-440<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200304010-00014" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">297</p><p class="content">A. D. McNaghten, Debra L. Hanson, Mark S. Dworkin, Jeffrey L. Jones.  (2003) Differences in Prescription of Antiretroviral Therapy in a Large Cohort of HIV-Infected Patients. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>32</b>:5, 499-505<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200304150-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">298</p><p class="content">Massimo Fantoni, Cosmo Del Borgo, Camillo Autore.  (2003) Evaluation and management of metabolic and coagulative disorders in HIV-infected patients receiving highly active antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>17</b>, S162-S169<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200304001-00020" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">299</p><p class="content">Peter Messeri, Gunjeong Lee, David M. Abramson, Angela Aidala, Mary Ann Chiasson, Dorothy Jones Jessop.  (2003) Antiretroviral Therapy and Declining AIDS Mortality in New York City. <i><span class="NLM_source">Medical Care</span></i> <b>41</b>:4, 512-521<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.MLR.0000053230.81725.EF" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">300</p><p class="content">Thu T Tran, Brian L Robbins, Frank H Pinkerton, Bernard Ferrua, Jacques Grassi, Arnold Fridland.  (2003) A new sensitive cartridge-RIA method for determination of stavudine (D4T) triphosphate in human cells in vivo. <i><span class="NLM_source">Antiviral Research</span></i> <b>58</b>:2, 125-129<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0166-3542(02)00192-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">301</p><p class="content">Antonia L. Moore, Ole Kirk, Anne M. Johnson, Christine Katlama, Anders Blaxhult, Manfred Dietrich, Robert Colebunders, Antonio Chiesi, Jens D. Lungren, Andrew N. Phillips.  (2003) Virologic, Immunologic, and Clinical Response to Highly Active Antiretroviral Therapy: the Gender Issue Revisited. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>32</b>:4, 452-461<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200304010-00017" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">302</p><p class="content">Audrey Brussel, Dominique Mathez, Sophie Broche-Pierre, Rémi Lancar, Thierry Calvez, Pierre Sonigo, Jacques Leibowitch.  (2003) Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection. <i><span class="NLM_source">AIDS</span></i> <b>17</b>:5, 645-652<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200303280-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">303</p><p class="content">Stephen L Becker.  (2003) The role of pharmacological enhancement in protease inhibitor-based highly active antiretroviral therapy. <i><span class="NLM_source">Expert Opinion on Investigational Drugs</span></i> <b>12</b>:3, 401-412<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/13543784.12.3.401" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">304</p><p class="content">Roberto Manfredi, Leonardo Calza, Francesco Chiodo.  (2003) Prospective Comparison of First-Line Nelfinavir Therapy versus Nelfinavir Introduction in Rescue Antiretroviral Regimens. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>17</b>:3, 105-114<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/108729103763807927" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">305</p><p class="content">Santiago Pérez-Hoyos, Julia del Amo, Roberto Muga, Jorge del Romero, Patricia García de Olalla, Rafael Guerrero, Ildefonso Hernàndez-Aguado.  (2003) Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters. <i><span class="NLM_source">AIDS</span></i> <b>17</b>:3, 353-359<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200302140-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">306</p><p class="content">P. BRAZILLE, N. DEREUDDRE-BOSQUET, C. LEPORT, P. CLAYETTE, O. BOYER, J.-L. VILDE, D. DORMONT, O. BENVENISTE.  (2003) Decreases in plasma TNF-alpha level and IFN-gamma mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients. <i><span class="NLM_source">Clinical and Experimental Immunology</span></i> <b>131</b>:2, 304-311<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2249.2003.02064.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">307</p><p class="content">Anna R Thorner, Eric S Rosenberg.  (2003) Early Versus Delayed Antiretroviral Therapy in Patients with HIV Infection. <i><span class="NLM_source">Drugs</span></i> <b>63</b>:13, 1325-1337<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2165/00003495-200363130-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">308</p><p class="content">Peter A Anton, Ronald T Mitsuyasu, Steven G Deeks, David T Scadden, Bridget Wagner, Christine Huang, Catherine Macken, Douglas D Richman, Cindy Christopherson, Flavia Borellini, Richard Lazar, Kristen M Hege.  (2003) Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects. <i><span class="NLM_source">AIDS</span></i> <b>17</b>:1, 53-63<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200301030-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">309</p><p class="content">Velia Ramírez-Amador, Lilly Esquivel-Pedraza, Juan Sierra-Madero, Gabriela Anaya-Saavedra, Imelda González-Ramírez, Sergio Ponce-de-León.  (2003) The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients. <i><span class="NLM_source">Medicine</span></i> <b>82</b>:1, 39-50<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00005792-200301000-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">310</p><p class="content">Apsara Kandanearatchi, Brenda Williams, Ian Paul Everall.  (2003) Assessing the Efficacy of Highly Active Antiretroviral Therapy in the Brain. <i><span class="NLM_source">Brain Pathology</span></i> <b>13</b>:1, 104-110<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1750-3639.2003.tb00011.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">311</p><p class="content">Claudine Buffet-Janvresse, H<img src="untitled" alt="" class="entityD">l<img src="untitled" alt="" class="entityD">ne Peigue-Lafeuille, Jacques Benichou, Astrid Vabret, Michel Branger, Pascale Trimoulet, Odile Goria, Henri Laurichesse, Abdelaziz Abbed, Renaud Verdon, Elisabeth Bouvet, Marie-Edith Lafon, Elisabeth Dussaix, .  (2003) HIV and HCV co-infection: Situation at six French university hospitals in the year 2000. <i><span class="NLM_source">Journal of Medical Virology</span></i> <b>69</b>:1, 7-17<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/jmv.10268" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">312</p><p class="content">Simon J. Potter, Dominic E. Dwyer, Nitin K. Saksena.  (2003) Differential Cellular Distribution of HIV-1 Drug Resistance in Vivo: Evidence for Infection of CD8+ T Cells during HAART. <i><span class="NLM_source">Virology</span></i> <b>305</b>:2, 339-352<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1006/viro.2002.1703" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">313</p><p class="content">Giuseppe Gumina, John S. Cooperwood, Chung K. Chu. Oxathiolane and Dioxolane Nucleosides. In: Antiviral Nucleosides. Elsevier, 2003:191-258.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/B978-044451319-9/50003-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">314</p><p class="content">Daniel A. Johnson, Douglas A. Jabs. Ophthalmologic Aspects of HIV Infection. In: AIDS and Other Manifestations of HIV Infection. Elsevier, 2003:697-730.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/B978-012764051-8/50028-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">315</p><p class="content">Harold W. Horowitz, Gary P. Wormser. Care of the Adult Patient with HIV Infection. In: AIDS and Other Manifestations of HIV Infection. Elsevier, 2003:305-370.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/B978-012764051-8/50015-9" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">316</p><p class="content">Robert T. Schooley. Antiretroviral Chemotherapy. In: AIDS and Other Manifestations of HIV Infection. Elsevier, 2003:841-854.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/B978-012764051-8/50033-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">317</p><p class="content">Joseph Kulkosky, Roger&nbsp;J. Pomerantz.  (2002) Approaching Eradication of Highly Active Antiretroviral Therapy–Persistent Human Immunodeficiency Virus Type 1 Reservoirs with Immune Activation Therapy. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>35</b>:12, 1520-1526<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/344959" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">318</p><p class="content">Pablo Barreiro, Nuria Camino, Carmen de Mendoza, Luisa Valer, Marina Núñez, Luz Martı́n-Carbonero, Juan González-Lahoz, Vincent Soriano.  (2002) Comparison of the efficacy, safety and predictive value of HIV genotyping using distinct ritonavir-boosted protease inhibitors. <i><span class="NLM_source">International Journal of Antimicrobial Agents</span></i> <b>20</b>:6, 438-443<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0924-8579(02)00250-9" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">319</p><p class="content">I.A. Teo, J. Morlese, J.W. Choi, S. Shaunak.  (2002) Reliable and reproducible LightCycler qPCR for HIV-1 DNA 2-LTR circles. <i><span class="NLM_source">Journal of Immunological Methods</span></i> <b>270</b>:1, 109-118<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0022-1759(02)00217-X" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">320</p><p class="content">Mauro Guarinieri.  (2002) Highly Active Antiretroviral Therapy Adherence: The Patient's Point of View. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>31</b>, S167-S169<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200212153-00017" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">321</p><p class="content">Veronica Svedhem, Annica Lindkvist, Knut Lidman, Anders S<img src="untitled" alt="" class="entityD">nnerborg.  (2002) Persistence of earlier HIV-1 drug resistance mutations at new treatment failure. <i><span class="NLM_source">Journal of Medical Virology</span></i> <b>68</b>:4, 473-478<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/jmv.10246" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">322</p><p class="content">Craig Demmer.  (2002) Renewing HIV Prevention Efforts among Youth. <i><span class="NLM_source">American Journal of Health Education</span></i> <b>33</b>:6, 322-328<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1080/19325037.2002.10604754" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">323</p><p class="content">Miriam Rabkin, Wafaa El-Sadr, David A Katzenstein, Joia Mukherjee, Henry Masur, Peter Mugyenyi, Paulay Munderi, Janet Darbyshire.  (2002) Antiretroviral treatment in resource-poor settings: clinical research priorities. <i><span class="NLM_source">The Lancet</span></i> <b>360</b>:9344, 1503-1505<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(02)11478-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">324</p><p class="content">Andrea A Howard, Julia H Arnsten, Yungtai Lo, David Vlahov, Josiah D Rich, Paula Schuman, Valerie E Stone, Dawn K Smith, Ellie E Schoenbaum.  (2002) A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:16, 2175-2182<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200211080-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">325</p><p class="content">Melissa Deanne Neuwelt, Melissa Deanne Neuwelt. Efavirenz versus nevirapine as a non-nucleoside reverse transcriptase inhibitor in initial combination antiretroviral therapy for HIV infection. In: The Cochrane Database of Systematic Reviews. John Wiley &amp; Sons, Ltd, 2002.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/14651858.CD004246" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">326</p><p class="content">Carol E. Golin, Honghu Liu, Ron D. Hays, Loren G. Miller, C. Keith Beck, Jeanette Ickovics, Andrew H. Kaplan, Neil S. Wenger.  (2002) A Prospective Study of Predictors of Adherence to Combination Antiretroviral Medication. <i><span class="NLM_source">Journal of General Internal Medicine</span></i> <b>17</b>:10, 756-765<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1525-1497.2002.11214.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">327</p><p class="content">Katherine V. Heath, Joel Singer, Michael V. O'Shaughnessy, Julio S.G. Montaner, Robert S. Hogg.  (2002) Intentional Nonadherence Due to Adverse Symptoms Associated With Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>31</b>:2, 211-217<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200210010-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">328</p><p class="content">Michael L. Green.  (2002) Evaluation and Management of Dyslipidemia in Patients with HIV Infection. <i><span class="NLM_source">Journal of General Internal Medicine</span></i> <b>17</b>:10, 797-810<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1525-1497.2002.20201.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">329</p><p class="content">Amrita Krishnan, John Zaia, Arturo Molina.  (2002) Stem Cell Transplantation and Gene Therapy for HIV-Related Lymphomas. <i><span class="NLM_source">Journal of Hematotherapy &amp; Stem Cell Research</span></i> <b>11</b>:5, 765-775<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/152581602760404577" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">330</p><p class="content">Wayne B. Dyer, Harmjan Kuipers, Marcel W. Coolen, Andrew F. Geczy, Janice Forrester, Cassy Workman, John S. Sullivan.  (2002) Correlates of Antiviral Immune Restoration in Acute and Chronic HIV Type 1 Infection: Sustained Viral Suppression and Normalization of T Cell Subsets. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>18</b>:14, 999-1010<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/08892220260235362" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">331</p><p class="content">Bin Fan, Michael G. Bartlett, James T. Stewart.  (2002) Determination of lamivudine/stavudine/efavirenz in human serum using liquid chromatography/electrospray tandem mass spectrometry with ionization polarity switch. <i><span class="NLM_source">Biomedical Chromatography</span></i> <b>16</b>:6, 383-389<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/bmc.169" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">332</p><p class="content">Frank Romanelli, Kerry Empey, Claire Pomeroy.  (2002) Macrocytosis as an Indicator of Medication (Zidovudine) Adherence in Patients with HIV Infection. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>16</b>:9, 405-411<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/108729102760330245" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">333</p><p class="content">William C. Holmes, Joseph L. Pace.  (2002) HIV-seropositive Individuals' Optimistic Beliefs About Prognosis and Relation to Medication and Safe Sex Adherence. <i><span class="NLM_source">Journal of General Internal Medicine</span></i> <b>17</b>:9, 677-683<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1525-1497.2002.00746.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">334</p><p class="content">Janet M. Raboud, Sandra Rae, Ryan Woods, Marianne Harris, Julio S. G. Montaner.  (2002) Consecutive rebounds in plasma viral load are associated with virological failure at 52 weeks among HIV-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:12, 1627-1632<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200208160-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">335</p><p class="content">Luis Menéndez-Arias.  (2002) Targeting HIV: antiretroviral therapy and development of drug resistance. <i><span class="NLM_source">Trends in Pharmacological Sciences</span></i> <b>23</b>:8, 381-388<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0165-6147(02)02054-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">336</p><p class="content">Thomas F. Kresina, Charles W. Flexner, Jacqueline Sinclair, Maria Almira Correia, Jack T. Stapleton, Samuel Adeniyi-Jones, Victoria Cargill, Laura W. Cheever.  (2002) Alcohol Use and HIV Pharmacotherapy. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>18</b>:11, 757-770<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/08892220260139495" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">337</p><p class="content">D Johnson.  (2002) Therapeutic management of HIV. <i><span class="NLM_source">Oral Diseases</span></i> <b>8</b>:s2, 17-20<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1034/j.1601-0825.2002.00005.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">338</p><p class="content">Matthias Egger, Margaret May, Geneviève Chêne, Andrew N Phillips, Bruno Ledergerber, François Dabis, Dominique Costagliola, Antonella D'Arminio Monforte, Frank de Wolf, Peter Reiss, Jens D Lundgren, Amy C Justice, Schlomo Staszewski, Catherine Leport, Robert S Hogg, Caroline A Sabin, M John Gill, Bernd Salzberger, Jonathan AC Sterne.  (2002) Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. <i><span class="NLM_source">The Lancet</span></i> <b>360</b>:9327, 119-129<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(02)09411-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">339</p><p class="content">E Voigt, A Wickesberg, J-C Wasmuth, P Gute, L Locher, B Salzberger, A Wohrmann, A Adam, L Weitner, JK Rockstroh.  (2002) First-line ritonavir/indinavir 100/800 mg twice daily plus nucleoside reverse transcriptase inhibitors in a German multicentre study: 48-week results. <i><span class="NLM_source">HIV Medicine</span></i> <b>3</b>:4, 277-282<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1468-1293.2002.00123.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">340</p><p class="content">Christian Laurent, Ndella Diakhaté, Ndeye Fatou Ngom Gueye, Mame Awa Touré, Papa Salif Sow, Mame Awa Faye, Mandoumbé Gueye, Isabelle Lanièce, Coumba Touré Kane, Florian Liégeois, Laurence Vergne, Souleymane Mboup, Salif Badiane, Ibrahima Ndoye, Eric Delaporte.  (2002) The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:10, 1363-1370<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200207050-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">341</p><p class="content">Michael Louie, Martin Markowitz.  (2002) Goals and milestones during treatment of HIV-1 infection with antiretroviral therapy: a pathogenesis-based perspective. <i><span class="NLM_source">Antiviral Research</span></i> <b>55</b>:1, 15-25<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0166-3542(02)00022-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">342</p><p class="content">C.J. Cohen, A. Dusek, J. Green, E.L. Johns, E. Nelson, M.A. Recny.  (2002) Long-Term Treatment with Subcutaneous T-20, a Fusion Inhibitor, in HIV-Infected Patients: Patient Satisfaction and Impact on Activities of Daily Living. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>16</b>:7, 327-335<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/108729102320231162" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">343</p><p class="content">Clay Cockerell, Philip Cohen. Cutaneous Manifestations of HIV Infection. In: Mucocutaneous Manifestations of Viral Diseases. CRC Press, 2002:307-395.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1201/b14016-15" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">344</p><p class="content">Bin Fan, James T. Stewart.  (2002) Determination of zidovudine/lamivudine/nevirapine in human plasma using ion-pair HPLC. <i><span class="NLM_source">Journal of Pharmaceutical and Biomedical Analysis</span></i> <b>28</b>:5, 903-908<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0731-7085(01)00708-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">345</p><p class="content">J. R. Ickovics, C. S. Meade.  (2002) Adherence to HAART among patients with HIV: Breakthroughs and barriers. <i><span class="NLM_source">AIDS Care</span></i> <b>14</b>:3, 309-318<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1080/09540120220123685" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">346</p><p class="content">Karine Titier, Fabrice Lagrange, Fabienne Péhourcq, Leila Edno-Mcheik, Nicholas Moore, Mathieu Molimard.  (2002) High-Performance Liquid Chromatographic Method for the Simultaneous Determination of the Six HIV-Protease Inhibitors and Two Non-Nucleoside Reverse Transcriptase Inhibitors in Human Plasma. <i><span class="NLM_source">Therapeutic Drug Monitoring</span></i> <b>24</b>:3, 417-424<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00007691-200206000-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">347</p><p class="content">P. Trimoulet, D. Neau, B. Le Bail, A. Rullier, M. Winnock, T. Galperine, E. Legrand, E. Schvoerer, M. Dupon, J.M. Ragnaud, P. Bioulac-Sage, G. Ch<img src="untitled" alt="" class="entityD">ne, H. Fleury, M.E. Lafon.  (2002) Intrahepatic HCV RNA loads in 37 HIV-HCV co-infected patients with controlled HIV infection. <i><span class="NLM_source">Journal of Medical Virology</span></i> <b>67</b>:2, 143-151<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/jmv.2203" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">348</p><p class="content">Evan Wood, Robert S. Hogg, Benita Yip, Mark W. Tyndall, Christopher H. Sherlock, Richard P. Harrigan, Michael V. O'Shaughnessy, Julio S.G. Montaner.  (2002) “Discordant” Increases in CD4 Cell Count Relative to Plasma Viral Load in a Closely Followed Cohort of Patients Initiating Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>30</b>:2, 159-166<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200206010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">349</p><p class="content">H PALACIO.  (2002) Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: a review of the literature*1. <i><span class="NLM_source">Public Health Reports</span></i> <b>117</b>:3, 233-251<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0033-3549(04)50158-9" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">350</p><p class="content">Soo Aleman, Karin Söderbärg, Ubaldo Visco-Comandini, Gisela Sitbon, Anders Sönnerborg.  (2002) Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:7, 1039-1044<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200205030-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">351</p><p class="content">Fatima Akeb, Bernard Ferrua, Christophe Creminon, Clotilde Roptin, Jacques Grassi, Marie-Claire Nevers, Roger Guedj, Rodolphe Garraffo, Danièle Duval.  (2002) Quantification of plasma and intracellular levels of the HIV protease inhibitor ritonavir by competitive ELISA. <i><span class="NLM_source">Journal of Immunological Methods</span></i> <b>263</b>:1-2, 1-9<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0022-1759(02)00026-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">352</p><p class="content">Curtis L. Cooper, M. A. Parbhakar, Jonathan B. Angel.  (2002) Hepatotoxicity Associated with Antiretroviral Therapy Containing Dual versus Single Protease Inhibitors in Individuals Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>34</b>:9, 1259-1263<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/339867" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">353</p><p class="content">Simon Paul, Holly M. Gilbert, Leah Lande, Carlos M. Vaamonde, Jonathan Jacobs, Sharp Malak, Kent A. Sepkowitz.  (2002) Impact of Antiretroviral Therapy on Decreasing Hospitalization Rates of HIV-Infected Patients in 2001. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>18</b>:7, 501-506<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922202317406646" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">354</p><p class="content">M. PERUZZI, C. AZZARI, L. GALLI, A. VIERUCCI, M. DE MARTINO.  (2002) Highly active antiretroviral therapy restores
              <i>in vitro</i>
              mitogen and antigen-specific T-lymphocyte responses in HIV-1 perinatally infected children despite virological failure. <i><span class="NLM_source">Clinical &amp; Experimental Immunology</span></i> <b>128</b>:2, 365-371<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2249.2002.01814.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">355</p><p class="content">Francis Mandy, Jan Nicholson, Brigitte Autran, George Janossy.  (2002) T-cell subset counting and the fight against AIDS: Reflections over a 20-year struggle. <i><span class="NLM_source">Cytometry</span></i> <b>50</b>:2, 39-45<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/cyto.10097" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">356</p><p class="content">L. P. Jacobson.  (2002) Evaluation of the Effectiveness of Highly Active Antiretroviral Therapy in Persons with Human Immunodeficiency Virus using Biomarker-based Equivalence of Disease Progression. <i><span class="NLM_source">American Journal of Epidemiology</span></i> <b>155</b>:8, 760-770<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/aje/155.8.760" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">357</p><p class="content">Annemarie M. C. van Rossum, Sibyl P. M. Geelen, Nico G. Hartwig, Tom F. W. Wolfs, Corry M. R. Weemaes, Henriette J. Scherpbier, Ellen G. van Lochem, Wim C. J. Hop, Martin Schutten, Albert D. M. E. Osterhaus, David M. Burger, Ronald de Groot, .  (2002) Results of 2 Years of Treatment with Protease‐Inhibitor–Containing Antiretroviral Therapy in Dutch Children Infected with Human Immunodeficiency Virus Type 1. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>34</b>:7, 1008-1016<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/339443" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">358</p><p class="content">G. LI PIRA, D. FENOGLIO, L. BOTTONE, P. TERRANOVA, E. PONTALI, F. CAROLI, M. SERI, J.-C. CAILLIEZ, G. KOOPMAN, R. ACCOLLA, F. DEL GALDO, G. ABBATE, R. DE PALMA, F. MANCA.  (2002) Preservation of clonal heterogeneity of the
              <i>Pneumocystis carinii</i>
              -specific CD4 T cell repertoire in HIV infected, asymptomatic individuals. <i><span class="NLM_source">Clinical &amp; Experimental Immunology</span></i> <b>128</b>:1, 155-162<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2249.2002.01799.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">359</p><p class="content">S. Kinloch-de Loes, B. Autran.  (2002) HIV-1 Therapeutic Vaccines. <i><span class="NLM_source">Journal of Infection</span></i> <b>44</b>:3, 152-159<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1053/jinf.2002.0987" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">360</p><p class="content">Simona La Seta Catamancio, Stefano Rusconi.  (2002) HIV-1 protease inhibitors in development. <i><span class="NLM_source">Expert Opinion on Investigational Drugs</span></i> <b>11</b>:3, 387-395<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/13543784.11.3.387" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">361</p><p class="content">Lena Serghides, Salima Nathoo, Sharon Walmsley, Kevin C. Kain.  (2002) CD36 deficiency induced by antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:3, 353-358<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200202150-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">362</p><p class="content">Joel N. Blankson, Deborah Persaud, Robert F. Siliciano.  (2002) T
              <scp xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">HE</scp>
              C
              <scp xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">HALLENGE OF</scp>
              V
              <scp xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">IRAL</scp>
              R
              <scp xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ESERVOIRS IN</scp>
              HIV-1 I
              <scp xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">NFECTION</scp>. <i><span class="NLM_source">Annual Review of Medicine</span></i> <b>53</b>:1, 557-593<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1146/annurev.med.53.082901.104024" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">363</p><p class="content">Bin Fan, James T. Stewart.  (2002) DETERMINATION OF LAMIVUDINE/DIDANOSINE/SAQUINAVIR IN HUMAN SERUM USING CAPILLARY ZONE ELECTROPHORESIS. <i><span class="NLM_source">Journal of Liquid Chromatography &amp; Related Technologies</span></i> <b>25</b>:2, 241-249<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1081/JLC-100108742" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">364</p><p class="content">Vincent Le&nbsp;Moing, Geneviève Chêne, Catherine Leport, Charlotte Lewden, Ségolène Duran, Michel Garré, Bernard Masquelier, Michel Dupon, François Raffi, .  (2002) Impact of Discontinuation of Initial Protease Inhibitor Therapy on Further Virological Response in a Cohort of Human Immunodeficiency Virus–Infected Patients. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>34</b>:2, 239-247<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/324354" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">365</p><p class="content">Gabriella d'Ettorre, Gabriele Forcina, Miriam Lichtner, Fabio Mengoni, Claudia D'Agostino, Anna P. Massetti, Claudio M. Mastroianni, Vincenzo Vullo.  (2002) Interleukin-15 in HIV infection: immunological and virological interactions in antiretroviral-naive and -treated patients. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:2, 181-188<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200201250-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">366</p><p class="content">Roberto Manfredi.  (2002) HIV Disease and Advanced Age. <i><span class="NLM_source">Drugs &amp; Aging</span></i> <b>19</b>:9, 647-669<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2165/00002512-200219090-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">367</p><p class="content">Giuseppe Nunnari, Miguel Otero, Geethanjali Dornadula, Michelle Vanella, Hui Zhang, Ian Frank, Roger J. Pomerantz.  (2002) Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:1, 39-45<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200201040-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">368</p><p class="content">Gail V. Matthews, Caroline. A. Sabin, Sundhiya Mandalia, Fiona Lampe, Andrew N. Phillips, Mark R. Nelson, Mark Bower, Margaret A. Johnson, Brian G. Gazzard.  (2002) Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:1, 53-61<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200201040-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">369</p><p class="content">Charles E. Frost, John Adams, Mark Shelton, Abdel-Hameed I. Mohammed Ebid, Lawrence J. Gugino, Ross Hewitt, Robin DiFrancesco, Elizabeth Ingalls, Stephen Cousins, J. Hu, Gene D. Morse.  (2002) Indinavir Pharmacokinetics during Different Phases of the Menstrual Cycle in HIV-Infected Women. <i><span class="NLM_source">Clinical Drug Investigation</span></i> <b>22</b>:2, 125-134<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2165/00044011-200222020-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">370</p><p class="content">Vincent Le Moing, Geneviève Chêne, Maria P. Carrieri, Ahmadou Alioum, Françoise Brun-Vézinet, Lionel Piroth, Jill P. Cassuto, Jean-Paul Moatti, François Raffi, Catherine Leport.  (2002) Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:1, 21-29<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200201040-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">371</p><p class="content">Alissa Scalera, Ahmed M. Bayoumi, Paul Oh, Nancy Risebrough, Neil Shear, Alice Lin-in Tseng.  (2002) Clinical and Economic Implications of Non-Adherence to HAART in HIV Infection. <i><span class="NLM_source">Disease Management and Health Outcomes</span></i> <b>10</b>:2, 85-91<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2165/00115677-200210020-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">372</p><p class="content">L Weiss, M Burgard, YD Cahen, ML Chaix, D Laureillard, J Gilquin, C Piketty, JP Viard, MD Kazatchkine, PM Girard, C Rouzioux.  (2002) Immunological and virological features of HIV-infected patients with increasing CD4 cell numbers despite virological failure during protease inhibitor-based therapy. <i><span class="NLM_source">HIV Medicine</span></i> <b>3</b>:1, 12-20<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1464-2662.2001.00095.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">373</p><p class="content">Anke Richter, Brett Hauber, Kit Simpson, Josephine A. Mauskopf, Dongping Yin.  (2002) A Monte Carlo Simulation for Modelling Outcomes of AIDS Treatment Regimens. <i><span class="NLM_source">PharmacoEconomics</span></i> <b>20</b>:4, 215-224<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2165/00019053-200220040-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">374</p><p class="content">R. J. Pomerantz.  (2002) Reservoirs of Human Immunodeficiency Virus Type 1: The Main Obstacles to Viral Eradication. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>34</b>:1, 91-97<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/338256" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">375</p><p class="content">Donato Calista, Massimo Morri, Alessandro Stagno, Antonio Boschini.  (2002) Changing Morbidity of Cutaneous Diseases in Patients with HIV After the Introduction of Highly Active Antiretroviral Therapy Including a Protease Inhibitor. <i><span class="NLM_source">American Journal of Clinical Dermatology</span></i> <b>3</b>:1, 59-62<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2165/00128071-200203010-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">376</p><p class="content">Victor Appay, Pokrath Hansasuta, Julian Sutton, Rachel D. Schrier, Joseph K. Wong, Manohar Furtado, Diane V. Havlir, Steven M. Wolinsky, Andrew J. McMichael, Douglas D. Richman, Sarah L. Rowland-Jones, Celsa A. Spina.  (2002) Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:2, 161-170<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200201250-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">377</p><p class="content">Milomir Djokic.  (2002) Savremena antiretrovirusna terapija. <i><span class="NLM_source">Vojnosanitetski pregled</span></i> <b>59</b>:4, 417-422<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2298/VSP0204417D" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">378</p><p class="content">Phillip M. Boiselle, Galit Aviram, Joel E. Fishman.  (2002) Update on lung disease in AIDS. <i><span class="NLM_source">Seminars in Roentgenology</span></i> <b>37</b>:1, 54-71<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1053/sroe.2002.29586" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">379</p><p class="content">Mark Holodniy, Veronica Miller. Human Immunodeficiency Virus. In: Practical Guidelines in Antiviral Therapy. Elsevier, 2002:95-125.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/B978-044450884-3/50005-2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">380</p><p class="content">José Moltó, Félix Gutiérrez, Antonia Mora, María del Mar Masiá, Clara Escolano, Eva González, Sergio Padilla, Alberto M. Hidalgo, Juan Córdoba.  (2002) Factores asociados a la resistencia a los inhibidores de la proteasa del virus de la inmunodeficiencia humana. <i><span class="NLM_source">Medicina Clínica</span></i> <b>118</b>:19, 721-724<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0025-7753(02)72512-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">381</p><p class="content">Elizabeth Connick.  (2001) Immune Reconstitution in HIV-1-Infected Individuals Treated with Potent Antiretroviral Therapy. <i><span class="NLM_source">Journal of Investigative Dermatology Symposium Proceedings</span></i> <b>6</b>:3, 212-218<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.0022-202x.2001.00049.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">382</p><p class="content">Ling C. Hsu, Eric Vittinghoff, Mitch H. Katz, Sandra K. Schwarcz.  (2001) Predictors of Use of Highly Active Antiretroviral Therapy (HAART) Among Persons With AIDS in San Francisco, 1996–1999. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>28</b>:4, 345-350<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200112010-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">383</p><p class="content">C.&nbsp;Robert Horsburgh,&nbsp;Jr., Jill Gettings, Lorraine&nbsp;N. Alexander, Jeffrey&nbsp;L. Lennox.  (2001) Disseminated
              <i>Mycobacterium avium</i>
              Complex Disease among Patients Infected with Human Immunodeficiency Virus, 1985–2000. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>33</b>:11, 1938-1943<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/324508" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">384</p><p class="content">Paul A. Glare.  (2001) Pain in patients with HIV infection: issues for the new millennium. <i><span class="NLM_source">European Journal of Pain</span></i> <b>5</b>, 43-48<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1053/eujp.2001.0279" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">385</p><p class="content">Anne Ma Dyrhol-Riise, Gianna Stent, Bård I. Røsok, Pål Voltersvik, Jan Olofsson, Birgitta Åsjö.  (2001) The Fas/FasL System and T Cell Apoptosis in HIV-1-Infected Lymphoid Tissue during Highly Active Antiretroviral Therapy. <i><span class="NLM_source">Clinical Immunology</span></i> <b>101</b>:2, 169-179<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1006/clim.2001.5101" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">386</p><p class="content">Linda Ahdieh Grant, Michael J. Silverberg, Herminia Palacio, Howard Minkoff, Kathryn Anastos, Mary A. Young, Marek Nowicki, Andrea Kovacs, Mardge Cohen, Alvaro Muñoz.  (2001) Discontinuation of potent antiretroviral therapy: predictive value of and impact on CD4 cell counts and HIV RNA levels. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:16, 2101-2108<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200111090-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">387</p><p class="content">Howard Minkoff, Linda Ahdieh, L. Stewart Massad, Kathryn Anastos, D. Heather Watts, Sandra Melnick, Laila Muderspach, Robert Burk, Joel Palefsky.  (2001) The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:16, 2157-2164<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200111090-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">388</p><p class="content">D. J. S. King, E. -L. Larsson-Sciard.  (2001) Clonal evolution of CD8+ T-cell expansions in HIV-infected patients on long-term HAART. <i><span class="NLM_source">Clinical and Experimental Immunology</span></i> <b>126</b>:2, 280-286<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2249.2001.01665.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">389</p><p class="content">Giuseppina Li Pira, Laura Bottone, Daniela Fenoglio, Paola Terranova, Emanuele Pontali, Federico Ivaldi, Francesco Del Galdo, Lorenzo Mortara, Arianna Loregian, Giorgio Palù, Annalisa Kunkl, Roberto Accolla, Raffaele De Palma, Fabrizio Manca.  (2001) Analysis of the antigen specific T cell repertoires in HIV infection. <i><span class="NLM_source">Immunology Letters</span></i> <b>79</b>:1-2, 85-91<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0165-2478(01)00269-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">390</p><p class="content">Nesrina Imami, Gareth Hardy, Catherine Burton, Antonio Pires, Jeffrey Pido-Lopez, Ron Moss, Brian Gazzard, Frances Gotch.  (2001) Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination. <i><span class="NLM_source">Immunology Letters</span></i> <b>79</b>:1-2, 63-76<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0165-2478(01)00267-X" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">391</p><p class="content">Dennis Israelski, Cheryl Gore-Felton, Rachel Power, Mary Jane Wood, Cheryl Koopman.  (2001) Sociodemographic Characteristics Associated with Medical Appointment Adherence among HIV-Seropositive Patients Seeking Treatment in a County Outpatient Facility. <i><span class="NLM_source">Preventive Medicine</span></i> <b>33</b>:5, 470-475<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1006/pmed.2001.0917" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">392</p><p class="content">S. W. Cole.  (2001) Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. <i><span class="NLM_source">Proceedings of the National Academy of Sciences</span></i> <b>98</b>:22, 12695-12700<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1073/pnas.221134198" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">393</p><p class="content">S. D. Zucker.  (2001) Mechanism of indinavir-induced hyperbilirubinemia. <i><span class="NLM_source">Proceedings of the National Academy of Sciences</span></i> <b>98</b>:22, 12671-12676<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1073/pnas.231140698" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">394</p><p class="content">Rieneke&nbsp;M.&nbsp;E. van&nbsp;Praag, Rolf&nbsp;P.&nbsp;G. van Heeswijk, Suzanne Jurriaans, Joep&nbsp;M.&nbsp;A. Lange, Richard&nbsp;M.&nbsp;W. Hoetelmans, Jan&nbsp;M. Prins.  (2001) Penetration of the Nucleoside Analogue Abacavir into the Genital Tract of Men Infected with Human Immunodeficiency Virus Type 1. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>33</b>:8, e91-e92<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/322682" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">395</p><p class="content"> (2001) British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. <i><span class="NLM_source">HIV Medicine</span></i> <b>2</b>:4, 276-313<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1464-2662.2001.00083.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">396</p><p class="content">Michael S. Saag, Pablo Tebas, Michael Sension, Marcus Conant, Robert Myers, Sharon K. Chapman, Robert Anderson.  (2001) Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511). <i><span class="NLM_source">AIDS</span></i> <b>15</b>:15, 1971-1978<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200110190-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">397</p><p class="content">S. L. Catz, S. C. Kalichman, E. G. Benotsch, J. Miller, T. Suarez.  (2001) Anticipated psychological impact of receiving medical feedback about HIV treatment outcomes. <i><span class="NLM_source">AIDS Care</span></i> <b>13</b>:5, 631-635<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1080/09540120120063250" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">398</p><p class="content">Secondo Sonza, Suzanne M. Crowe.  (2001) Reservoirs for HIV Infection and Their Persistence in the Face of Undetectable Viral Load. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>15</b>:10, 511-518<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/108729101753205676" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">399</p><p class="content">James G. Kahn, Brain Haile, Jennifer Kates, Sophia Chang.  (2001) Health and Federal Budgetary Effects of Increasing Access to Antiretroviral Medications for HIV by Expanding Medicaid. <i><span class="NLM_source">American Journal of Public Health</span></i> <b>91</b>:9, 1464-1473<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2105/AJPH.91.9.1464" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">400</p><p class="content">Diane Descamps, Vincent Calvez, Jacques Izopet, Claudine Buffet-Janvresse, Anne Schmuck, Philippe Colson, Annick Ruffault, Anne Maillard, Bernard Masquelier, Jacqueline Cottalorda, Martine Harzic, Françoise Brun-Vézinet, Dominique Costagliola.  (2001) Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:14, 1777-1782<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200109280-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">401</p><p class="content">David D. Celentano, Noya Galai, Ajay K. Sethi, Nina G. Shah, Steffanie A. Strathdee, David Vlahov, Joel E. Gallant.  (2001) Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:13, 1707-1715<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200109070-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">402</p><p class="content">Edward Lew, Laura Gallagher, Matthew Kuehnert, David Rimland, Marjorie Hubbard, Bharat Parekh, Elisabeth Zell, William Jarvis, Janine Jason.  (2001) Intracellular cytokines in the acute response to highly active antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:13, 1665-1670<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200109070-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">403</p><p class="content">Luciléia Teixeira, Hernan Valdez, Joseph M. McCune, Richard A. Koup, Andrew D. Badley, Marc K. Hellerstein, Laura A. Napolitano, Daniel C. Douek, Georgina Mbisa, Steven Deeks, Jeffrey M. Harris, Jason D. Barbour, Barry H. Gross, Isaac R. Francis, Robert Halvorsen, Robert Asaad, Michael M. Lederman.  (2001) Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:14, 1749-1756<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200109280-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">404</p><p class="content">Christina&nbsp;M. Kitchen, Scott&nbsp;G. Kitchen, Jeffrey&nbsp;A. Dubin, Michael&nbsp;S. Gottlieb.  (2001) Initial Virological and Immunologic Response to Highly Active Antiretroviral Therapy Predicts Long‐Term Clinical Outcome. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>33</b>:4, 466-472<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/321900" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">405</p><p class="content"> Albrecht ,  Mary A. ,  Bosch ,  Ronald J. ,  Hammer ,  Scott M. ,  Liou ,  Song-Heng ,  Kessler ,  Harold ,  Para ,  Michael F. ,  Eron ,  Joseph ,  Valdez ,  Hernan ,  Dehlinger ,  Marjorie ,  Katzenstein ,  David A. , .  (2001) Nelfinavir, Efavirenz, or Both after the Failure of Nucleoside Treatment of HIV Infection. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>345</b>:6, 398-407<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM200108093450602">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJM200108093450602} --></span></p></li><li class="even"><p class="number">406</p><p class="content">Paul M. Coplan, Alexander A. Nikas, Randi Y. Leavitt, Louise Doll, Michael L. Nessly, Mark J. DiNubile, Harry A. Guess.  (2001) Indinavir did not increase the short-term risk of adverse cardiovascular events relative to nucleoside reverse transcriptase inhibitor therapy in four phase III clinical trials. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:12, 1584-1586<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200108170-00020" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">407</p><p class="content">EDMUND V. CAPPARELLI, JOHN L. SULLIVAN, LYNNE MOFENSON, ELIZABETH SMITH, BOBBIE GRAHAM, PAULA BRITTO, MARK I. BECKER, DIANNE HOLLAND, JAMES D. CONNOR, KATHERINE LUZURIAGA.  (2001) Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infants. <i><span class="NLM_source">The Pediatric Infectious Disease Journal</span></i> <b>20</b>:8, 746-751<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00006454-200108000-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">408</p><p class="content">Jerome H. Kim, John R. Mascola, Silvia Ratto-Kim, Thomas C. VanCott, Lawrence Loomis-Price, Josephine H. Cox, Nelson L. Michael, Linda Jagodzinski, Clifton Hawkes, Douglas Mayers, Bruce L. Gilliam, Deborah C. Birx, Merlin L. Robb.  (2001) Selective Increases in HIV-Specific Neutralizing Antibody and Partial Reconstitution of Cellular Immune Responses during Prolonged, Successful Drug Therapy of HIV Infection. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>17</b>:11, 1021-1034<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922201300343708" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">409</p><p class="content">Christos M. Tsoukas, Howard M. Turner, George E. Hatzakis, Goeffrey P. Blake, John E. Goodhew, Donald L.P. Kilby, Colin M. Kovacs, Jonathan R. Luetkehoelter, Jean-Pierre Routy, Sharon L. Walmsley, Nicole F. Bernard.  (2001) Improvement of HIV-Specific Immunity in HIV-Infected Twins Treated with Highly Active Antiretroviral Therapy, Interleukin 2, and Syngeneic Adoptively Transferred Cells. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>17</b>:10, 887-900<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922201750290014" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">410</p><p class="content">Brian Conway, Mark A. Wainberg, David Hall, Marianne Harris, Peter Reiss, David Cooper, Stefano Vella, Robert Curry, Patrick Robinson, Joep M. A. Lange, Julio S. G. Montaner.  (2001) Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:10, 1269-1274<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200107060-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">411</p><p class="content">Diane V. Havlir, Peter B. Gilbert, Kara Bennett, Ann C. Collier, Martin S. Hirsch, Pablo Tebas, Elizabeth M. Adams, L. Joseph Wheat, Diane Goodwin, Steven Schnittman, M. K. Holohan, Douglas D. Richman.  (2001) Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:11, 1379-1388<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200107270-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">412</p><p class="content">Roger J. Pomerantz.  (2001) Residual HIV-1 infection during antiretroviral therapy: the challenge of viral persistence. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:10, 1201-1211<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200107060-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">413</p><p class="content">Hikaru Matsumoto, Tooru Kimura, Tomonori Hamawaki, Akira Kumagai, Toshiyuki Goto, Kouichi Sano, Yoshio Hayashi, Yoshiaki Kiso.  (2001) Design, synthesis, and biological evaluation of anti-HIV double-drugs. <i><span class="NLM_source">Bioorganic &amp; Medicinal Chemistry</span></i> <b>9</b>:6, 1589-1600<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0968-0896(01)00045-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">414</p><p class="content">Julie Johanson, Klara Abravaya, William Caminiti, Dwight Erickson, Richard Flanders, Gregor Leckie, Eve Marshall, Carolyn Mullen, Yoshihiro Ohhashi, Robert Perry, Julie Ricci, John Salituro, Andrea Smith, Ning Tang, Marilyn Vi, John Robinson.  (2001) A new ultrasensitive assay for quantitation of HIV-1 RNA in plasma. <i><span class="NLM_source">Journal of Virological Methods</span></i> <b>95</b>:1-2, 81-92<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0166-0934(01)00297-X" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">415</p><p class="content">Chaiwat Ungsedhapand, Eugene D. M. B. Kroon, Surapol Suwanagool, Kiat Ruxrungtham, Nongluk Yimsuan, Areerat Sonjai, Sasiwimol Ubolyam, Supranee Buranapraditkun, Surapee Tiengrim, Nadine Pakker, Chaiyos Kunanusont, Joep M. A. Lange, David A. Cooper, Praphan Phanuphak.  (2001) A Randomized, Open-Label, Comparative Trial of Zidovudine Plus Lamivudine Versus Zidovudine Plus Lamivudine Plus Didanosine in Antiretroviral-Naive HIV-1–Infected Thai Patients. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>27</b>:2, 116-123<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200106010-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">416</p><p class="content">Chaiwat Ungsedhapand, Eugene D. M. B. Kroon, Surapol Suwanagool, Kiat Ruxrungtham, Nongluk Yimsuan, Areerat Sonjai, Sasiwimol Ubolyam, Supranee Buranapraditkun, Surapee Tiengrim, Nadine Pakker, Chaiyos Kunanusont, Joep M. A. Lange, David A. Cooper, Praphan Phanuphak.  (2001) A Randomized, Open-Label, Comparative Trial of Zidovudine Plus Lamivudine Versus Zidovudine Plus Lamivudine Plus Didanosine in Antiretroviral-Naive HIV-1–Infected Thai Patients. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>27</b>:2, 116-123<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200106010-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">417</p><p class="content">Pere Domingo, Olga H Torres, Josep Ris, Guillermo Vazquez.  (2001) Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection. <i><span class="NLM_source">The American Journal of Medicine</span></i> <b>110</b>:8, 605-609<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0002-9343(01)00703-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">418</p><p class="content"> (2001) Use of antiretroviral therapies among HIV-infected men who have sex with men: a household-based sample of 4 major American cities. <i><span class="NLM_source">American Journal of Public Health</span></i> <b>91</b>:5, 767-773<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2105/AJPH.91.5.767" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">419</p><p class="content">Ole Kirk, Amanda Mocroft, Christian Pradier, Johan N. Bruun, Robert Hemmer, Bonaventura Clotet, Veronica Miller, Jean-Paul Viard, Andrew N. Phillips, Jens D. Lundgren.  (2001) Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:8, 999-1008<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200105250-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">420</p><p class="content">Brian M. Sadler, Peter J. Piliero, Sandra L. Preston, Peggy P. Lloyd, Yu Lou, Daniel S. Stein.  (2001) Pharmacokinetics and safety of amprenavir and ritonavir following multiple-dose, co-administration to healthy volunteers. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:8, 1009-1018<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200105250-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">421</p><p class="content">Douglas D. Richman.  (2001) HIV chemotherapy. <i><span class="NLM_source">Nature</span></i> <b>410</b>:6831, 995-1001<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1038/35073673" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">422</p><p class="content">Terence L. Chorba, Robert C. Holman, Matthew J. Clarke, Bruce L. Evatt.  (2001) Effects of HIV infection on age and cause of death for persons with hemophilia A in the United States. <i><span class="NLM_source">American Journal of Hematology</span></i> <b>66</b>:4, 229-240<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/ajh.1050" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">423</p><p class="content">M. A. McCrackin Stevenson, Douglas G. McBroom.  (2001) In vitro characterization of FIV-pPPR, a pathogenic molecular clone of feline immunodeficiency virus, and two drug-resistant pol gene mutants. <i><span class="NLM_source">American Journal of Veterinary Research</span></i> <b>62</b>:4, 588-594<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2460/ajvr.2001.62.588" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">424</p><p class="content">Rhonda G. Kost, Arlene Hurley, Linqi Zhang, Mika Vesanen, Andrew Talal, Scott Furlan, Paul Caldwell, Judy Johnson, Lynn Smiley, David Ho, Martin Markowitz.  (2001) Open-Label Phase II Trial of Amprenavir, Abacavir, and Fixed-Dose Zidovudine/Lamivudine in Newly and Chronically HIV-1–Infected Patients. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>26</b>:4, 332-339<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200104010-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">425</p><p class="content">Rhonda G. Kost, Arlene Hurley, Linqi Zhang, Mika Vesanen, Andrew Talal, Scott Furlan, Paul Caldwell, Judy Johnson, Lynn Smiley, David Ho, Martin Markowitz.  (2001) Open-Label Phase II Trial of Amprenavir, Abacavir, and Fixed-Dose Zidovudine/Lamivudine in Newly and Chronically HIV-1–Infected Patients. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>26</b>:4, 332-339<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200104010-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">426</p><p class="content">Patrizio Pezzotti, Marilena Pappagallo, Andrew N. Phillips, Stefano Boros, Catia Valdarchi, Alessandro Sinicco, Mauro Zaccarelli, Giovanni Rezza.  (2001) Response to Highly Active Antiretroviral Therapy According to Duration of HIV Infection. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>26</b>:5, 473-479<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200104150-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">427</p><p class="content">Patrizio Pezzotti, Marilena Pappagallo, Andrew N. Phillips, Stefano Boros, Catia Valdarchi, Alessandro Sinicco, Mauro Zaccarelli, Giovanni Rezza.  (2001) Response to Highly Active Antiretroviral Therapy According to Duration of HIV Infection. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>26</b>:5, 473-479<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200104150-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">428</p><p class="content">Brian M. Sadler, Gregory E. Chittick, Ronald E. Polk, Douglas Slain, Thomas M. Kerkering, Scott D. Studenberg, Yu Lou, Katy H. P. Moore, Joseph L. Woolley, Daniel S. Stein.  (2001) Metabolic Disposition and Pharmacokinetics of [
              <sup>14</sup>
              C]-Amprenavir, a Human Immunodeficiency Virus Type 1 (HIV-1) Protease Inhibitor, Administered As a Single Oral Dose to Healthy Male Subjects. <i><span class="NLM_source">The Journal of Clinical Pharmacology</span></i> <b>41</b>:4, 386-396<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1177/00912700122010249" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">429</p><p class="content">Pablo Tebas, Keith Henry, Robert Nease, Robert Murphy, John Phair, William G. Powderly.  (2001) Timing of antiretroviral therapy. Use of Markov modeling and decision analysis to evaluate the long-term implications of therapy. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:5, 591-599<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200103300-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">430</p><p class="content">Jose-Tomas Navarro, Josep-Maria Ribera, Albert Oriol, Manuel Vaquero, Joan Romeu, Montserrat Batlle, Alonso Flores, Fuensanta Milla, Evarist Feliu.  (2001) Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone. <i><span class="NLM_source">British Journal of Haematology</span></i> <b>112</b>:4, 909-915<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2141.2001.02656.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">431</p><p class="content">Mary E. Temple, Katalin I. Koranyi, Milap C. Nahata.  (2001) The Safety and Antiviral Effect of Protease Inhibitors in Children. <i><span class="NLM_source">Pharmacotherapy</span></i> <b>21</b>:3, 287-294<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1592/phco.21.3.287.34202" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">432</p><p class="content">Inez C. J. van der Sandt, Catherine M. P. Vos, Lobna Nabulsi, Margret C. M. Blom-Roosemalen, Heleen H. Voorwinden, Albertus G. de Boer, Douwe D. Breimer.  (2001) Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood???brain barrier. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:4, 483-491<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200103090-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">433</p><p class="content">Christian M. Leutenegger, Joanne Higgins, Timothy B. Matthews, Alice F. Tarantal, Paul A. Luciw, Niels C. Pedersen, Thomas W. North.  (2001) Real-Time TaqMan PCR as a Specific and More Sensitive Alternative to the Branched-Chain DNA Assay for Quantitation of Simian Immunodeficiency Virus RNA. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>17</b>:3, 243-251<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922201750063160" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">434</p><p class="content">Julio Collazos, Jose Mayo, Eduardo Martinez.  (2001) The Evolving Mode of Presentation of HIV-Infected Patients to Health Services of Northern Spain: 1985 through December 1999. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>15</b>:2, 67-71<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/108729101300003654" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">435</p><p class="content">Alexander H??nsel, Heiner C. Bucher, Reto N??esch, Manuel Battegay.  (2001) Reasons for Discontinuation of First Highly Active Antiretroviral Therapy in a Cohort of Proteinase Inhibitor???Naive HIV-Infected Patients. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i>191-193<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200102010-00016" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">436</p><p class="content">R.J Pomerantz.  (2001) Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy. <i><span class="NLM_source">Biomedicine &amp; Pharmacotherapy</span></i> <b>55</b>:1, 7-15<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0753-3322(00)00016-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">437</p><p class="content">Alexander Hänsel, Heiner C. Bucher, Reto Nüesch, Manuel Battegay.  (2001) Reasons for Discontinuation of First Highly Active Antiretroviral Therapy in a Cohort of Proteinase Inhibitor–Naive HIV-Infected Patients. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>26</b>:2, 191-193<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200102010-00016" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">438</p><p class="content">L Smeaton.  (2001) ACTG (AIDS Clinical Trials Group) 384 A Strategy Trial Comparing Consecutive Treatments for HIV-1. <i><span class="NLM_source">Controlled Clinical Trials</span></i> <b>22</b>:2, 142-159<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0197-2456(00)00126-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">439</p><p class="content">Koyu Hara, Mayumi Shiota, Hiroshi Kido, Yasushi Ohtsu, Takahito Kashiwagi, Jun Iwahashi, Nobuyuki Hamada, Kazutoshi Mizoue, Naoki Tsumura, Hirohisa Kato, Tetsuya Toyoda.  (2001) Influenza virus RNA polymerase PA subunit is a novel serine protease with Ser624 at the active site. <i><span class="NLM_source">Genes to Cells</span></i> <b>6</b>:2, 87-97<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2443.2001.00399.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">440</p><p class="content">Mark E. Sharkey, Mario Stevenson.  (2001) Two long terminal repeat circles and persistent HIV-1 replication. <i><span class="NLM_source">Current Opinion in Infectious Diseases</span></i> <b>14</b>:1, 5-11<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00001432-200102000-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">441</p><p class="content">Kendall A. Smith.  (2001) Low-dose daily interleukin-2 immunotherapy: accelerating immune restoration and expanding HIV-specific T-cell immunity without toxicity. <i><span class="NLM_source">AIDS</span></i> <b>15</b>, S28-S35<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200102002-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">442</p><p class="content">Neil M Ferguson, Christophe Fraser, Roy M Anderson.  (2001) Viral dynamics and anti-viral pharmacodynamics: rethinking in vitro measures of drug potency. <i><span class="NLM_source">Trends in Pharmacological Sciences</span></i> <b>22</b>:2, 97-100<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0165-6147(00)01615-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">443</p><p class="content">Roger Detels, Patrick Tarwater, John P. Phair, Joseph Margolick, Sharon A. Riddler, Alvaro Mu??oz.  (2001) Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:3, 347-355<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200102160-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">444</p><p class="content">R. Pat Bucy, J. Michael Kilby.  (2001) Perspectives on inducing efficient immune control of HIV-1 replication - a new goal for HIV therapeutics?. <i><span class="NLM_source">AIDS</span></i> <b>15</b>, S36-S42<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200102002-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">445</p><p class="content">Gustavo H. Kijak, Marı́a M. Avila, Horacio Salomón.  (2001) Mother-to-child transmission of drug-resistant HIV. <i><span class="NLM_source">Drug Resistance Updates</span></i> <b>4</b>:1, 29-37<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1054/drup.2001.0182" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">446</p><p class="content"> de Quiros ,  Juan C. Lopez Bernaldo ,  Miro ,  Jose M. ,  Peña ,  Jose M. ,  Podzamczer ,  Daniel ,  Alberdi ,  Juan C. ,  Martínez ,  Esteban ,  Cosin ,  Jaime ,  Claramonte ,  Xavier ,  Gonzalez ,  Juan ,  Domingo ,  Pere ,  Casado ,  Jose L. ,  Ribera ,  Esteban , the Grupo de Estudio del SIDA 04/98.  (2001) A Randomized Trial of the Discontinuation of Primary and Secondary Prophylaxis against <em>Pneumocystis carinii</em> Pneumonia after Highly Active Antiretroviral Therapy in Patients with HIV Infection. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>344</b>:3, 159-167<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM200101183440301">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJM200101183440301} --></span></p></li><li class="odd"><p class="number">447</p><p class="content">S. A. Stranford, J. C. Ong, B. Martinez-Marino, M. Busch, F. M. Hecht, J. Kahn, J. A. Levy.  (2001) Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection. <i><span class="NLM_source">Proceedings of the National Academy of Sciences</span></i> <b>98</b>:2, 597-602<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1073/pnas.98.2.597" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">448</p><p class="content">T. Igarashi, C. R. Brown, Y. Endo, A. Buckler-White, R. Plishka, N. Bischofberger, V. Hirsch, M. A. Martin.  (2001) Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans. <i><span class="NLM_source">Proceedings of the National Academy of Sciences</span></i> <b>98</b>:2, 658-663<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1073/pnas.98.2.658" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">449</p><p class="content">M. Narita, J. J. Stambaugh, E. S. Hollender, A. E. Pitchenik, D. Ashkin.  (2001) Reply. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>32</b>:2, 323-323<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/318466" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">450</p><p class="content">Ah Miners, Ca Sabin, P Trueman, M Youle, A Mocroft, M Johnson, Ej Beck.  (2001) Assessing the cost-effectiveness of HAART for adults with HIV in England. <i><span class="NLM_source">HIV Medicine</span></i> <b>2</b>:1, 52-58<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1468-1293.2001.00048.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">451</p><p class="content">Amanda Mocroft, Michael Youle, Antonia Moore, Caroline A. Sabin, Sara Madge, Alessandro Cozzi Lepri, Mervyn Tyrer, Clinton Chaloner, Debbie Wilson, Clive Loveday, Margaret A. Johnson, Andrew N. Phillips.  (2001) Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:2, 185-194<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200101260-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">452</p><p class="content">P Bossi, V Martinez, C Strady, F Bricaire.  (2001) Actualités sur les traitements antirétroviraux. <i><span class="NLM_source">La Revue de Médecine Interne</span></i> <b>22</b>:1, 42-52<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0248-8663(00)00284-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">453</p><p class="content">Secondo Sonza, Helen P. Mutimer, Robert Oelrichs, Darren Jardine, Katya Harvey, Amanda Dunne, Damian F. Purcell, Christopher Birch, Suzanne M. Crowe.  (2001) Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:1, 17-22<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200101050-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">454</p><p class="content">Robert L. Murphy, Scott Brun, Charles Hicks, Joseph J. Eron, Roy Gulick, Martin King, A. Clinton White, Constance Benson, Melanie Thompson, Harold A. Kessler, Scott Hammer, Richard Bertz, Ann Hsu, Anthony Japour, Eugene Sun.  (2001) ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:1, F1-F9<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200101050-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">455</p><p class="content">O Kirk, J Gerstoft, C Pedersen, H Nielsen, N Obel, Tl Katzenstein, L Mathiesen, Jd Lundgren.  (2001) Low body weight and type of protease inhibitor predict discontinuation and treatment-limiting adverse drug reactions among HIV-infected patients starting a protease inhibitor regimen: consistent results from a randomized trial and an observational cohort. <i><span class="NLM_source">HIV Medicine</span></i> <b>2</b>:1, 43-51<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1468-1293.2001.00045.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">456</p><p class="content">John Gill, Judith Feinberg.  (2001) Saquinavir Soft Gelatin Capsule. <i><span class="NLM_source">Drug Safety</span></i> <b>24</b>:3, 223-232<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2165/00002018-200124030-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">457</p><p class="content">Bin Fan, James Stewart.  (2001) DETERMINATION OF ZIDOVUDINE/ZALCITABINE/NEVIRAPINE IN HUMAN PLASMA BY ION-PAIR HPLC. <i><span class="NLM_source">Journal of Liquid Chromatography &amp; Related Technologies</span></i> <b>24</b>:19, 3017-3026<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1081/JLC-100107353" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">458</p><p class="content">Cynthia M. Hingtgen, Karen L. Roos. Chapter 12 Clinical Trials in Central Nervous System Infections. Elsevier, 2001:237-259.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1877-3419(09)70019-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">459</p><p class="content">J.I. Cuende.  (2001) Estudio de casos de infección por el virus de la inmunodeficiencia humana en prisiones de Castilla y León. <i><span class="NLM_source">Revista Clínica Española</span></i> <b>201</b>:5, 249-255<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0014-2565(01)70811-9" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">460</p><p class="content">G. Pérez domínguez, M. Torrens, R. Martín-santos.  (2001) Adhesión al tratamiento antirretroviral en pacientes toxicómanos con infección por el VIH. <i><span class="NLM_source">Trastornos Adictivos</span></i> <b>3</b>:1, 43-50<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1575-0973(01)70006-2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">461</p><p class="content">Joel R. Huff, James Kahn. . 2001:213.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016%2FS0065-3233%2801%2956007-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">462</p><p class="content">J Semple.  (2000) A critical examination of current HIV therapies. <i><span class="NLM_source">Biotechnology Advances</span></i> <b>18</b>:8, 635-652<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0734-9750(00)00052-5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">463</p><p class="content">Jacques Baillargeon, Michael&nbsp;J. Borucki, Stephanie Zepeda, Hal&nbsp;B. Jenson, Charles&nbsp;T. Leach.  (2000) Antiretroviral Prescribing Patterns in the Texas Prison System. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>31</b>:6, 1476-1481<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/317478" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">464</p><p class="content">Nicholas A. Kartsonis, Richard T. D'Aquila.  (2000) CLINICAL MONITORING OF HIV-1 INFECTION IN THE ERA OF ANTIRETROVIRAL RESISTANCE TESTING. <i><span class="NLM_source">Infectious Disease Clinics of North America</span></i> <b>14</b>:4, 879-899<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0891-5520(05)70138-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">465</p><p class="content">Sabine Yerly, Thomas V. Perneger, Samir Vora, Bernard Hirschel, Luc Perrin.  (2000) Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:18, 2805-2812<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200012220-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">466</p><p class="content">Ronald O. Valdiserri, Robert S. Janssen, James W. Buehler, Patricia L. Fleming.  (2000) The Context of HIV/AIDS Surveillance. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>25</b>, S97-S104<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200012152-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">467</p><p class="content">Gregory S. Zaric, Ahmed M. Bayoumi, Margaret L. Brandeau, Douglas K. Owens.  (2000) The Cost Effectiveness of Voluntary Prenatal and Routine Newborn HIV Screening in the United States. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i>403-416<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200012150-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">468</p><p class="content">Gregory S. Zaric, Ahmed M. Bayoumi, Margaret L. Brandeau, Douglas K. Owens.  (2000) The Cost Effectiveness of Voluntary Prenatal and Routine Newborn HIV Screening in the United States. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>25</b>:5, 403-416<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200012150-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">469</p><p class="content">Laurie Andrews, Gerald Friedland.  (2000) PROGRESS IN HIV THERAPEUTICS AND THE CHALLENGES OF ADHERENCE TO ANTIRETROVIRAL THERAPY. <i><span class="NLM_source">Infectious Disease Clinics of North America</span></i> <b>14</b>:4, 901-928<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0891-5520(05)70139-2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">470</p><p class="content">Claudia Monari, Arturo Casadevall, Franco Baldelli, Daniela Francisci, Donatella Pietrella, Francesco Bistoni, Anna Vecchiarelli.  (2000) Normalization of anti-cryptococcal activity and interleukin-12 production after highly active antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:17, 2699-2708<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200012010-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">471</p><p class="content">Salvatore T. Butera.  (2000) Therapeutic targeting of human immunodeficiency virus type-1 latency: current clinical realities and future scientific possibilities. <i><span class="NLM_source">Antiviral Research</span></i> <b>48</b>:3, 143-176<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0166-3542(00)00133-9" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">472</p><p class="content">Ronald O. Valdiserri, Robert S. Janssen, James W. Buehler, Patricia L. Fleming.  (2000) The Context of HIV/AIDS Surveillance. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i>S97-S104<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200012152-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">473</p><p class="content">Fran??ois Biron, B??n??dicte Ponceau, Damien Bouhour, Andr?? Boibieux, Bernard Verrier, Dominique Peyramond.  (2000) Long-Term Safety and Antiretroviral Activity of Hydroxyurea and Didanosine in HIV-Infected Patients. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i>329-336<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200012010-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">474</p><p class="content">Kalvin Yu, Eric S Daar.  (2000) Dual protease inhibitor therapy in the management of the HIV-1. <i><span class="NLM_source">Expert Opinion on Pharmacotherapy</span></i> <b>1</b>:7, 1331-1342<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/14656566.1.7.1331" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">475</p><p class="content">Xiao-Jian Zhou, Diane V. Havlir, Douglas D. Richman, Edward P. Acosta, Martin Hirsch, Ann C. Collier, Pablo Tebas, Jean-Pierre Sommadossi.  (2000) Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:18, 2869-2876<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200012220-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">476</p><p class="content">François Biron, Bénédicte Ponceau, Damien Bouhour, André Boibieux, Bernard Verrier, Dominique Peyramond.  (2000) Long-Term Safety and Antiretroviral Activity of Hydroxyurea and Didanosine in HIV-Infected Patients. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>25</b>:4, 329-336<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200012010-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">477</p><p class="content">Anding Shen, Janet D. Siliciano, Theodore C. Pierson, Christopher B. Buck, Robert F. Siliciano.  (2000) Establishment of Latent HIV-1 Infection of Resting CD4+ T Lymphocytes Does Not Require Inactivation of Vpr. <i><span class="NLM_source">Virology</span></i> <b>278</b>:1, 227-233<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1006/viro.2000.0650" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">478</p><p class="content">F. Raffi, B. Bonnet, V. Ferre, J.-L. Esnault, P. Perre, V. Reliquet, S. Leautez, C. Bouillant, O. Vergnoux, P. Weinbreck.  (2000) Substitution of a Nonnucleoside Reverse Transcriptase Inhibitor for a Protease Inhibitor in the Treatment of Patients with Undetectable Plasma Human Immunodeficiency Virus Type 1 RNA. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>31</b>:5, 1274-1278<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/317424" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">479</p><p class="content">David Sweg-Hsien Wu, Marshall Leedy Stoller.  (2000) Indinavir urolithiasis. <i><span class="NLM_source">Current Opinion in Urology</span></i> <b>10</b>:6, 557-561<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042307-200011000-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">480</p><p class="content">Kai Riecke, Thomas G. Schulz, Mehdi Shakibaei, Bernd Krause, Ibrahim Chahoud, Ralf Stahlmann.  (2000) Developmental toxicity of the HIV-protease inhibitor indinavir in rats. <i><span class="NLM_source">Teratology</span></i> <b>62</b>:5, 291-300<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/1096-9926(200011)62:5&amp;lt;291::AID-TERA3&amp;gt;3.0.CO;2-A" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">481</p><p class="content">Anat R. Feingold, Richard M. Rutstein, Debrah Meislich, Teneille Brown, Bret J. Rudy.  (2000) Protease Inhibitor Therapy in HIV-Infected Children. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>14</b>:11, 589-593<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/10872910050193761" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">482</p><p class="content">Richard B. Pollard.  (2000) Didanosine once daily: potential for expanded use. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:16, 2421-2428<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200011100-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">483</p><p class="content">Daan W. Notermans, Frank de Wolf, Peter Oudshoorn, H. Theo Cuijpers, Maria Pirillo, Friedrich W. Tiller, Daniel R. McClernon, Jan M. Prins, Joep M. A. Lange, Sven A. Danner, Jaap Goudsmit, Suzanne Jurriaans.  (2000) Evaluation of a Second-Generation Nucleic Acid Sequence-Based Amplification Assay for Quantification of HIV Type 1 RNA and the Use of Ultrasensitive Protocol Adaptations. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>16</b>:15, 1507-1517<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922200750006038" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">484</p><p class="content">David W. Haas, Lisa A. Clough, Benjamin W. Johnson, Victoria L. Harris, Paul Spearman, Grant R. Wilkinson, Courtney V. Fletcher, Susan Fiscus, Stephen Raffanti, Ruth Donlon, Judy McKinsey, Janet Nicotera, Dennis Schmidt, Ronald E. Shoup, Robert E. Kates, Robert M. Lloyd, Brendan Larder.  (2000) Evidence of a Source of HIV Type 1 within the Central Nervous System by Ultraintensive Sampling of Cerebrospinal Fluid and Plasma. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>16</b>:15, 1491-1502<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922200750006010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">485</p><p class="content">A. Isgrò, I. Mezzaroma, A. Aiuti, L. De Vita, F. Franchi, F. Pandolfi, C. Alario, F. Ficara, E. Riva, G. Antonelli, F. Aiuti.  (2000) Recovery of Hematopoietic Activity in Bone Marrow from Human Immunodeficiency Virus Type 1-Infected Patients during Highly Active Antiretroviral Therapy. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>16</b>:15, 1471-1479<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922200750005994" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">486</p><p class="content">Neil M. Graham.  (2000) Metabolic Disorders Among HIV-Infected Patients Treated With Protease Inhibitors: A Review. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>25</b>, S4-S11<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200010001-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">487</p><p class="content">Linqi Zhang, Chris Chung, Bor-Shen Hu, Tian He, Yong Guo, Alexandria J. Kim, Eva Skulsky, Xia Jin, Arlene Hurley, Bharat Ramratnam, Martin Markowitz, David D. Ho.  (2000) Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy. <i><span class="NLM_source">Journal of Clinical Investigation</span></i> <b>106</b>:7, 839-845<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1172/JCI10565" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">488</p><p class="content">Pierre‐Marie Girard, Marguerite Guiguet, Diane Bollens, Isabelle Goderel, Marie‐Caroline Meyohas, Isabelle Lecomte, Gilles Raguin, Jacques Frottier, Willy Rozenbaum, Patrice Jaillon.  (2000) Long‐Term Outcome and Treatment Modifications in a Prospective Cohort of Human Immunodeficiency Virus Type 1–Infected Patients on Triple‐Drug Antiretroviral Regimens. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>31</b>:4, 987-994<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/318154" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">489</p><p class="content">Da' N. Haddad, Christopher Birch, Tracy Middleton, Dominic E. Dwyer, Anthony L. Cunningham, Nitin K. Saksena.  (2000) Evidence for late stage compartmentalization of HIV-1 resistance mutations between lymph node and peripheral blood mononuclear cells. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:15, 2273-2281<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200010200-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">490</p><p class="content">Neil M. Graham.  (2000) Metabolic Disorders Among HIV-Infected Patients Treated With Protease Inhibitors: A Review. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i>S4-S11<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200010001-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">491</p><p class="content">Craig&nbsp;J. Hoesley, Michael&nbsp;S. Saag, Ashlee Chatham, J.&nbsp;Michael Kilby.  (2000) Prolonged Suppression of Human Immunodeficiency Virus Type 1 RNA during Dual Nucleoside Reverse‐Transcriptase–Inhibitor Therapy in Clinical Practice. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>31</b>:4, 1095-1097<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/318143" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">492</p><p class="content">Fabrizio Ensoli, Valeria Fiorelli, Cecilia Alario, Maria De Cristofaro, Donatella Santini Muratori, Arianna Novi, Maria Giovanna Cunsolo, Francesca Mazzetta, Antonello Giovannetti, Bianca Mollicone, Elena Pinter, Fernando Aiuti.  (2000) Decreased T Cell Apoptosis and T Cell Recovery during Highly Active Antiretroviral Therapy (HAART). <i><span class="NLM_source">Clinical Immunology</span></i> <b>97</b>:1, 9-20<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1006/clim.2000.4915" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">493</p><p class="content">Homira Behbahani, Alan Landay, Bruce K. Patterson, Paul Jones, John Pottage, Michelle Agnoli, Jan Andersson, Anna-Lena Spetz.  (2000) Normalization of Immune Activation in Lymphoid Tissue Following Highly Active Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>25</b>:2, 150-156<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200010010-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">494</p><p class="content">Rafik Samuel, Byungse Suh.  (2000) Antiretroviral therapy 2000. <i><span class="NLM_source">Archives of Pharmacal Research</span></i> <b>23</b>:5, 425-437<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF02976566" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">495</p><p class="content">G. Paolo Rizzardi, Giuseppe Tambussi, Pierre-Alexandre Bart, Aude G. Chapuis, Adriano Lazzarin, Giuseppe Pantaleo.  (2000) Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:15, 2257-2263<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200010200-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">496</p><p class="content">Homira Behbahani, Alan Landay, Bruce K. Patterson, Paul Jones, John Pottage, Michelle Agnoli, Jan Andersson, Anna-Lena Spetz.  (2000) Normalization of Immune Activation in Lymphoid Tissue Following Highly Active Antiretroviral Therapy. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i>150-156<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200010010-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">497</p><p class="content"> (2000) Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE. <i><span class="NLM_source">HIV Medicine</span></i> <b>1</b>:4, 224-231<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1468-1293.2000.00033.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">498</p><p class="content">David W Haas, Eduardo Arathoon, Melanie A Thompson, Rogiero de Jesus Pedro, Joel E Gallant, David E Uip, Judith Currier, L. Miguel Noriega, David S Lewi, Patricia Uribe, Jorge Benetucci, Pedro Cahn, David Paar, A. Clinton White, Ann C Collier, Carlos H Ramirez-Ronda, Charlotte Harvey, Mi-ok Chung, Devan Mehrotra, Jeffrey Chodakewitz, Bach-Yen Nguyen.  (2000) Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:13, 1973-1978<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200009080-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">499</p><p class="content">Peter B Gilbert, Heather J Ribaudo, Lisa Greenberg, George Yu, Ronald J Bosch, Camlin Tierney, Daniel R Kuritzkes.  (2000) Considerations in choosing a primary endpoint that measures durability of virological suppression in an antiretroviral trial. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:13, 1961-1972<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200009080-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">500</p><p class="content">K. H. Mayer, J. D. Passalaris, K. A. Sepkowitz, M. J. Glesby.  (2000) Coronary Artery Disease and Human Immunodeficiency Virus Infection. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>31</b>:3, 787-797<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/313995" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">501</p><p class="content">Veronica Miller, Caroline A. Sabin, Andrew N. Phillips, Carsten Rottmann, Holger Rabenau, Eckard Weidmann, Volker Rickerts, Stephan Findhammer, Eilke B. Helm, Schlomo Staszewski.  (2000) The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:14, 2129-2136<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200009290-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">502</p><p class="content"> (2000) Effect of ignoring the time of HIV seroconversion in estimating changes in survival over calendar time in observational studies: results from CASCADE*. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:13, 1899-1906<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200009080-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">503</p><p class="content">Olivier T Rutschmann, Pietro L Vernazza, Heiner C Bucher, Milos Opravil, Bruno Ledergerber, Amalio Telenti, Raffaele Malinverni, Enos Bernasconi, Catherine Fagard, Dominique Leduc, Luc Perrin, Bernard Hirschel.  (2000) Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:14, 2145-2151<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200009290-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">504</p><p class="content">Pierre-Alexandre Bart, G. Paolo Rizzardi, Giuseppe Tambussi, Jean-Philippe Chave, Aude G Chapuis, Cecilia Graziosi, Jean-Marc Corpataux, Nermin Halkic, Jean-Yves Meuwly, Miguel Munoz, Pascal Meylan, William Spreen, Hugh McDade, Sabine Yerly, Luc Perrin, Adriano Lazzarin, Giuseppe Pantaleo.  (2000) Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:13, 1887-1897<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200009080-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">505</p><p class="content">Marek Fischer, Huldrych F. Günthard, Milos Opravil, Beda Joos, Werner Huber, Leslie R. Bisset, Peter Ott, Jürg Böni, Rainer Weber, Richard W. Cone.  (2000) Residual HIV-RNA Levels Persist for Up to 2.5 Years in Peripheral Blood Mononuclear Cells of Patients on Potent Antiretroviral Therapy. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>16</b>:12, 1135-1140<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922200414974" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">506</p><p class="content">Andrew Wiznia, Kenneth Stanley, Paul Krogstad, George Johnson, Sophia Lee, James McNamara, John Moye, J. Brooks Jackson, Hermann Mendez, Rosaura Aguayo, Arry Dieudonne, Andrea Kovacs, Mahrukh Bamji, Elaine Abrams, Sohail Rana, John Sever, Sharon Nachman.  (2000) Combination Nucleoside Analog Reverse Transcriptase Inhibitor(s) Plus Nevirapine, Nelfinavir, or Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: Week 24 Results of a Randomized Controlled Trial - PACTG 377. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>16</b>:12, 1113-1121<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922200414956" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">507</p><p class="content">H Gehringer, J.R Bogner, F.D Goebel, H Nitschko, K von der Helm.  (2000) Sequence analysis of the HIV-1 protease coding region of 18 HIV-1-infected patients prior to HAART and possible implications on HAART. <i><span class="NLM_source">Journal of Clinical Virology</span></i> <b>17</b>:2, 137-141<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1386-6532(00)00086-X" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">508</p><p class="content">Carlo Calabrese, Sheryl H. Berman, John G. Babish, Xinfang Ma, Lynne Shinto, Melissa Dorr, Kameron Wells, Cynthia A. Wenner, Leanna J. Standish.  (2000) A phase I trial of andrographolide in HIV positive patients and normal volunteers. <i><span class="NLM_source">Phytotherapy Research</span></i> <b>14</b>:5, 333-338<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/1099-1573(200008)14:5&amp;lt;333::AID-PTR584&amp;gt;3.0.CO;2-D" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">509</p><p class="content">A. Mocroft, M. J. Gill, W. Davidson, A. N. Phillips.  (2000) Are There Gender Differences in Starting Protease Inhibitors, HAART, and Disease Progression Despite Equal Access to Care?. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>24</b>:5, 475-482<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200008150-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">510</p><p class="content">Conceiçao Aparecida Accetturi, Regina Pardini, Gedson H. Novaes Pinto, Gilberto Turcato, David Salomão Lewi, Ricardo Sobhie Diaz.  (2000) Effects of CCR5 Genetic Polymorphism and HIV-1 Subtype in Antiretroviral Response in Brazilian HIV-1–Infected Patients. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>24</b>:4, 399<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200008010-00016" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">511</p><p class="content">David Muir, David White, Julie King, Neville Verlander, Deenan Pillay.  (2000) Predictive value of the ultrasensitive HIV viral load assay in clinical practice. <i><span class="NLM_source">Journal of Medical Virology</span></i> <b>61</b>:4, 411-416<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/1096-9071(200008)61:4&amp;lt;411::AID-JMV1&amp;gt;3.0.CO;2-M" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">512</p><p class="content">A. Mocroft, M. J. Gill, W. Davidson, A. N. Phillips.  (2000) Are There Gender Differences in Starting Protease Inhibitors, HAART, and Disease Progression Despite Equal Access to Care?. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>24</b>:5, 475-482<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200008150-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">513</p><p class="content">Masahiko Fujinaga, Marta Schulte, Mark Holodniy.  (2000) Assessment of developmental toxicity of antiretroviral drugs using a rat whole embryo culture system. <i><span class="NLM_source">Teratology</span></i> <b>62</b>:2, 108-114<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/1096-9926(200008)62:2&amp;lt;108::AID-TERA7&amp;gt;3.0.CO;2-2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">514</p><p class="content">Charles Dumon, Caroline Solas, Isabelle Thuret, Hervé Chambost, Bruno Lacarelle, Gerard Michel, Alain Durand.  (2000) Relationship Between Efficacy, Tolerance, and Plasma Drug Concentration of Ritonavir in Children With Advanced HIV Infection. <i><span class="NLM_source">Therapeutic Drug Monitoring</span></i> <b>22</b>:4, 402-408<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00007691-200008000-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">515</p><p class="content">Conceiçao Aparecida Accetturi, Regina Pardini, Gedson H. Novaes Pinto, Gilberto Turcato, David Salomão Lewi, Ricardo Sobhie Diaz.  (2000) Effects of CCR5 Genetic Polymorphism and HIV-1 Subtype in Antiretroviral Response in Brazilian HIV-1–Infected Patients. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>24</b>:4, 399<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200008010-00016" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">516</p><p class="content">W. G. Powderly.  (2000) Prophylaxis for Opportunistic Infections in an Era of Effective Antiretroviral Therapy. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>31</b>:2, 597-601<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/313950" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">517</p><p class="content">S. K. Schwarcz.  (2000) Impact of Protease Inhibitors and Other Antiretroviral Treatments on Acquired Immunodeficiency Syndrome Survival in San Francisco, California, 1987-1996. <i><span class="NLM_source">American Journal of Epidemiology</span></i> <b>152</b>:2, 178-185<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/aje/152.2.178" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">518</p><p class="content">Amanda Mocroft, Helen Devereux, Sabine Kinloch-de-Loes, Debbie Wilson, Sara Madge, Michael Youle, Mervyn Tyrer, Clive Loveday, Andrew N. Phillips, Margaret A. Johnson.  (2000) Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:11, 1545-1552<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200007280-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">519</p><p class="content">Renan C. Castillo, Silvio Arango-Jaramillo, Rohan John, Brian C. Turner, Eric Zimmerman, David H. Schwartz.  (2000) Rapid Communication: Development of in Vitro Resistance to Macrophage-Tropic– and T-Cell-Line–Adapted HIV-1 Strains Among HIV-Positive Volunteers Treated With Highly Active Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>24</b>:3, 197-202<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200007010-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">520</p><p class="content"> (2000) HIV transmission and the cost-effectiveness of methadone maintenance. <i><span class="NLM_source">American Journal of Public Health</span></i> <b>90</b>:7, 1100-1111<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2105/AJPH.90.7.1100" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">521</p><p class="content">Renan C. Castillo, Silvio Arango-Jaramillo, Rohan John, Brian C. Turner, Eric Zimmerman, David H. Schwartz.  (2000) Rapid Communication: Development of in Vitro Resistance to Macrophage-Tropic– and T-Cell-Line–Adapted HIV-1 Strains Among HIV-Positive Volunteers Treated With Highly Active Antiretroviral Therapy. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>24</b>:3, 197-202<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200007010-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">522</p><p class="content">Kathleen E. Squires, Roy Gulick, Pablo Tebas, Jorge Santana, Victor Mulanovich, Rebecca Clark, Bienvenido Yangco, Steven I. Marlowe, David Wright, Calvin Cohen, Timothy Cooley, Joseph Mauney, Katharina Uffelman, Nancy Schoellkopf, Robert Grosso, Michael Stevens.  (2000) A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I). <i><span class="NLM_source">AIDS</span></i> <b>14</b>:11, 1591-1600<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200007280-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">523</p><p class="content">B Roca, C.J Gómez, A Arnedo.  (2000) Adherence, Side Effects and Efficacy of Stavudine plus Lamivudine plus Nelfinavir in Treatment-experienced HIV-infected Patients. <i><span class="NLM_source">Journal of Infection</span></i> <b>41</b>:1, 50-54<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1053/jinf.2000.0678" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">524</p><p class="content">Giorgio R. Sansone, J. Dermot Frengley.  (2000) Impact of haart on causes of death of persons with late-stage AIDS. <i><span class="NLM_source">Journal of Urban Health</span></i> <b>77</b>:2, 166-175<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF02390528" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">525</p><p class="content">Barbara Greenberg, Ruth Mccorkle, David Vlahov, Peter A. Selwyn.  (2000) Palliative care for HIV disease in the era of highly active antiretroviral therapy. <i><span class="NLM_source">Journal of Urban Health</span></i> <b>77</b>:2, 150-165<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF02390527" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">526</p><p class="content">Teresa Bini, Letizia Testa, Elisabetta Chiesa, Fulvio Adorni, Clara Abeli, Barbara Castelnuovo, Sara Melzi, Salvatore Sollima, Marco Bongiovanni, Antonella d'Arminio Monforte.  (2000) Outcome of a Second-Line Protease Inhibitor–Containing Regimen in Patients Failing or Intolerant of a First Highly Active Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>24</b>:2, 115-122<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200006010-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">527</p><p class="content">Mari M. Kitahata, Stephen E. Van Rompaey, Anne W. Shields.  (2000) Physician Experience in the Care of HIV-Infected Persons Is Associated With Earlier Adoption of New Antiretroviral Therapy. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>24</b>:2, 106-114<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200006010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">528</p><p class="content">Teresa Bini, Letizia Testa, Elisabetta Chiesa, Fulvio Adorni, Clara Abeli, Barbara Castelnuovo, Sara Melzi, Salvatore Sollima, Marco Bongiovanni, Antonella d'Arminio Monforte.  (2000) Outcome of a Second-Line Protease Inhibitor–Containing Regimen in Patients Failing or Intolerant of a First Highly Active Antiretroviral Therapy. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>24</b>:2, 115-122<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200006010-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">529</p><p class="content">Stefano Menzo, Stefano Rusconi, Alessia Monachetti, Maria Chiara Colombo, Michela Violin, Patrizia Bagnarelli, Pietro E. Varaldo, Mauro Moroni, Massimo Galli, Claudia Balotta, Massimo Clementi.  (2000) Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:9, 1101-1110<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200006160-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">530</p><p class="content">Mari M. Kitahata, Stephen E. Van Rompaey, Anne W. Shields.  (2000) Physician Experience in the Care of HIV-Infected Persons Is Associated With Earlier Adoption of New Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>24</b>:2, 106-114<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200006010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">531</p><p class="content">Rieneke M. E. van Praag, Gerrit J. Weverling, Peter Portegies, Suzanne Jurriaans, Xiao-Jian Zhou, Michele L. Turner-Foisy, Jean-Pierre Sommadossi, David M. Burger, Joep M. A. Lange, Richard M. W. Hoetelmans, Jan M. Prins.  (2000) Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:9, 1187-1194<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200006160-00016" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">532</p><p class="content">J??rgen K. Rockstroh, Frank Bergmann, Werner Wiesel, Ansgar Rieke, Albert Theisen, Gerd F??tkenheuer, Mark Oette, Horst Carls, Stefan Fenske, Mathias Nadler, Heribert Knechten.  (2000) Efficacy and safety of twice daily first-line ritonavir/indinavir plus double nucleoside combination therapy in HIV-infected individuals. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:9, 1181-1185<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200006160-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">533</p><p class="content">Keola K. Beale, W.Edward Robinson.  (2000) Combinations of reverse transcriptase, protease, and integrase inhibitors can be synergistic in vitro against drug-sensitive and RT inhibitor-resistant molecular clones of HIV-1. <i><span class="NLM_source">Antiviral Research</span></i> <b>46</b>:3, 223-232<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0166-3542(00)00083-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">534</p><p class="content">J. J. Eron.  (2000) HIV-1 Protease Inhibitors. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>30</b>:Supplement 2, S160-S170<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/313853" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">535</p><p class="content">W. A. O'Brien.  (2000) Resistance against Reverse Transcriptase Inhibitors. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>30</b>:Supplement 2, S185-S192<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/313858" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">536</p><p class="content">Annemarie M.C. van Rossum, Hubert G.M. Niesters, Sibyl P.M. Geelen, Henriëtte J. Scherpbier, Nico G. Hartwig, Corrie M.R. Weemaes, Arjo J.P. Veerman, Marja H. Suur, Elizabeth R. de Graeff-Meeder, Walentina A.T. Slieker, Wim C.J. Hop, Albert D.M.E. Osterbaus, David M. Burger, Ronald de Groot.  (2000) Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: A multicenter study in The Netherlands. <i><span class="NLM_source">The Journal of Pediatrics</span></i> <b>136</b>:6, 780-788<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0022-3476(00)94347-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">537</p><p class="content">S. Fleury, G. P. Rizzardi, A. Chapuis, G. Tambussi, C. Knabenhans, E. Simeoni, J.-Y. Meuwly, J.-M. Corpataux, A. Lazzarin, F. Miedema, G. Pantaleo.  (2000) Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy. <i><span class="NLM_source">Proceedings of the National Academy of Sciences</span></i> <b>97</b>:10, 5393-5398<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1073/pnas.97.10.5393" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">538</p><p class="content">M. Narita, J. J. Stambaugh, E. S. Hollender, D. Jones, A. E. Pitchenik, D. Ashkin.  (2000) Use of Rifabutin with Protease Inhibitors for Human Immunodeficiency Virus-Infected Patients with Tuberculosis. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>30</b>:5, 779-783<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/313771" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">539</p><p class="content">A Pugliese, D Isnardi, A Saini, T Scarabelli, R Raddino, D Torre.  (2000) Impact of Highly Active Antiretroviral Therapy in HIV-positive Patients with Cardiac Involvement. <i><span class="NLM_source">Journal of Infection</span></i> <b>40</b>:3, 282-284<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1053/jinf.2000.0672" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">540</p><p class="content">Nina Khanna, Thomas Klimkait, Veronique Schiffer, Jose Irigoyen, Amalio Telenti, Bernard Hirschel, Manuel Battegay.  (2000) Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:7, 791-799<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200005050-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">541</p><p class="content">Vincent Le Moing, Geneviève Chêne, Bernard Masquelier, Didier Sicard, Françoise Brun-Vézinet, Jacques Reynes, François Raffi.  (2000) Definition of Virologic Response and the Type of Assay Used for Quantification of Viral Load May Influence the Proportion of Responders to Antiretroviral Therapy. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>24</b>:1, 82-83<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200005010-00016" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">542</p><p class="content">Quan Dong Nguyen, John H Kempen, Stephen G Bolton, James P Dunn, Douglas A Jabs.  (2000) Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. <i><span class="NLM_source">American Journal of Ophthalmology</span></i> <b>129</b>:5, 634-639<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0002-9394(00)00356-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">543</p><p class="content">J.Christopher Macdonald, Marietta P Karavellas, Francesca J Torriani, Lawrence S Morse, Irene L Smith, J.Brian Reed, William R Freeman.  (2000) Highly active antiretroviral therapy–related immune recovery in AIDS patients with cytomegalovirus retinitis11The authors do not have any proprietary interest in any product mentioned in the text.. <i><span class="NLM_source">Ophthalmology</span></i> <b>107</b>:5, 877-881<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0161-6420(00)00023-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">544</p><p class="content">Vincent Le Moing, Geneviève Chêne, Bernard Masquelier, Didier Sicard, Françoise Brun-Vézinet, Jacques Reynes, François Raffi.  (2000) Definition of Virologic Response and the Type of Assay Used for Quantification of Viral Load May Influence the Proportion of Responders to Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>24</b>:1, 82-83<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200005010-00016" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">545</p><p class="content">Elisabeth H. Gisolf, Rolf P. G. van Heeswijk, Richard W. M. Hoetelmans, Sven A. Danner.  (2000) Decreased exposure to saquinavir in HIV-1-infected patients after long-term antiretroviral therapy including ritonavir and saquinavir. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:7, 801-805<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200005050-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">546</p><p class="content">Marlyse C. Knuchel, Herbert Kuster, Erika Schlaepfer, Alex Kallivroussis, Rainer Weber, Richard W. Cone.  (2000) Incomplete HIV-1 Activation in Latently Infected U1 Cells Demonstrated by Double in Situ Hybridization. <i><span class="NLM_source">Virology</span></i> <b>271</b>:1, 79-89<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1006/viro.2000.0307" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">547</p><p class="content">Christophe Fraser, Neil M. Ferguson, Azra C. Ghani, Jan M. Prins, Joep M. A. Lange, Jaap Goudsmit, Roy M. Anderson, Frank de Wolf.  (2000) Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:6, 659-669<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200004140-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">548</p><p class="content"> (2000) British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. <i><span class="NLM_source">HIV Medicine</span></i> <b>1</b>:2, 76-101<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1468-1293.2000.00013.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">549</p><p class="content">Josephine A. Mauskopf, Jerry M. Tolson, Kit N. Simpson, Sissi V. Pham, James Albright.  (2000) Impact of Zidovudine-Based Triple Combination Therapy on an AIDS Drug Assistance Program. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:4, 302-313<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200004010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">550</p><p class="content">W. Jeffrey Fessel, John F. Krowka, Haynes W. Sheppard, Marianne Gesner, Sebastian Tongson, Samuel Weinstein, Michael Ascher, Shirley Kwok, Cindy Christopherson.  (2000) Dissociation of Immunologic and Virologic Responses to Highly Active Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:4, 314-320<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200004010-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">551</p><p class="content">Richard D. Moore.  (2000) Cost Effectiveness of Combination HIV Therapy. <i><span class="NLM_source">PharmacoEconomics</span></i> <b>17</b>:4, 325-330<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2165/00019053-200017040-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">552</p><p class="content">Josephine A. Mauskopf, Jerry M. Tolson, Kit N. Simpson, Sissi V. Pham, James Albright.  (2000) Impact of Zidovudine-Based Triple Combination Therapy on an AIDS Drug Assistance Program. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:4, 302-313<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200004010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">553</p><p class="content">W. Jeffrey Fessel, John F. Krowka, Haynes W. Sheppard, Marianne Gesner, Sebastian Tongson, Samuel Weinstein, Michael Ascher, Shirley Kwok, Cindy Christopherson.  (2000) Dissociation of Immunologic and Virologic Responses to Highly Active Antiretroviral Therapy. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:4, 314-320<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200004010-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">554</p><p class="content">Theodore Pierson, Justin McArthur, Robert F. Siliciano.  (2000) Reservoirs for HIV-1: Mechanisms for Viral Persistence in the Presence of Antiviral Immune Responses and Antiretroviral Therapy. <i><span class="NLM_source">Annual Review of Immunology</span></i> <b>18</b>:1, 665-708<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1146/annurev.immunol.18.1.665" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">555</p><p class="content">G. Paolo Rizzardi, Rob J. De Boer, Shelley Hoover, Giuseppe Tambussi, Aude Chapuis, Nermin Halkic, Pierre-Alexandre Bart, Veronica Miller, Schlomo Staszewski, Daan W. Notermans, Luc Perrin, Cecil H. Fox, Joep M.A. Lange, Adriano Lazzarin, Giuseppe Pantaleo.  (2000) Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA. <i><span class="NLM_source">Journal of Clinical Investigation</span></i> <b>105</b>:6, 777-782<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1172/JCI9079" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">556</p><p class="content">Michael D. Stein, Marta E. Urdaneta, Jennifer Clarke, Jinana Maksad, Mindy Sobota, Lucy Hanna, Leona E. Markson.  (2000) Use of Antiretroviral Therapies by HIV-Infected Persons Receiving Methadone Maintenance. <i><span class="NLM_source">Journal of Addictive Diseases</span></i> <b>19</b>:1, 85-94<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1300/J069v19n01_07" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">557</p><p class="content">Jonathan Elford, Graham Bolding, Mark Maguire, Lorraine Sherr.  (2000) Combination Therapies for HIV and Sexual Risk Behavior Among Gay Men. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:3, 266-271<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200003010-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">558</p><p class="content"> (2000) AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:4, 367-374<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200003100-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">559</p><p class="content">Richard Horuk, Howard P. Ng.  (2000) Chemokine Receptor Antagonists. <i><span class="NLM_source">Medicinal Research Reviews</span></i> <b>20</b>:2, 155-168<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/(SICI)1098-1128(200003)20:2&amp;lt;155::AID-MED3&amp;gt;3.0.CO;2-G" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">560</p><p class="content">M. Louise Markert, Charles B. Hicks, John A. Bartlett, J. Les Harmon, Laura P. Hale, Michael L. Greenberg, Guido Ferrari, Janet Ottinger, Andreas Boeck, Amy L. Kloster, Tanya M. M, Laughlin, Karen B. Bleich, Ross M. Ungerleider, H. Kim Lyerly, William E. Wilkinson, Franck S. Rousseau, M Argo E. Heath-Chiozzi, John M. Leonard, Ashley T. Haase, George M ., R. Pat Bucy, Daniel C. Douek, Richard A. Koup, Barton F. Haynes, Dani P. Bolognesi, Kent J. Weinhold.  (2000) Effect of Highly Active Antiretroviral Therapy and Thymic Transplantation on Immunoreconstitution in HIV Infection. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>16</b>:5, 403-413<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922200309061" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">561</p><p class="content">Susan Cu-Uvin, Angela M. Caliendo, Steven Reinert, Albert Chang, Catherine Juliano-Remollino, Timothy P. Flanigan, Kenneth H. Mayer, Charles C. J. Carpenter.  (2000) Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:4, 415-421<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200003100-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">562</p><p class="content">Paolo Bonfanti, Laura Valsecchi, Fabio Parazzini, Silvia Carradori, Luigi Pusterla, Paolo Fortuna, Lia Timillero, Federica Alessi, Giancarlo Ghiselli, Andrea Gabbuti, Elisabetta Di Cintio, Canio Martinelli, Ivano Faggion, Simona Landonio, Tiziana Quirino.  (2000) Incidence of Adverse Reactions in HIV Patients Treated With Protease Inhibitors: A Cohort Study. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:3, 236-245<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200003010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">563</p><p class="content">Jonathan B. Angel, Kevin High, Frank Rhame, David Brand, James B. Whitmore, Jan M. Agosti, Mark J. Gilbert, Stanley Deresinski.  (2000) Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppression. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:4, 387-395<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200003100-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">564</p><p class="content">A. Fraternale, A. Casabianca, A. Tonelli, G. Vallanti, L. Chiarantini, G. Brandi, A. G. Celeste, M. Magnani.  (2000) Inhibition of Murine AIDS by Alternate Administration of Azidothymidine and Fludarabine Monophosphate. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:3, 209-220<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200003010-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">565</p><p class="content">Paolo Bonfanti, Laura Valsecchi, Fabio Parazzini, Silvia Carradori, Luigi Pusterla, Paolo Fortuna, Lia Timillero, Federica Alessi, Giancarlo Ghiselli, Andrea Gabbuti, Elisabetta Di Cintio, Canio Martinelli, Ivano Faggion, Simona Landonio, Tiziana Quirino.  (2000) Incidence of Adverse Reactions in HIV Patients Treated With Protease Inhibitors: A Cohort Study. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:3, 236-245<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200003010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">566</p><p class="content">Thomas M. Lampinen, Cathy W. Critchlow, Jane M. Kuypers, Carla S. Hurt, Paul J. Nelson, Stephen E. Hawes, Robert W. Coombs, King K. Holmes, Nancy B. Kiviat.  (2000) Association of antiretroviral therapy with detection of HIV-1 RNA and DNA in the anorectal mucosa of homosexual men. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:5, F69-F75<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200003310-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">567</p><p class="content">P. Barreiro, V. Soriano, N. Cabello, J. Gonzalez-Lahoz.  (2000) Is there a role for indinavir twice-daily in clinical practice?. <i><span class="NLM_source">Clinical Microbiology and Infection</span></i> <b>6</b>:3, 152-154<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1469-0691.2000.00034-3.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">568</p><p class="content">Antonella d'Arminio Monforte, Alessandro Cozzi Lepri, Giovanni Rezza, Patrizio Pezzotti, Andrea Antinori, Andrew N. Phillips, Gioacchino Angarano, Vincenzo Colangeli, Andrea De Luca, Giuseppe Ippolito, Liliana Caggese, Fabrizio Soscia, Gaetano Filice, Francesco Gritti, Pasquale Narciso, Umberto Tirelli, Mauro Moroni.  (2000) Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral na??ve patients. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:5, 499-507<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200003310-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">569</p><p class="content">Franco Pandolfi, Marina Pierdominici, Marco Marziali, Maria Livia Bernardi, Guido Antonelli, Vincenzo Galati, Gianpiero D'Offizi, Fernando Aiuti.  (2000) Low-Dose IL-2 Reduces Lymphocyte Apoptosis and Increases Naive CD4 Cells in HIV-1 Patients Treated with HAART. <i><span class="NLM_source">Clinical Immunology</span></i> <b>94</b>:3, 153-159<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1006/clim.2000.4837" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">570</p><p class="content">A. Fraternale, A. Casabianca, A. Tonelli, G. Vallanti, L. Chiarantini, G. Brandi, A. G. Celeste, M. Magnani.  (2000) Inhibition of Murine AIDS by Alternate Administration of Azidothymidine and Fludarabine Monophosphate. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:3, 209-220<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200003010-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">571</p><p class="content">Jonathan Elford, Graham Bolding, Mark Maguire, Lorraine Sherr.  (2000) Combination Therapies for HIV and Sexual Risk Behavior Among Gay Men. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:3, 266-271<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200003010-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">572</p><p class="content">S. K. Cinti, D. R. Kaul, P. E. Sax, L. R. Crane, P. H. Kazanjian.  (2000) Recurrence of Mycobacterium avium Infection in Patients Receiving Highly Active Antiretroviral Therapy and Antimycobacterial Agents. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>30</b>:3, 511-514<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/313705" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">573</p><p class="content">M. B. Regazzi.  (2000) Clinical pharmacokinetics of nelfinavir combined with efavirenz and stavudine during rescue treatment of heavily pretreated HIV-infected patients. <i><span class="NLM_source">Journal of Antimicrobial Chemotherapy</span></i> <b>45</b>:3, 343-347<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/jac/45.3.343" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">574</p><p class="content">Anne Ma Dyrhol-Riise, Pal Voltersvik, Bard I. Rosok, Jan Olofsson, Birgitta Asjo.  (2000) Normalization of CD4
              <sup>+</sup>
              Cell Numbers and Reduced Levels of Memory CD8
              <sup>+</sup>
              Cells in Blood and Tonsillar Tissue after Highly Active Antiretroviral Therapy in Early HIV Type-1 Infection. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>16</b>:3, 191-201<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922200309287" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">575</p><p class="content">Graeme J. Moyle.  (2000) Considerations in the choice of protease inhibitor-sparing regimens in initial therapy for HIV-1 infection. <i><span class="NLM_source">Current Opinion in Infectious Diseases</span></i> <b>13</b>:1, 19-25<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00001432-200002000-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">576</p><p class="content">Sabine Yerly, Laurent Kaiser, Thomas V. Perneger, Richard W. Cone, Milos Opravil, Jean-Philippe Chave, Hansjakob Furrer, Bernard Hirschel, Luc Perrin.  (2000) Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:3, 243-249<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200002180-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">577</p><p class="content">Dyrhol-Riise, Brantsaeter, Dunlop, Baklien, Skar, Asjo, Bruun, Rosok.  (2000) Early Changes in Peripheral Blood T Cell Subsets Induced by Antiretroviral Treatment of Human Immunodeficiency Virus-1 Positive Individuals. <i><span class="NLM_source">Scandinavian Journal of Immunology</span></i> <b>51</b>:2, 195-201<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-3083.2000.00659.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">578</p><p class="content">A. Fraternale, A. Tonelli, A. Casabianca, L. Chiarantini, G. F. Schiavano, A. G. Celeste, M. Magnani.  (2000) New Treatment Protocol Including Lympholytic and Antiretroviral Drugs to Inhibit Murine AIDS. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:2, 107-113<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200002010-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">579</p><p class="content">Brian Conway, Stephen D Shafran.  (2000) Pharmacology and clinical experience with amprenavir. <i><span class="NLM_source">Expert Opinion on Investigational Drugs</span></i> <b>9</b>:2, 371-382<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/13543784.9.2.371" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">580</p><p class="content">N. Clumeck, S. De Wit.  (2000) Update on highly active antiretroviral therapy: progress and strategies. <i><span class="NLM_source">Biomedicine &amp; Pharmacotherapy</span></i> <b>54</b>:1, 7-12<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0753-3322(00)88634-5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">581</p><p class="content">A. Fraternale, A. Tonelli, A. Casabianca, L. Chiarantini, G. F. Schiavano, A. G. Celeste, M. Magnani.  (2000) New Treatment Protocol Including Lympholytic and Antiretroviral Drugs to Inhibit Murine AIDS. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:2, 107-113<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200002010-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">582</p><p class="content">R.J. Pomerantz.  (2000) Residual HIV-1 replication. <i><span class="NLM_source">Biomedicine &amp; Pharmacotherapy</span></i> <b>54</b>:1, 13-15<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0753-3322(00)88635-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">583</p><p class="content">Karen A. Hennessey, Janis V. Giorgi, Andrew H. Kaplan, Barbara R. Visscher, Stephen Gange, Joseph B. Margolick, Sharon Riddler, John Phair, Roger Detels.  (2000) AIDS Onset at High CD4
              <sup>+</sup>
              Cell Levels Is Associated with High HIV Load. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>16</b>:2, 103-107<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922200309449" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">584</p><p class="content">Milos Opravil, Richard W. Cone, Marek Fischer, Pietro L. Vernazza, Stefano Bassetti, Patrizio Lorenzi, Leslie R. Bisset, Peter Ott, Werner Huber, Marlyse C. Knuchel, Malgorzata Roos, Ruedi Lüthy, Rainer Weber.  (2000) Effects of Early Antiretroviral Treatment on HIV-1 RNA in Blood and Lymphoid Tissue: A Randomized Trial of Double Versus Triple Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:1, 17-25<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200001010-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">585</p><p class="content">Francesc Puig-Basagoiti, Marta Cabana, Magda Guilera, Mireia Giménez-Barcons, Guillem Sirera, Cristina Tural, Bonaventura Clotet, José-María Sánchez-Tapias, Juan Rodés, Juan-Carlos Saiz, Miguel-Angel Martínez.  (2000) Prevalence and Route of Transmission of Infection With a Novel DNA Virus (TTV), Hepatitis C Virus, and Hepatitis G Virus in Patients Infected With HIV. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:1, 89-94<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200001010-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">586</p><p class="content">Peter A. Vanable, David G. Ostrow, David J. McKirnan, Kittiwut J. Taywaditep, Brent A. Hope.  (2000) Impact of combination therapies on HIV risk perceptions and sexual risk among HIV-positive and HIV-negative gay and bisexual men.. <i><span class="NLM_source">Health Psychology</span></i> <b>19</b>:2, 134-145<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1037/0278-6133.19.2.134" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">587</p><p class="content">Francesca J. Torriani, William R. Freeman, J. Christopher Macdonald, Marietta P. Karavellas, Deborah M. Durand, Douglas D. Jeffrey, Pascal R. A. Meylan, Rachel D. Schrier.  (2000) CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:2, 173-180<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200001280-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">588</p><p class="content">Carlos Briones, Antonio Mas, Gema Gómez-Mariano, Carmen Altisent, Luis Menéndez-Arias, Vincent Soriano, Esteban Domingo.  (2000) Dynamics of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapy. <i><span class="NLM_source">Virus Research</span></i> <b>66</b>:1, 13-26<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0168-1702(99)00120-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">589</p><p class="content">Javier Ena, Concepción Benito.  (2000) Achieving plasma HIV RNA below the level of detection in clinical practice. <i><span class="NLM_source">British Journal of Clinical Governance</span></i> <b>5</b>:2, 100-105<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1108/14664100010343971" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">590</p><p class="content">Francesc Puig-Basagoiti, Marta Cabana, Magda Guilera, Mireia Giménez-Barcons, Guillem Sirera, Cristina Tural, Bonaventura Clotet, José-María Sánchez-Tapias, Juan Rodés, Juan-Carlos Saiz, Miguel-Angel Martínez.  (2000) Prevalence and Route of Transmission of Infection With a Novel DNA Virus (TTV), Hepatitis C Virus, and Hepatitis G Virus in Patients Infected With HIV. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:1, 89-94<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200001010-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">591</p><p class="content">Monique H.E. Reijers, Hugo M. Weigel, Augustinus A.M. Hart, Reinier W. Ten Kate, Jan Willem Mulder, Peter Reiss, Hanneke Schuitemaker, Richard M.W. Hoetelmans, Gerrit Jan Weverling, Joep M.A. Lange.  (2000) Toxicity and drug exposure in a quadruple drug regimen in HIV–1 infected patients participating in the ADAM study. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:1, 59-68<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200001070-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">592</p><p class="content">FLORIAN HOFFMANN, GUNDULA NOTHEIS, UWE WINTERGERST, JOSEF EBERLE, LUTZ GÜRTLER, BERND H. BELOHRADSKY.  (2000) Comparison of ritonavir plus saquinavir- and nelfinavir plus saquinavir-containing regimens as salvage therapy in children with human immunodeficiency type 1 infection. <i><span class="NLM_source">The Pediatric Infectious Disease Journal</span></i> <b>19</b>:1, 47-51<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00006454-200001000-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">593</p><p class="content">Pythia T. Nieuwkerk, Elisabeth H. Gisolf, Robert Colebunders, Albert W. Wu, Sven A. Danner, Mirjam A. Sprangers.  (2000) Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:2, 181-187<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200001280-00014" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">594</p><p class="content">Carsten S. Larsen, Lars Østergård,.  (2000) Subcutaneous Interleukin-2 in Combination with Anti-retroviral Therapy for Treatment of HIV-1-Infected Subjects. <i><span class="NLM_source">Scandinavian Journal of Infectious Diseases</span></i> <b>32</b>:2, 153-160<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1080/003655400750045259" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">595</p><p class="content">Javier Ena, Concepción Benito.  (2000) Achieving plasma HIV RNA below the level of detection in clinical practice. <i><span class="NLM_source">Clinical Performance and Quality Healthcare</span></i> <b>8</b>:2, 100-105<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1108/10630270010800804" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">596</p><p class="content">Kathleen Mulligan, Carl Grunfeld, Viva W. Tai, Heather Algren, Miyin Pang, David N. Chernoff, Joan C. Lo, Morris Schambelan.  (2000) Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:1, 35-43<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200001010-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">597</p><p class="content">Kathleen Mulligan, Carl Grunfeld, Viva W. Tai, Heather Algren, Miyin Pang, David N. Chernoff, Joan C. Lo, Morris Schambelan.  (2000) Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:1, 35-43<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200001010-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">598</p><p class="content">Milos Opravil, Richard W. Cone, Marek Fischer, Pietro L. Vernazza, Stefano Bassetti, Patrizio Lorenzi, Leslie R. Bisset, Peter Ott, Werner Huber, Marlyse C. Knuchel, Malgorzata Roos, Ruedi Lüthy, Rainer Weber.  (2000) Effects of Early Antiretroviral Treatment on HIV-1 RNA in Blood and Lymphoid Tissue: A Randomized Trial of Double Versus Triple Therapy. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:1, 17-25<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200001010-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">599</p><p class="content">Maurizia Debiaggi, Francesca Zara, Angela Pistorio, Raffaele Bruno, Paolo Sacchi, Savino F.A. Patruno, Giorgio Achilli, Egidio Romero, Gaetano Filice.  (2000) Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy. <i><span class="NLM_source">International Journal of Infectious Diseases</span></i> <b>4</b>:4, 187-193<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1201-9712(00)90107-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">600</p><p class="content">M. Mercè Alsina, Fernando Bulla, Carlos Conill, Josep Mallolas, J. Bernardo Pérez-Cuevas, Màrius Lecha.  (2000) Influencia de la terapia antirretroviral de gran actividad en la evolución del sarcoma de Kaposi asociado al virus de la inmunodeficiencia humana. <i><span class="NLM_source">Medicina Clínica</span></i> <b>115</b>:19, 736-737<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0025-7753(00)71677-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">601</p><p class="content">François Clavel, Esther Race, Fabrizio Mammano. HIV drug resistance and viral fitness. Elsevier, 2000:41-66.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1054-3589(00)49023-X" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">602</p><p class="content">Osama Abu-ata, Jihad Slim, Geirge Perez, Stephen M. Smith. HIV therapeutics: Past, present, and future. Elsevier, 2000:1-40.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1054-3589(00)49022-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">603</p><p class="content">N. M. Ferguson, F. deWolf, A. C. Ghani, C. Fraser, C. A. Donnelly, P. Reiss, J. M. A. Lange, S. A. Danner, G. P. Garnett, J. Goudsmit, R. M. Anderson.  (1999) Antigen-driven CD4+ T cell and HIV-1 dynamics: Residual viral replication under highly active antiretroviral therapy. <i><span class="NLM_source">Proceedings of the National Academy of Sciences</span></i> <b>96</b>:26, 15167-15172<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1073/pnas.96.26.15167" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">604</p><p class="content"> Staszewski ,  Schlomo ,  Morales-Ramirez ,  Javier ,  Tashima ,  Karen T. ,  Rachlis ,  Anita ,  Skiest ,  Daniel ,  Stanford ,  James ,  Stryker ,  Richard ,  Johnson ,  Philip ,  Labriola ,  Dominic F. ,  Farina ,  Dianne ,  Manion ,  Douglas J. ,  Ruiz ,  Nancy M. , .  (1999) Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>341</b>:25, 1865-1873<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199912163412501">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199912163412501} --></span></p></li><li class="odd"><p class="number">605</p><p class="content">Amanda Mocroft, Sara Madge, Anne M. Johnson, Adriano Lazzarin, Nathan Clumeck, Frank-Detlef Goebel, Jean-Paul Viard, Jose Gatell, Anders Blaxhult, Jens D. Lundgren.  (1999) A Comparison of Exposure Groups in the EuroSIDA Study: Starting Highly Active Antiretroviral Therapy (HAART), Response to HAART, and Survival. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>22</b>:4, 369<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-199912010-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">606</p><p class="content">Shaffiq M. Essajee, Mimi Kim, Charles Gonzalez, Mona Rigaud, Aditya Kaul, Sulachni Chandwani, William Hoover, Robert Lawrence, Hans Spiegel, Henry Pollack, Keith Krasinski, William Borkowsky.  (1999) Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:18, 2523-2532<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199912240-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">607</p><p class="content">Kevin Maher, N. Klimas, M. A. Fletcher, V. Cohen, C. M. Maggio, J. Triplett, R. Valenzuela, G. Dickinson.  (1999) Disease Progression, Adherence, and Response to Protease Inhibitor Therapy for HIV Infection in an Urban Veterans Affairs Medical Center. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>22</b>:4, 358<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199912010-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">608</p><p class="content">Amanda Mocroft, Sara Madge, Anne M. Johnson, Adriano Lazzarin, Nathan Clumeck, Frank-Detlef Goebel, Jean-Paul Viard, Jose Gatell, Anders Blaxhult, Jens D. Lundgren.  (1999) A Comparison of Exposure Groups in the EuroSIDA Study: Starting Highly Active Antiretroviral Therapy (HAART), Response to HAART, and Survival. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>22</b>:4, 369<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199912010-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">609</p><p class="content">Ronald O. Valdiserri, David R. Holtgrave, Gary R. West.  (1999) Promoting early HIV diagnosis and entry into care. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:17, 2317-2330<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199912030-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">610</p><p class="content">Gaetano Romano, Margaret Kasten, Giulia De Falco, Pietro Micheli, Kamel Khalili, Antonio Giordano.  (1999) Regulatory functions of Cdk9 and of cyclin T1 in HIV Tat transactivation pathway gene expression. <i><span class="NLM_source">Journal of Cellular Biochemistry</span></i> <b>75</b>:3, 357-368<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/(SICI)1097-4644(19991201)75:3&amp;lt;357::AID-JCB1&amp;gt;3.0.CO;2-K" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">611</p><p class="content">Rita Murri, Massimo Fantoni, Cosmo Del Borgo, Immacolata Izzi, Raffaella Visonà, Fredy Suter, Maria Cristina Banfi, Enrico Barchi, Nicoletta Orchi, Oliviero Bosco, Albert W. Wu.  (1999) Intravenous Drug Use, Relationship With Providers, and Stage of HIV Disease Influence the Prescription Rates of Protease Inhibitors. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>22</b>:5, 461<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-199912150-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">612</p><p class="content">Rita Murri, Massimo Fantoni, Cosmo Del Borgo, Immacolata Izzi, Raffaella Visonà, Fredy Suter, Maria Cristina Banfi, Enrico Barchi, Nicoletta Orchi, Oliviero Bosco, Albert W. Wu.  (1999) Intravenous Drug Use, Relationship With Providers, and Stage of HIV Disease Influence the Prescription Rates of Protease Inhibitors. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>22</b>:5, 461<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199912150-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">613</p><p class="content">Elena Seminari, Franco Maggiolo, Paola Villani, Fredy Suter, Angelo Pan, Mario B. Regazzi, Carmine Tinelli, Renato Maserati.  (1999) Efavirenz, Nelfinavir, and Stavudine Rescue Combination Therapy in HIV-1–Positive Patients Heavily Pretreated With Nucleoside Analogues and Protease Inhibitors. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>22</b>:5, 453<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-199912150-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">614</p><p class="content">Kevin Maher, N. Klimas, M. A. Fletcher, V. Cohen, C. M. Maggio, J. Triplett, R. Valenzuela, G. Dickinson.  (1999) Disease Progression, Adherence, and Response to Protease Inhibitor Therapy for HIV Infection in an Urban Veterans Affairs Medical Center. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>22</b>:4, 358<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-199912010-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">615</p><p class="content">Roger, Breittmayer, Arlotto, Pugliese, Pradier, Bernard-Pomier, Dellamonica, Bernard.  (1999) Highly active anti-retroviral therapy (HAART) is associated with a lower level of CD4+ T cell apoptosis in HIV-infected patients. <i><span class="NLM_source">Clinical and Experimental Immunology</span></i> <b>118</b>:3, 412-416<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2249.1999.01076.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">616</p><p class="content">Barbara Greenberg, Alan Berkman, Rogelio Thomas, David Hoos, Ruth Finkelstein, Jacquie Astemborski, David Vlahov.  (1999) Evaluating supervised haart in late-stage HIV among drug users: A preliminary report. <i><span class="NLM_source">Journal of Urban Health</span></i> <b>76</b>:4, 468-480<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF02351504" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">617</p><p class="content">Amy E. Weber, Raja Alakawaf, Julio S.G. Montaner, Michael V. O‚Shaughnessy, Robert S. Hogg.  (1999) Bitter pill: the current state of antiretroviral care in selected nations around the globe. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:17, 2480<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199912030-00024" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">618</p><p class="content">Felipe García, Joan Romeu, Inmaculada Grau, María Antonia Sambeat, David Dalmau, Hernado Knobel, Juan Luis Gomez-Sirvent, Julio Arrizabalaga, Anna Cruceta, Bonaventura Clotet, Daniel Podzamczer, Tomás Pumarola, Teresa Gallart, William A. O‚Brien, José M Miró, José M Gatell.  (1999) A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:17, 2377-2388<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199912030-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">619</p><p class="content">Elena Seminari, Franco Maggiolo, Paola Villani, Fredy Suter, Angelo Pan, Mario B. Regazzi, Carmine Tinelli, Renato Maserati.  (1999) Efavirenz, Nelfinavir, and Stavudine Rescue Combination Therapy in HIV-1–Positive Patients Heavily Pretreated With Nucleoside Analogues and Protease Inhibitors. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>22</b>:5, 453<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199912150-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">620</p><p class="content">Marta Cabana, Bonaventura Clotet, Miguel-Angel Mart<img src="untitled" alt="" class="entityD">nez.  (1999) Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors. <i><span class="NLM_source">Journal of Medical Virology</span></i> <b>59</b>:4, 480-490<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/(SICI)1096-9071(199912)59:4&amp;lt;480::AID-JMV10&amp;gt;3.0.CO;2-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">621</p><p class="content">Zelalem Temesgen, Alan J. Wright.  (1999) Antiretrovirals. <i><span class="NLM_source">Mayo Clinic Proceedings</span></i> <b>74</b>:12, 1284-1301<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.4065/74.12.1284" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">622</p><p class="content">Ivano Mezzaroma, Maurizio Carlesimo, Elena Pinter, Donatella Santini Muratori, Fiorella Di Sora, Flavia Chiarotti, Maria Giovanna Cunsolo, Giovanna Sacco, Fernando Aiuti.  (1999) Clinical and Immunologic Response without Decrease in Virus Load in Patients with AIDS after 24 Months of Highly Active Antiretroviral Therapy. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>29</b>:6, 1423-1430<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/313520" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">623</p><p class="content">Alessandra Viganò, Len Dally, Dorella Bricalli, Natascia Sala, Maria Pirillo, Marina Saresella, Daria Trabattoni, Stefano Vella, Mario Clerici, Nicola Principi.  (1999) Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection. <i><span class="NLM_source">The Journal of Pediatrics</span></i> <b>135</b>:6, 675-682<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0022-3476(99)70084-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">624</p><p class="content">Antonio Chiesi, Amanda Mocroft, Len G. Dally, Veronica Miller, Christine Katlama, Bruno Ledergerber, Court Pedersen, Andrew N. Phillips, Romano Arcieri, Jens D. Lundgren.  (1999) Regional survival differences across Europe In HIV-positive people: the EuroSIDA study. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:16, 2281-2288<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199911120-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">625</p><p class="content">Shaker Itani, John A. Bartlett.  (1999) STRATEGIES OF ANTIRETROVIRAL THERAPY IN ADULTS. <i><span class="NLM_source">Urologic Clinics of North America</span></i> <b>26</b>:4, 809-820<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0094-0143(05)70221-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">626</p><p class="content">Katy H. P. Moore, Jo E. Barrett, Shuching Shaw, Gary E. Pakes, Richard Churchus, Anu Kapoor, Judy Lloyd, Michael G. Barry, David Back.  (1999) The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:16, 2239-2250<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199911120-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">627</p><p class="content">R. Paredes, T. Puig, A. Arnó, E. Negredo, M. Balagué, A. Bonjoch, A. Jou, A. Tuldrà, C. Tural, G. Sirera, A. Veny, J. Romeu, L. Ruiz, B. Clotet.  (1999) High-Dose Saquinavir Plus Ritonavir: Long-Term Efficacy in HIV-Positive Protease Inhibitor–Experienced Patients and Predictors of Virologic Response. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>22</b>:2, 132<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-199910010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">628</p><p class="content">Surendra J. Chavan, Seetha L. Tamma, Mark Kaplan, Merril Gersten, Savita G. Pahwa.  (1999) Reduction in T Cell Apoptosis in Patients with HIV Disease Following Antiretroviral Therapy. <i><span class="NLM_source">Clinical Immunology</span></i> <b>93</b>:1, 24-33<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1006/clim.1999.4770" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">629</p><p class="content">Jeffrey S.A Stringer, Sten H Vermund.  (1999) Prevention of mother-to-child transmission of HIV-1. <i><span class="NLM_source">Current Opinion in Obstetrics and Gynecology</span></i> <b>11</b>:5, 427-434<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00001703-199910000-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">630</p><p class="content">Yves Benhamou, Marie Bochet, Vincent Di Martino, Frederic Charlotte, Felipe Azria, Anne Coutellier, Michel Vidaud, Fran<img src="untitled" alt="" class="entityD">ois Bricaire, Pierre Opolon, Christine Katlama, Thierry Poynard, .  (1999) Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. <i><span class="NLM_source">Hepatology</span></i> <b>30</b>:4, 1054-1058<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/hep.510300409" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">631</p><p class="content">R. Paredes, T. Puig, A. Arnó, E. Negredo, M. Balagué, A. Bonjoch, A. Jou, A. Tuldrà, C. Tural, G. Sirera, A. Veny, J. Romeu, L. Ruiz, B. Clotet.  (1999) High-Dose Saquinavir Plus Ritonavir: Long-Term Efficacy in HIV-Positive Protease Inhibitor–Experienced Patients and Predictors of Virologic Response. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>22</b>:2, 132<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199910010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">632</p><p class="content">DOUGLAS C. WATSON, TERESA L. COLLINS-JONES, SUSAN LOVELACE.  (1999) Antiretroviral Therapy of Pediatric HIV Infection: Making Hope a Reality. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>13</b>:10, 587-599<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/apc.1999.13.587" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">633</p><p class="content">A. Mocroft, CA. Sabin, M. Youle, L. Swaden, M. Tyrer, D. Wilson, S. Madge, MA. Johnson, AN. Phillips.  (1999) Changing treatment patterns among patients with HIV: Royal Free Hospital 1987-97. <i><span class="NLM_source">HIV Medicine</span></i> <b>1</b>:1, 32-39<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1468-1293.1999.00006.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">634</p><p class="content">Richard D. Moore, Richard E. Chaisson.  (1999) Natural history of HIV infection in the_era of combination antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:14, 1933-1942<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199910010-00017" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">635</p><p class="content">Hug, Naef, Bucher, Sponagel, Lehmann, Battegay.  (1999) Treatment for human immunodeficiency virus with indinavir may cause relevant urological side-effects, effectively treatable by rehydration. <i><span class="NLM_source">BJU International</span></i> <b>84</b>:6, 610-614<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1464-410x.1999.00263.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">636</p><p class="content">Choo Beng Chew, Frank Zheng, Karen Byth, Mark Van Asten, Cassy Workman, Dominic E. Dwyer.  (1999) Comparison of three commercial assays for the quantification of plasma HIV-1 RNA from individuals with low viral loads. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:14, 1977<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199910010-00022" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">637</p><p class="content">M.G. Sturgill, J.R. Seibold, S.E. Boruchoff, K.C. Yeh, H. Haddix, P. deutsch.  (1999) Trimethoprim/Sulfamethoxazole Does Not Affect the Steady-State Disposition of Indinavir. <i><span class="NLM_source">Journal of Clinical Pharmacology</span></i> <b>39</b>:10, 1077-1084<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1177/00912709922011737" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">638</p><p class="content">Soo Aleman, Ubaldo Visco-Comandini, Karin Lore, Anders Sonnerborg.  (1999) Long-Term Effects of Antiretroviral Combination Therapy on HIV Type 1 DNA Levels. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>15</b>:14, 1249-1254<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922299310142" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">639</p><p class="content">A. D. McNaghten, Debra L. Hanson, Jeffery L. Jones, Mark S. Dworkin, John W. Ward.  (1999) Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:13, 1687-1695<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199909100-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">640</p><p class="content">Ole Kirk, Jens D. Lundgren, Court Pedersen, Henrik Nielsen, Jan Gerstoft.  (1999) Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:13, 1647-1651<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199909100-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">641</p><p class="content">Duncan R. Churchill, Alexander S. Pym, Sarah Galpin, Russell Foxall, Chris Stainsby, John R. Clarke, Steve Kaye, Stuart Bloor, Brendan A. Larder, Ben Wills, Eugene Sun, Abdel G. Babiker, David J. Back, Jonathan N. Weber.  (1999) The Rabbit Study: Ritonavir and Saquinavir in Combination in Saquinavir-Experienced and Previously Untreated Patients. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>15</b>:13, 1181-1189<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922299310278" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">642</p><p class="content">Peng Xia, Zheng-Yu Yang, Yi Xia, Yun-Qing Zheng, L.Mark Cosentino, Kuo-Hsiung Lee.  (1999) Anti-AIDS agents. Part 36:1 17-carboxylated steroids as potential anti-HIV agents. <i><span class="NLM_source">Bioorganic &amp; Medicinal Chemistry</span></i> <b>7</b>:9, 1907-1911<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0968-0896(99)00169-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">643</p><p class="content">Bernardino Roca, Cayetano J. Gómez, Alberto Arnedo.  (1999) Stavudine, lamivudine and indinavir in drug abusing and non-drug abusing HIV-infected patients: Adherence, side effects and efficacy. <i><span class="NLM_source">Journal of Infection</span></i> <b>39</b>:2, 141-145<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0163-4453(99)90006-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">644</p><p class="content">Cynthia A. Derdeyn, Caroline Costello, J. Michael Kilby, Greg Sfakianos, Michael S. Saag, Richard Kaslow, R. Pat Bucy.  (1999) Correlation between Circulating Stromal Cell-Derived Factor 1 Levels and CD4+ Cell Count in Human Immunodeficiency Virus Type 1-Infected Individuals. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>15</b>:12, 1063-1071<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922299310359" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">645</p><p class="content">Deepali Kumar, Karl Parato, Ashok Kumar, Eugene Sun, D. William Cameron, Jonathan B. Angel.  (1999) Sustained Suppression of Plasma HIV RNA Is Associated with an Increase in the Production of Mitogen-Induced MIP-1alpha and MIP-1beta. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>15</b>:12, 1073-1077<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922299310368" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">646</p><p class="content">B. Rosenwirth, W.M.J.M. Bogers, I.G. Nieuwenhuis, P. Haaft, H. Niphuis, E.M. Kuhn, N. Bischofberger, V. Erfle, G. Sutter, P. Berglund, P. Liljestrom, K. Uberla, J.L. Heeney.  (1999) An anti-HIV strategy combining chemotherapy and therapeutic vaccination. <i><span class="NLM_source">Journal of Medical Primatology</span></i> <b>28</b>:4-5, 195-205<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1600-0684.1999.tb00270.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">647</p><p class="content">A. Mocroft, C. A. Sabin, M. Youle, S. Madge, M. Tyrer, H. Devereux, J. Deayton, A. Dykhoff, M. C. I. Lipman, A. N. Phillips, M. A. Johnson.  (1999) Changes in AIDS-Defining Illnesses in a London Clinic, 1987–1998. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>21</b>:5, 401<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199908150-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">648</p><p class="content">DOUGLAS C. WATSON, JOHN J. FARLEY.  (1999) Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1. <i><span class="NLM_source">The Pediatric Infectious Disease Journal</span></i> <b>18</b>:8, 682-689<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00006454-199908000-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">649</p><p class="content">A. Mocroft, C. A. Sabin, M. Youle, S. Madge, M. Tyrer, H. Devereux, J. Deayton, A. Dykhoff, M. C. I. Lipman, A. N. Phillips, M. A. Johnson.  (1999) Changes in AIDS-Defining Illnesses in a London Clinic, 1987–1998. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>21</b>:5, 401<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-199908150-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">650</p><p class="content">Laura W. Cheever, Albert W. Wu.  (1999) Medication adherence among HIV-infected patients: Understanding the complex behavior of patients taking this complex therapy. <i><span class="NLM_source">Current Infectious Disease Reports</span></i> <b>1</b>:4, 401-407<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s11908-999-0049-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">651</p><p class="content">Christian Pradier, Alain Pesce, Patrizia Carrieri, Jacqueline Cottalorda, Patrice Boyer, Christian Senesi, Jean-Gabriel Fuzibet, Pierre Dellamonica, Jill-Patrice Cassuto.  (1999) Effect of indinavir and higher CD4+ T-cell count on viral load response after 6 months of highly active Antiretroviral Therapy. <i><span class="NLM_source">Clinical Therapeutics</span></i> <b>21</b>:8, 1313-1320<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0149-2918(99)80032-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">652</p><p class="content">Khurram Z. Rana, Michael N. Dudley.  (1999) Intracellular Phosphorylation of Zidovudine in an In Vitro Hollow Fiber Model. <i><span class="NLM_source">Pharmacotherapy</span></i> <b>19</b>:8, 979-983<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1592/phco.19.11.979.31572" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">653</p><p class="content">Jean-Marie Poirier, Pascal Robidou, Patrice Jaillon.  (1999) Determination of Indinavir in Plasma by Solid-phase Extraction and Column Liquid Chromatography. <i><span class="NLM_source">Therapeutic Drug Monitoring</span></i> <b>21</b>:4, 404-410<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00007691-199908000-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">654</p><p class="content">G. Foulds, L. LaBoy-Goral, G.C.G. Wei, G. Apeseloff.  (1999) The Effect of Azithromycin on the Pharmacokinetics of Indinavir. <i><span class="NLM_source">Journal of Clinical Pharmacology</span></i> <b>39</b>:8, 842-847<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1177/00912709922008371" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">655</p><p class="content">Marinunzia Catucci, Giulietta Venturi, Laura Romano, Maria Letizia Riccio, Angelo De Milito, Pier E. Valensin, Maurizio Zazzi.  (1999) Development and Significance of the HIV-1 Reverse Transcriptase M184V Mutation During Combination Therapy With Lamivudine, Zidovudine, and Protease Inhibitors. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>21</b>:3, 203<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-199907010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">656</p><p class="content">Amanda Mocroft, Simon Barry, Caroline A. Sabin, Alessandro Cozzi Lepri, Sabine Kinloch, Anthony Drinkwater, Marc Lipman, Michael Youle, Margaret A. Johnson, Andrew N. Phillips.  (1999) The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:10, 1255-1261<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199907090-00016" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">657</p><p class="content">Ivano Mezzaroma, Maurizio Carlesimo, Elena Pinter, Cecilia Alario, Giovanna Sacco, Donatella Santini Muratori, Maria Livia Bernardi, Roberto Paganelli, Fernando Aiuti.  (1999) Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:10, 1187-1193<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199907090-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">658</p><p class="content">Achim Schwenk, Gisela Kremer, Oliver Cornely, Volker Diehl, Gerd Fätkenheuer, Bernd Salzberger.  (1999) Body weight changes with protease inhibitor treatment in undernourished HIV-infected patients. <i><span class="NLM_source">Nutrition</span></i> <b>15</b>:6, 453-457<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0899-9007(99)00083-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">659</p><p class="content">Lori A. Panther, Robert W. Coombs, Sandra A. Aung, Corazone dela Rosa, David Gretch, Lawrence Corey.  (1999) Unintegrated HIV-1 circular 2-LTR proviral DNA as a marker of recently infected cells: Relative effect of recombinant CD4, zidovudine, and saquinavir in vitro. <i><span class="NLM_source">Journal of Medical Virology</span></i> <b>58</b>:2, 165-173<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/(SICI)1096-9071(199906)58:2&amp;lt;165::AID-JMV11&amp;gt;3.0.CO;2-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">660</p><p class="content">Guislaine Carcelain, Catherine Blanc, Jacques Leibowitch, Philippe Mariot, Dominique Mathez, Véronique Schneider, Adrien Gérard Saimot, Florence Damond, François Simon, Patrice Debré, Brigitte Autran, Pierre-Marie Girard.  (1999) T cell changes after combined nucleoside analogue therapy in HIV primary infection. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:9, 1077-1081<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199906180-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">661</p><p class="content">JULIO COLLAZOS, JOSE MAYO, EDUARDO MARTÍNEZ.  (1999) Changing Spectrum of HIV Infection and Its Associated Conditions in Spain: The End of the Beginning?. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>13</b>:6, 347-353<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/apc.1999.13.347" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">662</p><p class="content">ALFRED D. KOHAN, NOEL A. ARMENAKAS, JOHN A. FRACCHIA.  (1999) INDINAVIR UROLITHIASIS. <i><span class="NLM_source">The Journal of Urology</span></i>1765-1768<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00005392-199906000-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">663</p><p class="content">Angela Ibáñez, Teresa Puig, Johannes Elias, Bonaventura Clotet, Lidia Ruiz, Miguel-Angel Martínez.  (1999) Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:9, 1045-1049<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199906180-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">664</p><p class="content">Wenzhe Li, Robert W. Coombs, Ann C. Collier, Vidmantas A. Raisys.  (1999) Determination of Indinavir, A HIV-1 Protease Inhibitor, in Human Plasma Using Ion-pair Reversed-phase High-Performance Liquid Chromatography. <i><span class="NLM_source">Therapeutic Drug Monitoring</span></i> <b>21</b>:3, 360<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00007691-199906000-00021" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">665</p><p class="content">MURLI PURSWANI, ROSEMARY JOHANN-LIANG, JOSEPH CERVIA, GARY J. NOEL.  (1999) Effect of changing antiretroviral therapy on human immunodeficiency virus viral load: experience with fifty-four perinatally infected children. <i><span class="NLM_source">The Pediatric Infectious Disease Journal</span></i> <b>18</b>:6, 512-516<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00006454-199906000-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">666</p><p class="content">ALFRED D. KOHAN, NOEL A. ARMENAKAS, JOHN A. FRACCHIA.  (1999) INDINAVIR UROLITHIASIS: AN EMERGING CAUSE OF RENAL COLIC IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS. <i><span class="NLM_source">The Journal of Urology</span></i> <b>161</b>:6, 1765-1768<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0022-5347(05)68795-2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">667</p><p class="content">Luc Lebeau, Thierry Brossette, Laure Goujon, Christophe Créminon, Jacques Grassi, Charles Mioskowski.  (1999) Synthesis of haptens for the development of a solid-phase immobilized epitope-immunoassay (SPIE-IA) of AZT-TP. <i><span class="NLM_source">Tetrahedron Letters</span></i> <b>40</b>:23, 4323-4326<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0040-4039(99)00785-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">668</p><p class="content">G.C. Mistry, A. Laurent, A.T. Sterrett, P.J. deutsch.  (1999) Effect of Indinavir on the Single-Dose Pharmacokinetics of Theophylline in Healthy Subjects. <i><span class="NLM_source">Journal of Clinical Pharmacology</span></i> <b>39</b>:6, 636-642<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1177/00912709922008146" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">669</p><p class="content"> Zhang ,  Linqi ,  Ramratnam ,  Bharat ,  Tenner-Racz ,  Klara ,  He ,  Yuxian ,  Vesanen ,  Mika ,  Lewin ,  Sharon ,  Talal ,  Andrew ,  Racz ,  Paul ,  Perelson ,  Alan S. ,  Korber ,  Bette T. ,  Markowitz ,  Martin ,  Guo ,  Yong ,  Duran ,  Margarita ,  Hurley ,  Arlene ,  Tsay ,  John ,  Huang ,  Yu-Ching ,  Wang ,  Chia-Ching ,  Ho ,  David D. , .  (1999) Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>340</b>:21, 1605-1613<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199905273402101">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199905273402101} --></span></p></li><li class="even"><p class="number">670</p><p class="content">N Dupin, V Rubin De Cervens, I Gorin, V Calvez, E Pessis, M Grandadam, C Rabian, J P Viard, J M Huraux, J Escande.  (1999) The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma. <i><span class="NLM_source">British Journal of Dermatology</span></i> <b>140</b>:5, 875-881<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2133.1999.02818.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">671</p><p class="content">R. Pat Bucy, Richard D. Hockett, Cynthia A. Derdeyn, Michael S. Saag, Kathleen Squires, Michael Sillers, Ronald T. Mitsuyasu, J. Michael Kilby.  (1999) Initial increase in blood CD4+ lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. <i><span class="NLM_source">Journal of Clinical Investigation</span></i> <b>103</b>:10, 1391-1398<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1172/JCI5863" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">672</p><p class="content">Schlomo Staszewski, Veronica Miller, Caroline Sabin, Christine Schlecht, Peter Gute, Silke Stamm, Thomas Leder, Annemarie Berger, Eckhart Weidemann, Andrew Hill, Andrew Phillips.  (1999) Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:8, 951-956<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199905280-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">673</p><p class="content">Mary Ann Chiasson, Louise Berenson, Wenhui Li, Steven Schwartz, Tejinder Singh, Susan Forlenza, Benjamin A. Mojica, Margaret A. Hamburg.  (1999) Declining HIV/AIDS Mortality in New York City. <i><span class="NLM_source">JAIDS: Journal of Acquired Immune Deficiency Syndromes</span></i> <b>21</b>:1, 59-64<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-199905010-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">674</p><p class="content">Jeffrey S. Murray, Michael R. Elashoff, Lauren C. Iacono-Connors, Therese A. Cvetkovich, Kimberly A. Struble.  (1999) The use of plasma HIV RNA as a study endpoint in efficacy trials of antiretroviral drugs. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:7, 797-804<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199905070-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">675</p><p class="content">Hoori C Hovanessian.  (1999) New Developments in the Treatment of HIV Disease: An Overview. <i><span class="NLM_source">Annals of Emergency Medicine</span></i> <b>33</b>:5, 546-555<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0196-0644(99)70341-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">676</p><p class="content">David H Spach, Roy Colven.  (1999) Resolution of recalcitrant hand warts in an HIV-infected patient treated with potent antiretroviral therapy. <i><span class="NLM_source">Journal of the American Academy of Dermatology</span></i> <b>40</b>:5, 818-821<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1053/jd.1999.v40.a95646" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">677</p><p class="content">HOMER L. TWIGG, DIAA M. SOLIMAN, RICHARD B. DAY, KENNETH S. KNOX, RODNEY J. ANDERSON, DAVID S. WILKES, CAROL T. SCHNIZLEIN-BICK.  (1999) Lymphocytic Alveolitis, Bronchoalveolar Lavage Viral Load, and Outcome in Human Immunodeficiency Virus Infection. <i><span class="NLM_source">American Journal of Respiratory and Critical Care Medicine</span></i> <b>159</b>:5, 1439-1444<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1164/ajrccm.159.5.9808031" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">678</p><p class="content"> Furrer ,  Hansjakob ,  Egger ,  Matthias ,  Opravil ,  Milos ,  Bernasconi ,  Enos ,  Hirschel ,  Bernard ,  Battegay ,  Manuel ,  Telenti ,  Amalio ,  Vernazza ,  Pietro L. ,  Rickenbach ,  Martin ,  Flepp ,  Markus ,  Malinverni ,  Raffaele , .  (1999) Discontinuation of Primary Prophylaxis against <em>Pneumocystis carinii</em> Pneumonia in HIV-1–Infected Adults Treated with Combination Antiretroviral Therapy. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>340</b>:17, 1301-1306<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199904293401701">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199904293401701} --></span></p></li><li class="odd"><p class="number">679</p><p class="content">John Cook, Erik Dasbach, Paul Coplan, Leona Markson, Dongping Yin, Anne Meibohm, Bach-Yen Nguyen, Jeffrey Chodakewitz, John Mellors.  (1999) Modeling the Long-Term Outcomes and Costs of HIV Antiretroviral Therapy Using HIV RNA Levels: Application to a Clinical Trial. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>15</b>:6, 499-508<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922299311024" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">680</p><p class="content"> Martin ,  Daniel F. ,  Kuppermann ,  Baruch D. ,  Wolitz ,  Richard A. ,  Palestine ,  Alan G. ,  Li ,  Hong ,  Robinson ,  Charles A. , the Roche Ganciclovir Study Group.  (1999) Oral Ganciclovir for Patients with Cytomegalovirus Retinitis Treated with a Ganciclovir Implant. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>340</b>:14, 1063-1070<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199904083401402">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199904083401402} --></span></p></li><li class="odd"><p class="number">681</p><p class="content">Graeme J Moyle.  (1999) Efavirenz: shifting the HAART paradigm in adult HIV-1 infection. <i><span class="NLM_source">Expert Opinion on Investigational Drugs</span></i> <b>8</b>:4, 473-486<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/13543784.8.4.473" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">682</p><p class="content">Thierry Brossette, Alain Valleix, Laure Goujon, Christophe Cre´minon, Jacques Grassi, Charles Mioskowski, Luc Lebeau.  (1999) Synthesis of a non-hydrolyzable AZT-triphosphate analogue designed for the production of anti-AZT-TP antibodies. <i><span class="NLM_source">Tetrahedron Letters</span></i> <b>40</b>:17, 3391-3394<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0040-4039(99)00497-9" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">683</p><p class="content">BRADLEY F. SCHWARTZ, NOAH SCHENKMAN, NOEL A. ARMENAKAS, MARSHALL L. STOLLER.  (1999) IMAGING CHARACTERISTICS OF INDINAVIR CALCULI. <i><span class="NLM_source">The Journal of Urology</span></i>1085-1087<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00005392-199904000-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">684</p><p class="content">A. Gringeri, M. Musicco, P. Hermans, Z. Bentwich, M. Cusini, A. Bergamasco, E. Santagostino, A. Burny, B. Bizzini, D. Zagury.  (1999) Active Anti-Interferon-α Immunization: A European-Israeli, Randomized, Double-Blind, Placebo-Controlled Clinical Trial in 242 HIV-1-Infected Patients (the EURIS Study). <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology</span></i> <b>20</b>:4, 358-370<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199904010-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">685</p><p class="content">Marc Renaud, Christine Katlama, Alain Mallet, Vincent Calvez, Guislaine Carcelain, Roland Tubiana, Marc Jouan, Eric Caumes, Henri Agut, François Bricaire, Patrice Debré, Brigitte Autran.  (1999) Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:6, 669-676<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199904160-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">686</p><p class="content">Avidan U. Neumann, Roland Tubiana, Vincent Calvez, Catherine Robert, Tai-Sheng Li, Henri Agut, Brigitte Autran, Christine Katlama.  (1999) HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:6, 677-683<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199904160-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">687</p><p class="content">Eric G. Bing, Amy M. Kilbourne, Ronald A. Brooks, Ellen F. Lazarus, Mark Senak.  (1999) Protease Inhibitor Use Among a Community Sample of People With HIV Disease. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology</span></i> <b>20</b>:5, 474-480<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199904150-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">688</p><p class="content">BRADLEY F. SCHWARTZ, NOAH SCHENKMAN, NOEL A. ARMENAKAS, MARSHALL L. STOLLER.  (1999) IMAGING CHARACTERISTICS OF INDINAVIR CALCULI. <i><span class="NLM_source">The Journal of Urology</span></i> <b>161</b>:4, 1085-1087<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0022-5347(01)61596-9" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">689</p><p class="content">Mark A. Perazella.  (1999) Crystal-induced acute renal failure. <i><span class="NLM_source">The American Journal of Medicine</span></i> <b>106</b>:4, 459-465<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0002-9343(99)00041-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">690</p><p class="content">Miguel-Angel Martı́nez, Marta Cabana, Angela Ibáñez, Bonaventura Clotet, Albert Arnó, Lidia Ruiz.  (1999) Human Immunodeficiency Virus Type 1 Genetic Evolution in Patients with Prolonged Suppression of Plasma Viremia. <i><span class="NLM_source">Virology</span></i> <b>256</b>:2, 180-187<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1006/viro.1999.9601" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">691</p><p class="content">Richard L. Hengel, Bonnie M. Jones, M. Susan Kennedy, Marjorie R. Hubbard, J. Steven Mcdougal.  (1999) Lymphocyte Kinetics and Precursor Frequency-Dependent Recovery of CD4+CD45RA+CD62L+ Naive T Cells Following Triple-Drug Therapy for HIV Type 1 Infection. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>15</b>:5, 435-443<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922299311187" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">692</p><p class="content">Marc Vaillancourt, David Irlbeck, Terri Smith, Robert W. Coombs, Ronald Swanstrom.  (1999) The HIV Type 1 Protease Inhibitor Saquinavir Can Select for Multiple Mutations that Confer Increasing Resistance. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>15</b>:4, 355-363<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922299311321" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">693</p><p class="content">Bruno Ledergerber, Matthias Egger, Milos Opravil, Amalio Telenti, Bernard Hirschel, Manuel Battegay, Pietro Vernazza, Philippe Sudre, Markus Flepp, Hansjakob Furrer, Patrick Francioli, Rainer Weber.  (1999) Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. <i><span class="NLM_source">The Lancet</span></i> <b>353</b>:9156, 863-868<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(99)01122-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">694</p><p class="content">R.W. Shafer, D.A Vuitton.  (1999) Highly active antiretroviral therapy (Haart) for the treatment of infection with human immunodeficiency virus type 1. <i><span class="NLM_source">Biomedicine &amp; Pharmacotherapy</span></i> <b>53</b>:2, 73-86<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0753-3322(99)80063-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">695</p><p class="content">Daniel R. Kaul, Sandro K. Cinti, Peggy L. Carver, Powel H. Kazanjian.  (1999) HIV Protease Inhibitors: Advances in Therapy and Adverse Reactions, Including Metabolic Complications. <i><span class="NLM_source">Pharmacotherapy</span></i> <b>19</b>:3, 281-298<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1592/phco.19.4.281.30937" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">696</p><p class="content">E. N. van Roon, J. M. Verzijl, J. R. Juttmann, A. W. Lenderink, M. J. Blans, A. C. G. Egberts.  (1999) Incidence of Discontinuation of Highly Active Antiretroviral Combination Therapy (HAART) and Its Determinants. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology</span></i> <b>20</b>:3, 290-294<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199903010-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">697</p><p class="content">P. Bonfanti, A. Capetti, G. Rizzardini.  (1999) HIV disease treatment in the era of HAART. <i><span class="NLM_source">Biomedicine &amp; Pharmacotherapy</span></i> <b>53</b>:2, 93-105<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0753-3322(99)80066-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">698</p><p class="content">S. Segerer, J. R. Bogner, R. Walli, O. Loch, F. -D. Goebel.  (1999) Hyperlipidemia under treatment with proteinase inhibitors. <i><span class="NLM_source">Infection</span></i> <b>27</b>:2, 77-81<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF02560501" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">699</p><p class="content">Cristina Gervasoni, Anna Lisa Ridolfo, Giuliana Trifirò, Sara Santambrogio, Guido Norbiato, Massimo Musicco, Mario Clerici, Massimo Galli, Mauro Moroni.  (1999) Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy. <i><span class="NLM_source">Aids</span></i> <b>13</b>:4, 465-471<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199903110-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">700</p><p class="content"> Havlir ,  Diane V. ,  Barnes ,  Peter F. , .  (1999) Tuberculosis in Patients with Human Immunodeficiency Virus Infection. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>340</b>:5, 367-373<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199902043400507">Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199902043400507} --></span></p></li><li class="odd"><p class="number">701</p><p class="content">Schlomo Staszewski, Veronica Miller, Caroline Sabin, Amina Carlebach, Anna-Marie Berger, Eckhart Weidmann, Eilke B. Helm, Andrew Hill, Andrew Phillips.  (1999) Virological response to protease inhibitor therapy in an HIV clinic cohort. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:3, 367-373<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199902250-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">702</p><p class="content">William Cameron, Anthony J. Japour, Yi Xu, Ann Hsu, John Mellors, Charles Farthing, Calvin Cohen, Donald Poretz, Martin Markowitz, Steve Follansbee, Jonathan B. Angel, Deborah McMahon, David Ho, Viswanath Devanarayan, Richard Rode, Miklos P. Salgo, Dale J. Kempf, Richard Granneman, John M. Leonard, Eugene Sun.  (1999) Ritonavir and saquinavir combination therapy for the treatment of HIV infection. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:2, 213-224<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199902040-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">703</p><p class="content">Norbert A. Foudraine, Egbert Hovenkamp, Daan W. Notermans, Pieter L. Meenhorst, Michèl R. Klein, Joep M.A. Lange, Frank Miedema, Peter Reiss.  (1999) Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:2, 177-184<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199902040-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">704</p><p class="content">Frédéric Martinon, Christian Michelet, Isabelle Peguillet, Yassine Taoufik, Philippe Lefebvre, Cécile Goujard, Jean-Gérard Guillet, Jean-François Delfraissy, Olivier Lantz.  (1999) Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:2, 185-194<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199902040-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">705</p><p class="content">Joel Blankson, Deborah Persaud, Robert F. Siliciano.  (1999) Latent reservoirs for HIV-1. <i><span class="NLM_source">Current Opinion in Infectious Diseases</span></i> <b>12</b>:1, 5-11<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00001432-199902000-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">706</p><p class="content">Jonathan M. Schapiro, Mark A. Winters, Jody Lawrence, Thomas C. Merigan.  (1999) Clinical cross-resistance between the HIV-1 protease inhibitors saquinavir and indinavir and correlations with genotypic mutations. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:3, 359-365<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199902250-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">707</p><p class="content">Gary Marks, Scott Burris, Thomas A. Peterman.  (1999) Reducing sexual transmission of HIV from those who know they are infected: the need for personal and collective responsibility. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:3, 297-306<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199902250-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">708</p><p class="content">William G. Powderly.  (1999) Immune reconstitution and the consequences for opportunistic infection treatment and prevention. <i><span class="NLM_source">Current Infectious Disease Reports</span></i> <b>1</b>:1, 99-104<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s11908-999-0016-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">709</p><p class="content">Simon Paul, Holly M. Gilbert, Wendy Ziecheck, Jonathan Jacobs, Kent A. Sepkowitz.  (1999) The impact of potent antiretroviral therapy on the characteristics of hospitalized patients with HIV infection. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:3, 415-418<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199902250-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">710</p><p class="content">Y Gérard, L Maulin, L Dubreuil, Y Mouton.  (1999) Inhibiteurs de protéase du VIH : interactions médicamenteuses. <i><span class="NLM_source">La Revue de Médecine Interne</span></i> <b>20</b>:2, 141-150<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0248-8663(99)83031-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">711</p><p class="content">Khurram Z. Rana, Michael N. Dudley.  (1999) Human Immunodeficiency Virus Protease Inhibitors. <i><span class="NLM_source">Pharmacotherapy</span></i> <b>19</b>:1, 35-59<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1592/phco.19.1.35.30513" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">712</p><p class="content">Mauro Schechter, Cláudio J. Struchiner, Lee H. Harrison.  (1999) Protease inhibitors as initial therapy for individuals with an intermediate risk of HIV disease progression: is more necessarily better?. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:1, 97-102<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199901140-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">713</p><p class="content">Cecilia Simonelli, Stefania Zanussi, Simonetta Sandri, Manola Comar, Antonio Lucenti, Renato Talamini, Maria Teresa Bortolin, Mauro Giacca, Paolo De Paoli, Umberto Tirelli.  (1999) Concomitant Therapy With Subcutaneous Interleukin-2 and Zidovudine Plus Didanosine in Patients With Early Stage HIV Infection. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology</span></i> <b>20</b>:1, 20-27<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199901010-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">714</p><p class="content">Lidia Ruiz, Jan van Lunzen, Albert Arno, Hans-Jürgen Stellbrink, Claus Schneider, Miquel Rull, Elena Castellà, Isabel Ojanguren, Douglas D. Richman, Bonaventura Clotet, Klara Tenner-Racz, Paul Racz.  (1999) Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:1, F1-F8<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199901140-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">715</p><p class="content">Isabelle Thuret, Gerard Michel, Hervé Chambost, Catherine Tamalet, Patricia Giraud, Corinne Brunet, Henri Perrimond.  (1999) Combination antiretroviral therapy including ritonavir in children infected with human immunodeficiency. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:1, 81-87<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199901140-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">716</p><p class="content">T.T.Y. HO, K.C.W. CHAN, K.H. WONG, S.S. LEE.  (1999) Indinavir-Associated Facial Lipodystrophy in HIV-Infected Patients. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>13</b>:1, 11-16<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/apc.1999.13.11" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">717</p><p class="content">Steven Forsythe, Charles Gilks.  (1999) Economic issues and antiretroviral therapy in developing countries. <i><span class="NLM_source">Transactions of the Royal Society of Tropical Medicine and Hygiene</span></i> <b>93</b>:1, 1-3<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0035-9203(99)90157-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">718</p><p class="content">Ole Kirk, Terese L. Katzenstein, Jan Gerstoft, Lars Mathiesen, Henrik Nielsen, Court Pedersen, Jens D. Lundgren.  (1999) Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:1, F9-F16<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199901140-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">719</p><p class="content">Manuel Battegay, Thomas Harr, Lucas Sponagel.  (1999) Salvage treatment against human immunodeficiency virus. <i><span class="NLM_source">Annals of Medicine</span></i> <b>31</b>:4, 253-260<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.3109/07853899908995888" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">720</p><p class="content">Brian G Turner, Michael F Summers.  (1999) Structural biology of HIV. <i><span class="NLM_source">Journal of Molecular Biology</span></i> <b>285</b>:1, 1-32<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1006/jmbi.1998.2354" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">721</p><p class="content">Ian V.D. Weller. The Impact of Antiviral Therapy on HIV Disease. In: HIV and the New Viruses. Elsevier, 1999:189-206.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/B978-012200741-5/50014-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">722</p><p class="content">NICOLA PRINCIPI, PAOLA MARCHISIO, SUSANNA ESPOSITO, PAOLO ROSSI, GUIDO CASTELLI GATTINARA, LUISA GALLI, CLARA GABIANO, GIAN VINCENZO ZUCCOTTI, PAOLA ORLANDI.  (1998) Zidovudine Therapy and HIV Type 1 Mutations in Children with Symptomatic HIV Type 1 Infection: Effect of Switching to Didanosine or Zidovudine Plus Didanosine Therapy. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>14</b>:18, 1653-1659<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.1998.14.1653" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">723</p><p class="content"> Zhang ,  Hui ,  Dornadula ,  Geethanjali ,  Beumont ,  Maria ,  Livornese ,  Lawrence   Jr. ,  Van Uitert ,  Bonnie ,  Henning ,  Kelly ,  Pomerantz ,  Roger J. , .  (1998) Human Immunodeficiency Virus Type 1 in the Semen of Men Receiving Highly Active Antiretroviral Therapy. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>339</b>:25, 1803-1809<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199812173392502">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199812173392502} --></span></p></li><li class="even"><p class="number">724</p><p class="content"> Haase ,  Ashley T. ,  Schacker ,  Timothy W. , .  (1998) Potential for the Transmission of HIV-1 despite Highly Active Antiretroviral Therapy. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>339</b>:25, 1846-1848<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199812173392510">Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199812173392510} --></span></p></li><li class="odd"><p class="number">725</p><p class="content">Peiyuan Wang, Joon H Hong, John S Cooperwood, Chung K Chu.  (1998) Recent advances in l-nucleosides: chemistry and biology. <i><span class="NLM_source">Antiviral Research</span></i> <b>40</b>:1-2, 19-44<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0166-3542(98)00041-2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">726</p><p class="content">Keith Henry, Alejo Erice, Camlin Tierney, Henry H. Balfour, Margaret A. Fischl, Anne Kmack, Song-Heng Liou, Antoinette Kenton, Martin S. Hirsch, John Phair, Ana Martinez, James O. Kahn.  (1998) A Randomized, Controlled, Double-Blind Study Comparing the Survival Benefit of Four Different Reverse Transcriptase Inhibitor Therapies (Three-Drug, Two-Drug, and Alternating Drug) for the Treatment of Advanced AIDS. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology</span></i> <b>19</b>:4, 339-349<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199812010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">727</p><p class="content">Douglas A. Jabs, Stephen G. Bolton, J.P. Dunn, Alan G. Palestine.  (1998) Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy. <i><span class="NLM_source">American Journal of Ophthalmology</span></i> <b>126</b>:6, 817-822<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0002-9394(98)00285-2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">728</p><p class="content">John P.A. loannidis, Thomas R. OʼBrien, James J. Goedert.  (1998) Evaluation of guidelines for initiation of highly active antiretroviral therapy in a longitudinal cohort of HIV-infected individuals. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:18, 2417-2423<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199818000-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">729</p><p class="content">Sharon B. Brodie, Marla J. Keller, Bruce M. Ewenstein, Paul E. Sax.  (1998) Variation in incidence of indinavir-associated nephrolithiasis among HIV-positive patients. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:18, 2433-2437<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199818000-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">730</p><p class="content">Donna B. Jeffe, Karen L. Meredith, Linda M. Mundy, Victoria J. Fraser.  (1998) Factors Associated With HIV-Infected Patients' Recognition and Use of HIV Medications. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology</span></i> <b>19</b>:4, 350-360<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199812010-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">731</p><p class="content">Julio SG Montaner, Robert Hogg, Janet Raboud, Richard Harrigan, Michael O'Shaughnessy.  (1998) Antiretroviral treatment in 1998. <i><span class="NLM_source">The Lancet</span></i> <b>352</b>:9144, 1919-1922<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(98)07532-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">732</p><p class="content">WEN-ZHE HO, JIAN-PING LAI, MOHAMAD BOUHAMDAN, LINGXUN DUAN, ROGER J. POMERANTZ, STUART E. STARR.  (1998) Inhibition of HIV Type 1 Replication in Chronically Infected Monocytes and Lymphocytes by Retrovirus-Mediated Gene Transfer of Anti-Rev Single-Chain Variable Fragments. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>14</b>:17, 1573-1580<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.1998.14.1573" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">733</p><p class="content">JULIO COLLAZOS, JOSE MAYO, EDUARDO MARTÍNEZ.  (1998) Hospitalization Parameters in Patients Infected with HIV: An Analysis of the Period 1992-1997. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>12</b>:11, 861-866<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/apc.1998.12.861" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">734</p><p class="content">Schlomo Staszewski, Christine Katlama, Thomas Harrer, Patrice Massip, Patrick Yeni, Amy Cutrell, Stephanie M. Tortell, Richard P. Harrigan, Helen Steel, Randall E. Lanier, Gillian Pearce.  (1998) A dose-ranging study to evaluate the safety and efficacy of abacavir alone or in combination with zidovudine and lamivudine in antiretroviral treatment-naive subjects. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:16, F197-F202<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199816000-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">735</p><p class="content">Samuel R. Friedman, Mark A. Wainberg, Ernest Drucker.  (1998) Therapeutic ethics and communities at risk in the presence of potential mutation to resistant strains to HIV antiviral medications. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:16, 2089-2093<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199816000-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">736</p><p class="content">Göran Bratt, Anders Karlsson, Ann-Charlotte Leandersson, Jan Albert, Britta Wahren, Eric Sandström.  (1998) Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:16, 2193-2202<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199816000-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">737</p><p class="content">G. T. Brice, J. L. Riley, F. Villinger, A. Mayne, C. D. Hillyer, C. H. June, A. A. Ansari.  (1998) Development of an Animal Model for Autotransfusion Therapy: In Vitro Characterization and Analysis of Anti-CD3/CD28 Expanded Cells. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology</span></i> <b>19</b>:3, 210-220<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199811010-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">738</p><p class="content">Ulrich R. Hengge, Manfred Goos, Stefan Esser, Vanessa Exner, Heidi Dötterer, Heidi Wiehler, Carsten Borchard, Karsten Müller, Alexandra Beckmann, Marie-Therese Eppner, Annemarie Berger, Melanie Fiedler.  (1998) Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:17, F225-F234<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199817000-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">739</p><p class="content">Robert S. Hogg, Amy E. Weber, Kevin J.P. Craib, Aslam H. Anis, Michael V. OʼShaughnessy, Martin T. Schechter, Julio S.G. Montaner.  (1998) One world, one hope. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:16, 2203-2209<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199816000-00016" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">740</p><p class="content">JOHN STANSELL, JAMES M. BARRETT, ELIZABETH HAMEL, DIANE LAPINS, RICHARD DALY.  (1998) Impact of Protease Inhibitor—Containing Antiretroviral Therapy on Healthcare Costs of HIV-Infected Patients in a Multisite U.S. Sample. <i><span class="NLM_source">Disease Management</span></i> <b>1</b>:6, 269-276<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/dis.1998.1.269" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">741</p><p class="content">Geneviève Chêne, Christine Binquet, Jean-François Moreau, Didier Neau, Isabelle Pellegrin, Denis Malvy, Joël Ceccaldi, Denis Lacoste, François Dabis.  (1998) Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:17, 2313-2320<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199817000-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">742</p><p class="content">Gene M Shearer.  (1998) HIV-Induced Immunopathogenesis. <i><span class="NLM_source">Immunity</span></i> <b>9</b>:5, 587-593<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1074-7613(00)80656-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">743</p><p class="content">A Mocroft, S Vella, TL Benfield, A Chiesi, V Miller, P Gargalianos, A d'Arminio Monforte, I Yust, JN Bruun, AN Phillips, JD Lundgren.  (1998) Changing patterns of mortality across Europe in patients infected with HIV-1. <i><span class="NLM_source">The Lancet</span></i> <b>352</b>:9142, 1725-1730<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(98)03201-2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">744</p><p class="content">Amanda Mocroft, M John Gill, William Davidson, Andrew N. Phillips.  (1998) Predictors of a viral response and subsequent virological treatment failure in patients with HIV starting a protease inhibitor. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:16, 2161-2167<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199816000-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">745</p><p class="content">Yu Hsiou, Kalyan Das, Jianping Ding, Arthur D. Clark, Jörg-Peter Kleim, Manfred Rösner, Irvin Winkler, Günther Riess, Stephen H. Hughes, Edward Arnold.  (1998) Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance. <i><span class="NLM_source">Journal of Molecular Biology</span></i> <b>284</b>:2, 313-323<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1006/jmbi.1998.2171" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">746</p><p class="content"> Havlir ,  Diane V. ,  Marschner ,  Ian C. ,  Hirsch ,  Martin S. ,  Collier ,  Ann C. ,  Tebas ,  Pablo ,  Bassett ,  Roland L. ,  Ioannidis ,  John P.A. ,  Holohan ,  M.K. ,  Leavitt ,  Randi ,  Boone ,  Gloria ,  Richman ,  Douglas D. , .  (1998) Maintenance Antiretroviral Therapies in HIV-Infected Subjects with Undetectable Plasma HIV RNA after Triple-Drug Therapy. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>339</b>:18, 1261-1268<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199810293391801">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199810293391801} --></span></p></li><li class="odd"><p class="number">747</p><p class="content"> Pialoux ,  Gilles ,  Raffi ,  François ,  Brun-Vezinet ,  Françoise ,  Meiffrédy ,  Vincent ,  Flandre ,  Philippe ,  Gastaut ,  Jean-Albert ,  Dellamonica ,  Pierre ,  Yeni ,  Patrick ,  Delfraissy ,  Jean-François ,  Aboulker ,  Jean-Pierre , .  (1998) A Randomized Trial of Three Maintenance Regimens Given after Three Months of Induction Therapy with Zidovudine, Lamivudine, and Indinavir in Previously Untreated HIV-1–Infected Patients. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>339</b>:18, 1269-1276<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199810293391802">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199810293391802} --></span></p></li><li class="even"><p class="number">748</p><p class="content">CLAY SMITH, SCOTT LILLY, G. DIEGO MIRALLES.  (1998) <b>Minireview</b>
              : Treatment of HIV Infection with Cytoreductive Agents. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>14</b>:15, 1305-1313<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.1998.14.1305" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">749</p><p class="content">BRUCE L. LEVINE, JULIO COTTE, CAROLYNN C. SMALL, RICHARD G. CARROLL, JAMES L. RILEY, WENDY B. BERNSTEIN, DENNIS E. VAN EPPS, R. ALAN HARDWICK, CARL H. JUNE.  (1998) Large-Scale Production of CD4+ T Cells from HIV-1-Infected Donors After CD3/CD28 Costimulation*. <i><span class="NLM_source">Journal of Hematotherapy</span></i> <b>7</b>:5, 437-448<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/scd.1.1998.7.437" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">750</p><p class="content">Christian Michelet, Cedric Arvieux, Cecile François, Jean Marc Besnier, Jean Philippe Rogez, Jean Philippe Breux, Faouzi Souala, Clotilde Allavena, François Raffi, Michel Garre, François Cartier.  (1998) Opportunistic infections occurring during highly active antiretroviral treatment. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:14, 1815-1822<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199814000-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">751</p><p class="content">Roelien H. Enting, Richard M.W. Hoetelmans, Joep M.A. Lange, David M. Burger, Jos H. Beijnen, Peter Portegies.  (1998) Antiretroviral drugs and the central nervous system. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:15, 1941-1955<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199815000-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">752</p><p class="content">Ole Kirk, Amanda Mocroft, Terese L. Katzenstein, Adriano Lazzarin, Francisco Antunes, Patrick Francioli, Ray P. Brettle, Jacqueline M. Parkin, Juan Gonzales-Lahoz, Jens D. Lundgren.  (1998) Changes in use of antiretroviral therapy in regions of Europe over time. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:15, 2031-2039<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199815000-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">753</p><p class="content">Olivia Keita-Perse, Pierre-Marie Roger, Christian Pradier, Pascal Pugliese, Jacqueline Cottalorda, Pierre Dellamonica.  (1998) Do viral load and CD8 cell count at initiation of tritherapy influence the increase of CD4 T-cell count?. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:15, F175-F179<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199815000-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">754</p><p class="content">Franck Carbonnel, Caroline Maslo, Laurent Beaugerie, Fabrice Carrat, Edith Wirbel, Christian Aussel, Jean Gérard Gobert, Pierre Marie Girard, Jean Pierre Gendre, Jacques Cosnes, Willy Rozenbaum.  (1998) Effect of indinavir on HIV-related wasting. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:14, 1777-1784<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199814000-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">755</p><p class="content">Gilbert R. Kaufmann, Chris Duncombe, Philip Cunningham, Alexander Beveridge, Andrew Carr, David Sayer, Martyn French, David A. Cooper.  (1998) Treatment response and durability of a double protease inhibitor therapy with saquinavir and ritonavir in an observational cohort of HIV-1-infected individuals. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:13, 1625-1630<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199813000-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">756</p><p class="content">Valerie E. Stone, Jennifer Clarke, Joan Lovell, Kathleen A. Steger, Lisa R. Hirschhorn, Stephen Boswell, Alicia D. Monroe, Michael D. Stein, Tamra J. Tyree, Kenneth H. Mayer.  (1998) HIV/AIDS Patients' Perspectives on Adhering to Regimens Containing Protease Inhibitors. <i><span class="NLM_source">Journal of General Internal Medicine</span></i> <b>13</b>:9, 586-593<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1525-1497.1998.00180.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">757</p><p class="content">Carmen Vidal, Felipe García, José María Gatell, Manuel Leal, Bonaventura Clotet, Tomás Pumarola, José María Miró, José Mallolas, Lídia Ruiz, Anna Cruceta, Cecilia Tortajada.  (1998) Predictive Factors Influencing Peak Viral Load Drop in Response to Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral-Naive HIV-1-Infected Patients. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology</span></i> <b>19</b>:1, 55-60<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199809010-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">758</p><p class="content">Marisela Silva, Paul R. Skolnik, Sherwood L. Gorbach, Donna Spiegelman, Ira B. Wilson, M Gabriela Fernández-DiFranco, Tamsin A. Knox.  (1998) The effect of protease inhibitors on weight and body composition in HIV-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:13, 1645-1651<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199813000-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">759</p><p class="content">Antonella dʼArminio Monforte, Letizia Testa, Fulvio Adorni, Elisabetta Chiesa, Teresa Bini, G Carla Moscatelli, Clara Abeli, Stefano Rusconi, Salvatore Sollima, Claudia Balotta, Massimo Musicco, Massimo Galli, Mauro Moroni.  (1998) Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:13, 1631-1637<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199813000-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">760</p><p class="content">Laure Goujon, Thierry Brossette, Nathalie Dereudre-Bosquet, Christophe Creminon, Pascal Clayette, Dominique Dormont, Charles Mioskowski, Luc Lebeau, Jacques Grassi.  (1998) Monitoring of intracellular levels of 5′-monophosphate-AZT using an enzyme immunoassay. <i><span class="NLM_source">Journal of Immunological Methods</span></i> <b>218</b>:1-2, 19-30<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0022-1759(98)00101-X" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">761</p><p class="content">Robert T. Dodge, Kenneth W. Shipp, G. Diego Miralles.  (1998) Improved gastrointestinal tolerance and palatability of didanosine in adults by the use of pediatric powder formulation. <i><span class="NLM_source">Journal of the Association of Nurses in AIDS Care</span></i> <b>9</b>:5, 27-31<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1055-3290(98)80030-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">762</p><p class="content">Norbert A. Foudraine, Jacques J. de Jong, Gerrit Jan Weverling, Birgit H.B. van Benthem, Jaap Maas, Ireneus P.M. Keet, Suzanne Jurriaans, Marijke T.L. Roos, Kati Vandermeulen, Frank de Wolf, Joep M.A. Lange.  (1998) An open randomized controlled trial of zidovudine plus lamivudine versus stavudine plus lamivudine. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:12, 1513-1519<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199812000-00014" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">763</p><p class="content">Howard L. Minkoff.  (1998) Human immunodeficiency virus infection in pregnancy. <i><span class="NLM_source">Seminars in Perinatology</span></i> <b>22</b>:4, 293-308<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0146-0005(98)80018-9" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">764</p><p class="content">W Edward Robinson.  (1998) l-Chicoric acid, an inhibitor of human immunodeficiency virus type 1 (HIV-1) integrase, improves on the in vitro anti-HIV-1 effect of Zidovudine plus a protease inhibitor (AG1350). <i><span class="NLM_source">Antiviral Research</span></i> <b>39</b>:2, 101-111<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0166-3542(98)00037-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">765</p><p class="content"> Cohen ,  Oren J. ,  Fauci ,  Anthony S. , .  (1998) Transmission of Multidrug-Resistant Human Immunodeficiency Virus — The Wake-Up Call. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>339</b>:5, 341-343<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199807303390511">Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199807303390511} --></span></p></li><li class="even"><p class="number">766</p><p class="content">T.-W. Chun, D. Engel, M. M. Berrey, T. Shea, L. Corey, A. S. Fauci.  (1998) Early establishment of a pool of latently infected, resting CD4+ T cells during primary HIV-1 infection. <i><span class="NLM_source">Proceedings of the National Academy of Sciences</span></i> <b>95</b>:15, 8869-8873<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1073/pnas.95.15.8869" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">767</p><p class="content">Wayne A. Marasco, SiYi Chen, Jennifer H. Richardson, Urban Ramstedt, Susan Dana Jones.  (1998) Intracellular Antibodies Against HIV-1 Envelope Protein for AIDS Gene Therapy. Dana Farber Cancer Institute, Boston, Massachusetts. <i><span class="NLM_source">Human Gene Therapy</span></i> <b>9</b>:11, 1627-1642<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/hum.1998.9.11-1627" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">768</p><p class="content">Gerrit J. Weverling, Joep M.A. Lange, Suzanne Jurriaans, Jan M. Prins, Vladimir V. Lukashov, Daan W. Notermans, Marijke Roos, Hanneke Schuitemaker, Richard M.W. Hoetelmans, Sven A. Danner, Jaap Goudsmit, Frank de Wolf.  (1998) Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:11, F117-F122<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199811000-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">769</p><p class="content">Alessandro Cozzi Lepri, George Davey Smith, Amanda Mocroft, Caroline A. Sabin, Richard W. Morris, Andrew N. Phillips.  (1998) A practical approach to adjusting for attrition bias in HIV clinical trials with serial marker responses. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:10, 1155-1161<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199810000-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">770</p><p class="content">Paul C. Bellman.  (1998) Clinical experience with adding delavirdine to combination therapy in patients in whom multiple antiretroviral treatment including protease inhibitors has failed. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:11, 1333-1340<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199811000-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">771</p><p class="content">M. V. RAGNI.  (1998) Progression of HIV in haemophilia. <i><span class="NLM_source">Haemophilia</span></i> <b>4</b>:4, 601-609<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2516.1998.440601.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">772</p><p class="content">Caroline J. Decker, Leena M. Laitinen, Gary W. Bridson, Scott A. Raybuck, Roger D. Tung, Pravin R. Chaturvedi.  (1998) Metabolism of amprenavir in liver microsomes: Role of CYP3A4 inhibition for drug interactions. <i><span class="NLM_source">Journal of Pharmaceutical Sciences</span></i> <b>87</b>:7, 803-807<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1021/js980029p" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">773</p><p class="content">Akhteruzzaman Molla, G Richard Granneman, Eugene Sun, Dale J Kempf.  (1998) Recent developments in HIV protease inhibitor therapy. <i><span class="NLM_source">Antiviral Research</span></i> <b>39</b>:1, 1-23<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0166-3542(98)00011-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">774</p><p class="content">Steven G. Deeks, Robert M. Grant, George W. Beatty, Christopher Horton, Jill Detmer, Scott Eastman.  (1998) Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:10, F97-F102<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199810000-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">775</p><p class="content">HULDRYCH F. GÜNTHARD, JOSEPH K. WONG, CAROLINE C. IGNACIO, DIANE V. HAVLIR, DOUGLAS D. RICHMAN.  (1998) Comparative Performance of High-Density Oligonucleotide Sequencing and Dideoxynucleotide Sequencing of HIV Type 1
              <i>pol</i>
              from Clinical Samples. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>14</b>:10, 869-876<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.1998.14.869" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">776</p><p class="content">Jose L. Casado, Maria J. Perez-Elías, Antonio Antela, Raquel Sabido, Paloma Martí-Belda, Fernando Dronda, Jesús Blazquez, Carmen Quereda.  (1998) Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:11, F131-F135<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199811000-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">777</p><p class="content">Sylvain Fleury, Rob J. De Boer, G. Paolo Rizzardi, Katja C. Wolthers, Sigrid A. Otto, Craig C. Welbon, Cecilia Graziosi, Christian Knabenhans, Hugo Soudeyns, Piere-Alexander Bart, Serge Gallant, Jean-Marc Corpataux, Michel Gillet, Pascal Meylan, Pierre Schnyder, Jean-Yves Meuwly, William Spreen, Michel P. Glauser, Frank Miedema, Giuseppe Pantaleo.  (1998) Limited CD4+ T-cell renewal in early HIV-1 infection: Effect of highly active antiretroviral therapy. <i><span class="NLM_source">Nature Medicine</span></i> <b>4</b>:7, 794-801<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1038/nm0798-794" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">778</p><p class="content">Butt, Sands, Nandwani.  (1998) Correspondence. The prevalence of skin diseases in human immunodeficiency infection and its relationship to the degree of immunosuppression. <i><span class="NLM_source">British Journal of Dermatology</span></i> <b>139</b>:1, 156-156<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2133.1998.02339.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">779</p><p class="content">Monique HE Reijers, Gerrit Jan Weverling, Suzanne Jurriaans, Ferdinand WNM Wit, Hugo M Weigel, Reinier W Ten Kate, Jan Willem Mulder, PH Jos Frissen, Remko van Leeuwen, Peter Reiss, Hanneke Schuitemaker, Frank de Wolf, Joep MA Lange.  (1998) Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study. <i><span class="NLM_source">The Lancet</span></i> <b>352</b>:9123, 185-190<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(98)06193-5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">780</p><p class="content">UWE WINTERGERST, FLORIAN HOFFMANN, BRIGITTE SÖLDER, GUNDULA NOTHEIS, THEONI PETROPOULOU, JOSEF EBERLE, LUTZ GÜRTLER, BERND H. BELOHRADSKY.  (1998) Comparison of two antiretroviral triple combinations including the protease inhibitor indinavir in children infected with human immunodeficiency virus. <i><span class="NLM_source">The Pediatric Infectious Disease Journal</span></i> <b>17</b>:6, 495-499<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00006454-199806000-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">781</p><p class="content">Brian Conway, Rafick-Pierre Sékaly.  (1998) Combination therapy for HIV: towards long term control of disease progression. <i><span class="NLM_source">Expert Opinion on Investigational Drugs</span></i> <b>7</b>:6, 941-961<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/13543784.7.6.941" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">782</p><p class="content">TS Li, R Tubiana, C Katlama, V Calvez, H Ait Mohand, B Autran.  (1998) Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. <i><span class="NLM_source">The Lancet</span></i> <b>351</b>:9117, 1682-1686<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(97)10291-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">783</p><p class="content">Bryn Duffy, Chad Schwietert, Alex France, Niti Mann, Krista Culbertson, Benjamin Harmon, John P. McCue.  (1998) Transition metals as protease inhibitors. <i><span class="NLM_source">Biological Trace Element Research</span></i> <b>64</b>:1-3, 197-213<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF02783336" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">784</p><p class="content">Maria Denise Mileno, Frank J. Bia.  (1998) THE COMPROMISED TRAVELER. <i><span class="NLM_source">Infectious Disease Clinics of North America</span></i> <b>12</b>:2, 369-412<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0891-5520(05)70010-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">785</p><p class="content">Christophe Piketty, Philippe Castiel, Laurent Belec, Dominique Batisse, Ali Si Mohamed, Jacques Gilquin, Gustavo Gonzalez-Canali, Didier Jayle, Marina Karmochkine, Laurence Weiss, Jean Pierre Aboulker, Michel D. Kazatchkine.  (1998) Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:7, 745-750<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199807000-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">786</p><p class="content">ANDREW P. KEAVENY, MICHAEL S. KARASIK.  (1998) Hepatobiliary and Pancreatic Infections in AIDS: Part One. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>12</b>:5, 347-357<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/apc.1998.12.347" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">787</p><p class="content">Diana Finzi, Robert F Siliciano.  (1998) Viral Dynamics in HIV-1 Infection. <i><span class="NLM_source">Cell</span></i> <b>93</b>:5, 665-671<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0092-8674(00)81427-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">788</p><p class="content">Olivier T. Rutschmann, Milos Opravil, Anne Iten, Raffaele Malinverni, Pietro L. Vernazza, Heiner C. Bucher, Enos Bernasconi, Philippe Sudre, Dominique Leduc, Sabine Yerly, Luc H. Perrin, Bernard Hirschel.  (1998) A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:8, F71-77<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199808000-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">789</p><p class="content">James W.T.Cohen Stuart, Charles A.B Boucher, David A Cooper, George J Galasso, Douglas D Richman, Howard C Thomas, Richard J Whitley.  (1998) Summary of the III International Consensus Symposium on Combined Antiviral Therapy. <i><span class="NLM_source">Antiviral Research</span></i> <b>38</b>:2, 75-93<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0166-3542(98)00021-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">790</p><p class="content"> Flexner ,  Charles .  (1998) HIV-Protease Inhibitors. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>338</b>:18, 1281-1293<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199804303381808">Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199804303381808} --></span></p></li><li class="odd"><p class="number">791</p><p class="content">Donald M Coen.  (1998) The persistence of (HIV in) memory (T cells). <i><span class="NLM_source">Trends in Microbiology</span></i> <b>6</b>:4, 129-130<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0966-842X(98)01232-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">792</p><p class="content">Joachim Krischer, Olivier Rutschmann, Bernard Hirschel, Sonia Vollenweider-Roten, Jean-Hilaire Saurat, Marc Pechère.  (1998) Regression of Kaposi’s sarcoma during therapy with HIV-1 protease inhibitors: A prospective pilot study. <i><span class="NLM_source">Journal of the American Academy of Dermatology</span></i> <b>38</b>:4, 594-598<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0190-9622(98)70124-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">793</p><p class="content">David E. Ott, Suzanne M. Hewes, W.Gregory Alvord, Louis E. Henderson, Larry O. Arthur.  (1998) Inhibition of Friend Virus Replication by a Compound That Reacts with the Nucleocapsid Zinc Finger: Anti-Retroviral Effect Demonstratedin Vivo. <i><span class="NLM_source">Virology</span></i> <b>243</b>:2, 283-292<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1006/viro.1998.9062" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">794</p><p class="content">Gary S Reiter.  (1998) Human immunodeficiency virus (HIV) in America, 1981 to 1997: Epidemiologic and therapeutic considerations. <i><span class="NLM_source">Seminars in Ultrasound, CT and MRI</span></i> <b>19</b>:2, 122-127<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0887-2171(98)90054-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">795</p><p class="content">Dale J. Kempf, Richard A. Rode, Yi Xu, Eugene Sun, Margo E. Heath-Chiozzi, Joaquin Valdes, Anthony J. Japour, Sven Danner, Charles Boucher, Akhteruzzaman Molla, John M. Leonard.  (1998) The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:5, F9-F14<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199805000-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">796</p><p class="content">M. Barry, F. Mulcahy, D. J. Back.  (1998) Antiretroviral therapy for patients with HIV disease. <i><span class="NLM_source">British Journal of Clinical Pharmacology</span></i> <b>45</b>:3, 221-228<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2125.1998.00673.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">797</p><p class="content">Robert S. Hogg, Stephanie A. Rhone, Benita Yip, Chris Sherlock, Brian Conway, Martin T. Schechter, Michael V. OʼShaughnessy, Julio S.G. Montaner.  (1998) Antiviral effect of double and triple drug combinations amongst HIV-infected adults. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:3, 279-284<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199803000-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">798</p><p class="content">Warren A. Andiman.  (1998) Medical management of the pregnant woman infected with human immunodeficiency virus type 1 and her child. <i><span class="NLM_source">Seminars in Perinatology</span></i> <b>22</b>:1, 72-86<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0146-0005(98)80009-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">799</p><p class="content">Anton Pozniak.  (1998) Surrogacy in HIV-1 clinical trials. <i><span class="NLM_source">The Lancet</span></i> <b>351</b>:9102, 536-537<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(98)22008-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">800</p><p class="content">Mark A. Wainberg, D. William Cameron.  (1998) HIV resistance to antiviral drugs: public health implications. <i><span class="NLM_source">Drug Resistance Updates</span></i> <b>1</b>:2, 104-108<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1368-7646(98)80025-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">801</p><p class="content">Daan W. Notermans, Suzanne Jurriaans, Frank de Wolf, Norbert A. Foudraine, Jacques J. de Jong, Winston Cavert, Caspar M. Schuwirth, Robert H. Kauffmann, Pieter L. Meenhorst, Hugh McDade, Carolyn Goodwin, John M. Leonard, Jaap Goudsmit.  (1998) Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:2, 167-173<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199802000-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">802</p><p class="content"> (1997) End-of-Life Care in HIV Disease Let's Talk. <i><span class="NLM_source">Journal of General Internal Medicine</span></i> <b>12</b>:12, 784-786<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1525-1497.1997.07166.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">803</p><p class="content">J. K. Wong, H. F. Gunthard, D. V. Havlir, Z.-Q. Zhang, A. T. Haase, C. C. Ignacio, S. Kwok, E. Emini, D. D. Richman.  (1997) Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. <i><span class="NLM_source">Proceedings of the National Academy of Sciences</span></i> <b>94</b>:23, 12574-12579<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1073/pnas.94.23.12574" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">804</p><p class="content">Robert S Hogg, Aslam Anis, Amy E Weber, Michael V Schechter, Martin T Schechter.  (1997) Triple-combination antiretroviral therapy in sub-Saharan Africa. <i><span class="NLM_source">The Lancet</span></i> <b>350</b>:9088, 1406<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(05)65188-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">805</p><p class="content">B. J. Doranz.  (1997) A Small-molecule Inhibitor Directed against the Chemokine Receptor CXCR4 Prevents its Use as an HIV-1 Coreceptor. <i><span class="NLM_source">Journal of Experimental Medicine</span></i> <b>186</b>:8, 1395-1400<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1084/jem.186.8.1395" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">806</p><p class="content"> Hammer ,  Scott M. ,  Squires ,  Kathleen E. ,  Hughes ,  Michael D. ,  Grimes ,  Janet M. ,  Demeter ,  Lisa M. ,  Currier ,  Judith S. ,  Eron ,  Joseph J.   Jr. ,  Feinberg ,  Judith E. ,  Balfour ,  Henry H.   Jr. ,  Deyton ,  Lawrence R. ,  Chodakewitz ,  Jeffrey A. ,  Fischl ,  Margaret A. ,  Phair ,  John P. ,  Pedneault ,  Louise ,  Nguyen ,  Bach-Yen ,  Cook ,  Jon C. , .  (1997) A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>337</b>:11, 725-733<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199709113371101">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199709113371101} --></span></p></li><li class="odd"><p class="number">807</p><p class="content"> Steinbrook ,  Robert , .  (1997) Battling HIV on Many Fronts. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>337</b>:11, 779-781<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199709113371109">Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199709113371109} --></span></p></li><li class="lastChild even"><p class="number">808</p><p class="content">Paul A Volberding.  (1997) Protease inhibitors vindicated. <i><span class="NLM_source">The Lancet</span></i> <b>350</b>, SIII10<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(97)90043-X" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li></ol></div></dd></dl>
    





    


</div>


        
        





<div id="rightRail" class="">
    <!-- omit the institutional logo from the following pages -->
    
            
            <div id="institutionBox">
                
                <p>Access Provided By:<br><span class="institutionName">National University Ireland Galway  - IREL</span></p>
                
                <div style="clear: both;"></div>
            </div>
            
        
    
                        











<!-- toolsContainer -->
<div id="toolsContainer">
	<!-- toolsBox -->
	<div id="toolsBox">
		<h3>Tools</h3>
		<ul class="firstGroup">
			
			<li class="downloadPDF firstChild">
				<a href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/pdf/10.1056/NEJM199709113371102" class="zone-tools-articlePdf">

					
					PDF
				</a>
			</li>
			
			
			<li class="printPage">
				<a href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199709113371102" class="viewType-Print viewClass-Print zone-tools-articlePrint">

					
					Print
				</a>
			</li>
			
			<li class="downloadCitation lastChild">
				<a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showCitFormats?doi=10.1056%2FNEJM199709113371102" class="viewType-Layer viewClass-MediumLayer zone-tools-downloadCitation event-layer-downloadCitation-open">

					
					Download Citation
				</a>
			</li>
			
			
			
			
			
            
		</ul>
		<ul class="secondGroup">
			<li class="emailPage firstChild">
				<a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showMailPage?href=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;title=Treatment+with+Indinavir%2C+Zidovudine%2C+and+Lamivudine+in+Adults+with+Human+Immunodeficiency+Virus+Infection+and+Prior+Antiretroviral+Therapy&amp;doi=10.1056%2FNEJM199709113371102" class="viewType-Layer viewClass-MediumLayer zone-tools-articleEmail">

					
					
					
					E-Mail
				</a>
			</li>
			
			<li class="savePage">
				<a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/addTag?uactid=savePage&amp;uacturi=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;doi=10.1056%2FNEJM199709113371102" id="savePage" class="viewType-Layer viewClass-MediumLayer zone-tools-articleSave">

					
						
						
					
					Save
				</a>
			</li>
			
			<li class="getAlert">
				<a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/addCitationAlert?context=add&amp;uactid=getAlert&amp;uacturi=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;doi=10.1056%2FNEJM199709113371102" id="getAlert" class="viewType-Layer viewClass-MediumLayer zone-tools-articleEmailAlert">

					
					
						
						
					
					Article Alert
				</a>
			</li>
			
			
			
			
			<li class="reprints"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/page/about-nejm/reprints" class="zone-tools-reprints">Reprints</a></li>
            <li class="permissions"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/https%3A%2F%2Fs100.copyright.com%2FAppDispatchServlet%3Fauthor%3DRoy%2BM.%2BGulick%252C%2BJohn%2BW.%2BMellors%252C%2BDiane%2BHavlir%252C%2Bet%2Bal.%26contentID%3D10.1056%252FNEJM199709113371102%26issueNum%3D11%26orderBeanReset%3Dtrue%26publication%3Dnejm%26publicationDate%3D09%252F11%252F1997%26publisherName%3Dmassmed%26title%3DTreatment%2Bwith%2BIndinavir%252C%2BZidovudine%252C%2Band%2BLamivudine%2Bin%2BAdults%2Bwith%2BHuman%2BImmunodeficiency%2BVirus%2BInfection%2Band%2BPrior%2BAntiretroviral%2BTherapy%26volumeNum%3D337" class="zone-tools-permissions">Permissions</a></li>
			<li class="addThisIcon lastChild"><a href="http://www.addthis.com/bookmark.php" class="addthis_button zone-tools-share-click" target="_top">Share/Bookmark</a></li>
		</ul>
	</div>
	<!-- /toolsBox -->
	<!-- toolsAd -->
	<div class="toolsAd">
		

<div class="bottomAd">
    
    <div class="ad">
        














<div id="CM8ShowAd1369847410790" title="MicroTools" class="MicroTools CM8">
<noscript><a href="http://web.checkm8.com/adam/ep/click/mms.nej.articles/MicroTools"><img src="http://web.checkm8.com/adam/noscript?cat=mms.nej.articles&amp;page=1369847410790&amp;format=MicroTools" border="0" alt="Advertisement" /></a></noscript>

</div>
    </div>
</div>
	</div>
	<!-- /toolsAd -->
</div>
<!-- /toolsContainer -->

                    
                









<div id="related"><div id="relatedContent"><h3>Related Articles</h3><ul><li class="firstChild lastChild"><p class="articleType"><pub-title xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" title-type="toc-heading-title" title-length="standard" title-usage="default" translit-method="none" is-translated="false" media-type="text-xml" source="default" xml:lang="EN">Editorial</pub-title></p><p class="articleLink"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199709113371109">Battling HIV on Many Fronts</a></p><p class="articleDate">September 11, 1997 | R. Steinbrook</p></li></ul></div><div id="topics"><h3>Topics</h3><ul><li class="firstChild lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/browse?subtopic=18_3">HIV/​AIDS</a></li></ul></div><div id="moreIn"><h3>More In</h3><ul><li class="firstChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/browse?category=research">Research</a></li><li class="lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/toc/nejm/337/11/">September 11, 1997</a></li></ul></div></div>

                
                    
                
        
                


<div id="rightRailAd">
<div class="bannerAdTower">
<div class="rightTower">















<div id="CM8ShowAd1369847410790" title="MedRectangle" class="MedRectangle CM8">
<noscript><a href="http://web.checkm8.com/adam/ep/click/mms.nej.articles/MedRectangle"><img src="http://web.checkm8.com/adam/noscript?cat=mms.nej.articles&amp;page=1369847410790&amp;format=MedRectangle" border="0" alt="Advertisement" /></a></noscript>

</div>
</div>
</div>
</div>
                



















<div id="trendsMod" class="mod pad">
    <div class="modHead">
        <h3>Trends</h3>
        
                <h4>Most Viewed (Last Week)</h4>
            
    </div>
    <div class="modBody">
        
        <ul class="csf">
            
            <li class="firstChild">
                <div class="articleType">Original Article</div>
                <div class="articleLink">
                    <a href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJMoa1214103">Prone Positioning in Severe Acute Respiratory Distress Syndrome</a>
                </div>

                
                
                        <div class="articleDate">May 20, 2013
                            
                                | C. Guérin and Others
                            
                        </div>
                    


            </li>
            
            <li>
                <div class="articleType">Case Records of the Massachusetts General Hospital</div>
                <div class="articleLink">
                    <a href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJMcpc1215971">Case Challenge</a>
                </div>

                
                
                        <div class="articleDate">May 22, 2013
                            
                                | null
                            
                        </div>
                    


            </li>
            
            <li class="lastChild">
                <div class="articleType">Review Article</div>
                <div class="articleLink">
                    <a href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJMra1216063">Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy</a>
                </div>

                
                
                        <div class="articleDate">May 23, 2013
                            
                                | P. Libby
                            
                        </div>
                    


            </li>
            
        </ul>
    </div>
    <div class="modFoot">
        <p class="moreLink"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/journal-articles">More Trends</a></p>
    </div>
    

<div class="bottomAd">
    
    <div class="ad">
        














<div id="CM8ShowAd1369847410809" title="MicroTrends" class="MicroTrends CM8">
<noscript><a href="http://web.checkm8.com/adam/ep/click/mms.nej.articles/MicroTrends"><img src="http://web.checkm8.com/adam/noscript?cat=mms.nej.articles&amp;page=1369847410809&amp;format=MicroTrends" border="0" alt="Advertisement" /></a></noscript>

</div>
    </div>
</div>
</div>


                
                
                        












<script type="text/javascript" src="untitled_001.dat"></script><div id="nejm_jobs">  <div style="padding: 0px; margin: 0px; background: none repeat ; 0% rgb(255, 51, 0); clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-width: none; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 300px; border: 1px solid rgb(255, 51, 0); height: 1px; max-height: 1px; overflow: hidden; line-height: 1px; font-size: 1px;"></div> <!-- top red rectangle --><div id="nejm-widget" style="padding: 0px; margin: 0px; background: none repeat ; 0% rgb(255, 255, 255); clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; vertical-align: baseline; font-weight: normal; float: none; height: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 300px; border-right: 1px solid rgb(207, 207, 207); border-width: medium 1px 1px; border-style: none solid solid; border-color: -moz-use-text-color rgb(207, 207, 207) rgb(207, 207, 207); -moz-border-top-colors: none; -moz-border-right-colors: none; -moz-border-bottom-colors: none; -moz-border-left-colors: none; border-image: none; line-height: 12px; font-size: 14px;"><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 10px; line-height: 10px;">&nbsp;</div><div style="padding: 0px; margin: 0px 0px 0px 10px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;">	<a target="nejm-win" style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; line-height: 1px; text-decoration: none;" href="http://www.nejmcareercenter.org/?query=fjw">		<img alt="CareerCenter" style="background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: inline; margin: 0px; padding: 0px; border: medium none;" src="nejmCCID-JobsWidget.gif">	</a></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 10px; line-height: 10px;">&nbsp;</div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border-right: medium none; border-left: medium none; -moz-border-top-colors: none; -moz-border-right-colors: none; -moz-border-bottom-colors: none; -moz-border-left-colors: none; border-image: none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 100%; border-width: 1px medium; border-style: solid none; border-color: rgb(207, 207, 207) -moz-use-text-color;"> <!-- content --><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 10px; line-height: 10px;">&nbsp;</div><div style="padding: 0px; margin: 0px 0px 4px 10px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: 'Times New Roman',Times,serif; font-size: 11px; color: rgb(51, 51, 51); font-weight: bold;">PHYSICIAN JOBS</div><div style="padding: 0px; margin: 0px 0px 0px 10px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 10px; color: rgb(102, 102, 102);">May 29, 2013</div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 8px; line-height: 8px;">&nbsp;</div><div style="padding: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; margin: 0px 10px;"><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Tahoma; font-size: 9px; color: black; font-weight: bold;">Emergency Medicine</span></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><a target="nejm-job-win" style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 11px; color: rgb(0, 104, 146); text-decoration: none;" onmouseover="jlho(this);" onmouseout="jlou(this);" href="http://www.nejmcareercenter.org/job/16003/one-medical-group/?query=fjwp">ONE MEDICAL GROUP</a></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 10px; color: rgb(51, 51, 51); text-transform: uppercase;">California</span></div></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 8px; line-height: 8px;">&nbsp;</div><div style="padding: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; margin: 0px 10px;"><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Tahoma; font-size: 9px; color: black; font-weight: bold;">Chiefs/Directors/Dept. Heads</span></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><a target="nejm-job-win" style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 11px; color: rgb(0, 104, 146); text-decoration: none;" onmouseover="jlho(this);" onmouseout="jlou(this);" href="http://www.nejmcareercenter.org/job/17008/medical-director-lincoln-medical-center-fayetteville-tennessee/?query=fjwp">MEDICAL DIRECTOR, LINCOLN MEDICAL CENTER, FAYETTEVILLE, TENNESSEE</a></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 10px; color: rgb(51, 51, 51); text-transform: uppercase;">Tennessee</span></div></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 8px; line-height: 8px;">&nbsp;</div><div style="padding: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; margin: 0px 10px;"><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Tahoma; font-size: 9px; color: black; font-weight: bold;">Nephrology</span></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><a target="nejm-job-win" style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 11px; color: rgb(0, 104, 146); text-decoration: none;" onmouseover="jlho(this);" onmouseout="jlou(this);" href="http://www.nejmcareercenter.org/job/16818/southwest-kidney-institute-phoenix-tucson-arizona/?query=fjwf">SOUTHWEST KIDNEY INSTITUTE, PHOENIX/TUCSON, ARIZONA</a></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 10px; color: rgb(51, 51, 51); text-transform: uppercase;">Arizona</span></div></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 8px; line-height: 8px;">&nbsp;</div><div style="padding: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; margin: 0px 10px;"><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Tahoma; font-size: 9px; color: black; font-weight: bold;">Hematology/Oncology</span></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><a target="nejm-job-win" style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 11px; color: rgb(0, 104, 146); text-decoration: none;" onmouseover="jlho(this);" onmouseout="jlou(this);" href="http://www.nejmcareercenter.org/job/17009/medical-oncologist-hematologist-orlando-florida/?query=fjwf">MEDICAL ONCOLOGIST/HEMATOLOGIST, ORLANDO, FLORIDA</a></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 10px; color: rgb(51, 51, 51); text-transform: uppercase;">Florida</span></div></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 8px; line-height: 8px;">&nbsp;</div><div style="padding: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; margin: 0px 10px;"><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Tahoma; font-size: 9px; color: black; font-weight: bold;">Physical Medicine &amp; Rehabilitation</span></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><a target="nejm-job-win" style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 11px; color: rgb(0, 104, 146); text-decoration: none;" onmouseover="jlho(this);" onmouseout="jlou(this);" href="http://www.nejmcareercenter.org/job/16343/physician-physical-medicine-and-rehabilitation/?query=fjws">Physician - Physical Medicine &amp; Rehabilitation</a></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 10px; color: rgb(51, 51, 51); text-transform: uppercase;">Wisconsin</span></div></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 8px; line-height: 8px;">&nbsp;</div><div style="padding: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; margin: 0px 10px;"><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Tahoma; font-size: 9px; color: black; font-weight: bold;">Hospitalist</span></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><a target="nejm-job-win" style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 11px; color: rgb(0, 104, 146); text-decoration: none;" onmouseover="jlho(this);" onmouseout="jlou(this);" href="http://www.nejmcareercenter.org/job/16984/hospitalist-massachusetts/?query=fjwf">HOSPITALIST, MASSACHUSETTS</a></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 10px; color: rgb(51, 51, 51); text-transform: uppercase;">Massachusetts</span></div></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 10px; line-height: 10px;">&nbsp;</div></div> <!-- content --><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"> <!-- footer --><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 5px; line-height: 5px;">&nbsp;</div><div style="padding: 0px; margin: 0px 10px 0px 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; text-align: right;"><a target="nejm-win" style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: 'Times New Roman',Times,serif; font-size: 13px; color: rgb(255, 51, 0); text-decoration: none; text-align: right;" href="http://www.nejmcareercenter.org/?query=fjw">nejmcareercenter.org</a></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 9px; line-height: 9px;">&nbsp;</div></div> <!-- footer --><img style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; float: none;" src="__utm.gif" height="1" width="1"></div> <!-- nejm-widget --></div>

                    
                
                



<!-- placeholder id=null, description=N-siteWide-email -->
    <div class="emailAlert"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=4138&amp;url=https%3A%2F%2Fcdf.nejm.org%2Fcampaigns%2Fgenericlp.aspx%3Fcpc%3DGMAAALLV0612C%26alertType%3Dcollection%26rcpc%3DFMAAALLV0612C%26rpromo%3DONFQSU24%26URL%3Dhttp%253A%252F%252Fwww.nejm.org%252Fdoi%252Ffull%252F10.1056%252FNEJM199709113371102&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252"><img src="AlertsAndUpdates.gif"></a>


</div>



	
      		<!-- placeholder id=null, description=N-ad-article-rightRail-1 -->
    			  <a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=4272&amp;url=%2Faction%2FcdfProxy%3Faction%3Dcampaign%26url%3Dhttp%253A%252F%252Fwww.nejm.org%252Fdoi%252Ffull%252F10.1056%252FNEJM199709113371102%26cpc%3DFMAAALLV1012A%26promo%3DONFQPP04&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252"><img src="InstPPTAccess_300x150.jpg"></a>
    		
      	
    
</div>

   




    
<script type="text/javascript">

    $("#cdfRegister").attr("href", $("#cdfRegister").attr('href') + "&url=" + window.location.href);
</script>


</div>



<div id="footer">
    <!-- placeholder id=null, description=N-ad-footer-1 -->
        <div class="rightAd"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=2078&amp;url=%2Fcontinuing-medical-education&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252"><img src="CME_300Exams_175x48.gif"></a></div>
    
    <!-- placeholder id=null, description=N-footer -->
        <dl>
  <dt class="firstChild">Content:</dt>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2F&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" tabindex="100">Home</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Ftoc%2Fnejm%2Fmedical-journal&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Current Issue</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fmedical-article-index&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Articles</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fmedical-index&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Issue Index</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fmedical-specialties&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Specialties &amp; Topics</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fmultimedia&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Multimedia &amp; Images</a></dd>
  <dd class="lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fmedical-index&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Archive 1812-1989</a></dd>
</dl>
<dl>
  <dt class="firstChild">Information For:</dt>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Faction%2FcdfProxy%3Faction%3DauthorCenter&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Authors</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Faction%2FcdfProxy%3Faction%3DauthorCenter&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Reviewers</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fproducts-and-services&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Subscribers</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Finstitution%2Fresource-center&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Institutions</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fmedia&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Media</a></dd>
  <dd class="lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fhow-to-advertise&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Advertisers</a></dd>
</dl>
<dl>
  <dt class="firstChild">Services:</dt>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Faction%2FcdfProxy%3Faction%3Dsubscribe%26promo%3DONFLRNA4&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Subscribe</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Faction%2FcdfProxy%3Faction%3Drenew%26promo%3DONFLRNA1&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Renew</a></dd> 

  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Faction%2FcdfProxy%3Faction%3DpayBill%26promo%3DBNFLNBA1&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" rel="nofollow">Pay Bill</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Faction%2FcdfProxy%3Faction%3Dactivate%26promo%3DONFLNAA1&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Activate Subscription</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fnejm-account&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" rel="nofollow">Create or Manage Account</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fnejm-alerts&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Alerts</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Faction%2FshowPodcastsFeeds&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">RSS &amp; Podcasts</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Faction%2FcdfProxy%3Faction%3DauthorCenter&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" rel="nofollow">Submit a Manuscript</a></dd>
  <dd class="lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fmobile-applications&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" rel="nofollow">Mobile</a></dd>
</dl>
<dl>
  <dt class="firstChild">Resources:</dt>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=http%3A%2F%2Fwww.nejmjobs.org%2F&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Physician Jobs</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Freprints&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" rel="nofollow">Reprints</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fpermissions&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" rel="nofollow">Permissions</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fmedical-conference&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Medical Meetings</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fupcoming-medical-conventions&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Conventions</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Ffrequently-asked-questions&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" rel="nofollow">FAQs</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=http%3A%2F%2Fwww.jwatch.org%2F&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Journal Watch</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fhelp&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" rel="nofollow">Help</a></dd>
<dd class="lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fcontact-nejm&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" rel="nofollow">Contact Us</a></dd>
</dl>
<dl>
  <dt class="firstChild">NEJM:</dt>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fhistory-and-mission&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">About</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fproducts-and-services&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Product Information</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Feditors-and-publishers&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" rel="nofollow">Editors &amp; Publishers</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2F200th-anniversary-about&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" rel="nofollow">200th Anniversary</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fterms-of-use&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" rel="nofollow">Terms of Use</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fprivacy-policy&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" rel="nofollow">Privacy Policy</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fcopyright-information&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" rel="nofollow">Copyright</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fadvertising-policy&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" rel="nofollow">Advertising Policies</a></dd>
   <dd class="lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=http%3A%2F%2Fnejmgroup.org%2F&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">NEJM Group</a></dd>
</dl>
<dl>
  <dt class="firstChild">CME:</dt>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fcme%2Fweekly-cme-program&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Weekly CME Program</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fcontinuing-medical-education&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Browse Weekly Exams</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fcontinuing-medical-education%2Fcme-info&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Your CME Activity</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Faction%2FcdfProxy%3Faction%3DcmeWeekly%26promo%3DONF4NA1V&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Purchase Exams</a></dd>
  <dd class="lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fcme%2Freview-cme&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Review CME Program</a></dd>
</dl>


<div class="socialNetworking">
  <div class="head">Follow us</div>
  <ul>
    <li class="firstChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=http%3A%2F%2Fwww.facebook.com%2FTheNewEnglandJournalofMedicine&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" class="facebook"><img src="facebook.gif" alt="Facebook"></a></li>
    <li><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=http%3A%2F%2Ftwitter.com%2Fnejm&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" class="twitter"><img src="twitter.gif" alt="Twitter"></a></li>
    <li><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=http%3A%2F%2Fwww.youtube.com%2Fnejmvideo&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" class="youTube"><img src="youtube.gif" alt="YouTube"></a></li>
    <li class="lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=http%3A%2F%2Fblogs.nejm.org%2Fnow%2F&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252" class="nowNejmBlog"><img src="nowatnejm.gif" alt="Now@NEJM Blog"></a></li>
  </ul>
</div>
    
    <!-- placeholder id=null, description=N-ad-footer-2 -->
        <div class="rightAd2"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3261&amp;url=http%3A%2F%2Fwww.nejmgroup.org%2F&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252"><img src="NEJMgroup.gif"></a></div>
    
</div>










<div style="display: none;" class="corners dropDown dropDown-myNejm">


	
<div class="wrap"><div class="topRow tl"><div class="tr"><div class="t">&nbsp;</div></div></div><div class="middleRow l"><div class="r"><div class="content"><dl class="column firstChild lastChild">
		<!-- placeholder id=null, description=N-menu-MyNEJM -->
	</dl></div></div></div><div class="bottomRow bl"><div class="br"><div class="b">&nbsp;</div></div></div></div></div>



<div style="display: none; left: 522px; top: 245px;" class="corners dropDown dropDown-articles">



<div class="wrap"><div class="topRow tl"><div class="tr"><div class="t">&nbsp;</div></div></div><div class="middleRow l"><div class="r"><div class="content"><dl style="height: 133px;" class="column more firstChild">
<dt class="firstChild">Article Category</dt>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-articles/research">Research</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-articles/review">Reviews</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-articles/clinical-cases">Clinical Cases</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-articles/perspective">Perspective</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-articles/commentary">Commentary</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-articles/other">Other</a></dd>
<dd class="moreLink lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-article-index">Browse all articles</a></dd>
</dl><dl style="height: 133px;" class="column multimedia more lastChild">
<dt class="firstChild">Multimedia</dt>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/multimedia/medical-videos">Videos in Clinical Medicine</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/multimedia/images-in-clinical-medicine">Images in Clinical Medicine</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/multimedia/interactive-medical-case">Interactive Medical Cases</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/multimedia/audio-summary">Weekly Audio Summaries</a></dd>
<dd class="moreLink lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/multimedia">Browse all multimedia</a></dd>
</dl></div></div></div><div class="bottomRow bl"><div class="br"><div class="b">&nbsp;</div></div></div></div></div>


<div style="display: none;" class="corners dropDown dropDown-issueArchive">

<div class="wrap"><div class="topRow tl"><div class="tr"><div class="t">&nbsp;</div></div></div><div class="middleRow l"><div class="r"><div class="content"><dl class="column more firstChild lastChild">
<dd class="firstChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/toc/nejm/medical-journal">This Week</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/toc/nejm/lastweek">Last Week</a></dd>
<dd class="moreLink lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-index">Browse full index</a></dd>
</dl></div></div></div><div class="bottomRow bl"><div class="br"><div class="b">&nbsp;</div></div></div></div></div>


<div style="display: none;" class="corners dropDown dropDown-topics">






<div class="wrap"><div class="topRow tl"><div class="tr"><div class="t">&nbsp;</div></div></div><div class="middleRow l"><div class="r"><div class="content"><dl class="column more firstChild">
    <!-- placeholder id=null, description=N-menu-selectedSpecialties -->
        <dt class="firstChild">Selected Specialties</dt>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fcardiology&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Cardiology</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fendocrinology&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Endocrinology</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fgastroenterology&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Gastroenterology</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fgenetics&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Genetics</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Foncology-hematology&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Hematology/Oncology</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Finfectious-disease&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Infectious Disease</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fnephrology&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Nephrology</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fneurology-neurosurgery&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Neurology/Neurosurgery</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fgynecology-obstetrics&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Obstetrics/Gynecology</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fpediatrics&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Pediatrics</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fclinical-practice-center&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Primary Care/Hospitalist</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fpulmonary&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Pulmonary/Critical Care</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fsurgery&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Surgery</a></dd>
<dd class="moreLink lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fmedical-specialties&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Browse all Specialties &amp; Topics</a></dd>
    
</dl><dl class="column more lastChild">
    <!-- placeholder id=null, description=N-menu-featuredTopics -->
        <dt class="firstChild">Featured Topics</dt>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1366&amp;url=%2Fclinical-practice-center&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Clinical Practice Center</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1366&amp;url=%2Fhealth-policy-and-reform&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Health Policy and Reform</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1366&amp;url=%2Fmedicine-and-society&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Medicine and Society</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1366&amp;url=%2Fpage%2Fglobal-health&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Global Health</a></dd>
<dd class="lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1366&amp;url=%2Fpage%2Finfluenza&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371102&amp;pubId=40005252">Influenza A (H7N9)</a></dd>
    
</dl></div></div></div><div class="bottomRow bl"><div class="br"><div class="b">&nbsp;</div></div></div></div></div>



<div style="display: none;" class="corners dropDown dropDown-authors">

<div class="wrap"><div class="topRow tl"><div class="tr"><div class="t">&nbsp;</div></div></div><div class="middleRow l"><div class="r"><div class="content"><dl class="firstChild lastChild">
<dd class="firstChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/cdfProxy?action=authorCenter">Author Center</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/cdfProxy?action=authorCenter">Submit a Manuscript or Letter</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/cdfProxy?action=authorCenter">Track a Manuscript</a></dd>
<dd class="lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/cdfProxy?action=authorCenter">Help</a></dd>
</dl></div></div></div><div class="bottomRow bl"><div class="br"><div class="b">&nbsp;</div></div></div></div></div>


























<script type="text/javascript">

/* <![CDATA[ */
var google_conversion_id = 1070139620;
var google_conversion_language = "en";
var google_conversion_format = "3";
var google_conversion_color = "666666";
var google_conversion_label = "_s1RCLTo-QEQ5JGk_gM";
var google_conversion_value = 0;
/* ]]> */
</script>
<script type="text/javascript" src="conversion.js">
</script><img src="untitled_002.dat" border="0" height="1" width="1">
<noscript>

<div style="display:inline;">
<img height="1" width="1" style="border-style:none;" alt="" src="http://www.googleadservices.com/pagead/conversion/1070139620/?value=0&amp;label=_s1RCLTo-QEQ5JGk_gM&amp;guid=ON&amp;script=0"/>
</div>
</noscript>







<div id="copyright">
    
    
            <p>Copyright © 2013 <a href="http://www.massmed.org/">Massachusetts Medical Society</a>. All rights reserved.</p>
        
</div>
<!--[if IE]></div><![endif]-->
<script language="javascript" src="searchbox_suggest_v1.js" type="text/javascript"></script>
<script language="javascript" type="text/javascript">

    try {
        __SLI_customisations[ __SLI_ApplicationName ][ 'ShowBrandingFooter' ] = false;
        sli_load();
    }
    catch (ex) {
        // If SLI scripts cannot be loaded, disable search hints
    }
</script>

<input id="showLayers" value="true" type="hidden">


    <!-- placeholder id=null, description=N-Layers_CONFIG -->
    <!-- placeholder id=null, description=N-ad-lauchLayer-1 -->
    <!-- placeholder id=null, description=N-ad-promoLayer-1 -->
    
    
    

    <input id="IsInstitution" value="true" type="hidden">
    <input id="IsSubscriber" value="false" type="hidden">
    <input id="CustomerId" value="" type="hidden">
    <input id="firstAd" value="" type="hidden">
    <input id="secondAd" value="" type="hidden">




<script type="text/javascript">

        jQuery.extend(jQuery.mmsLayers.config, {
        rules: [{
                "name": "Launch Layer Ad",
                "frequency": 30,
                "showOnPage": 5,
                "enabled": false,
                "cookieName": "MarketingLaunchLayer",
                "styleClass": "launchLayer"
        },
        {
                "name": "Promo Layer Ad",
                "frequency": 42,
                "enabled": true,
                "cookieName": "PromoLayer",
                "styleClass": "promoLayer"
        },
        {
                "name": "Iperceptions - Ion Layer Ad",
                "showOnPage": 1,
                 "enabled": true,
               "test": false,
               "cookieName":"Iperceptions"
        }]
     });
    </script>

<script type="text/javascript">

    var _sf_async_config={uid:36099,domain:"nejm.org"};
    (function(){
        function loadChartbeat() {
            window._sf_endpt=(new Date()).getTime();
            var e = document.createElement('script');
            e.setAttribute('language', 'javascript');
            e.setAttribute('type', 'text/javascript');
            e.setAttribute('src',
                    (("https:" == document.location.protocol) ?
                            "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" :
                            "http://static.chartbeat.com/") +
                            "js/chartbeat.js");
            document.body.appendChild(e);
        }
        var oldonload = window.onload;
        window.onload = (typeof window.onload != 'function') ?
                loadChartbeat : function() { oldonload(); loadChartbeat(); };
    })();

</script>

<!-- Load Footer JS via Ad Placeholders -->
<!-- placeholder id=null, description=N-config-js-global-bottom -->





        
<div style="position: absolute; display: none;" id="cluetip-waitimage"></div><div style="display: none; position: absolute;" id="cluetip"><div style="z-index: 1999; opacity: 0.1; top: 1px; left: 1px; position: absolute; background-color: rgb(0, 0, 0);"></div><div style="z-index: 1999; opacity: 0.1; top: 2px; left: 2px; position: absolute; background-color: rgb(0, 0, 0);"></div><div style="z-index: 1999; opacity: 0.1; top: 3px; left: 3px; position: absolute; background-color: rgb(0, 0, 0);"></div><div style="z-index: 1999; opacity: 0.1; top: 4px; left: 4px; position: absolute; background-color: rgb(0, 0, 0);"></div><div style="z-index: 1999; opacity: 0.1; top: 5px; left: 5px; position: absolute; background-color: rgb(0, 0, 0);"></div><div style="z-index: 1999; opacity: 0.1; top: 6px; left: 6px; position: absolute; background-color: rgb(0, 0, 0);"></div><div style="position: relative; z-index: 2000;" id="cluetip-outer"><h3 id="cluetip-title"></h3><div id="cluetip-inner"></div></div><div id="cluetip-extra"></div><div id="cluetip-arrows" class="cluetip-arrows"></div></div><div id="ui-datepicker-div" class="ui-datepicker ui-widget ui-widget-content ui-helper-clearfix ui-corner-all ui-helper-hidden-accessible"></div><script src="chartbeat.js" type="text/javascript" language="javascript"></script></body>
</html>
